This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-000008-3dgjv0x1 | The liver as a site of T- cell apoptosis: graveyard, or killing field? |
| cord-009388-k3exf8a4 | Rodent models in neuroscience research: is it a rat race? |
| cord-000638-ss1435el | Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? |
| cord-001707-piyo00yg | A turning tide among teenagers? |
| cord-006716-n371b91w | Reproductive health policy and HIV: where do women fit in? |
| cord-004335-bw3tziup | The dendritic cell system and its role in immunogenicity Dendritic cells and the control of immunity Visualizing priming of virus- specific CD8+ T cells by infected dendritic cells in vivo Endogenous MHC class II processing of a viral nuclear antigen after autophagy Systemic activation of dendritic cells by Toll- like receptor ligands or malaria infection impairs cross- presentation and antiviral immunity Dendritic cells in viral pathogenesis: Protective or defective? |
| cord-011155-zraqyx78 | Does Economic Strengthening improve viral suppression among adolescents living with HIV? |
| cord-010499-yefxrj30 | : where will it stop? |
| cord-007188-tcq8lnwg | 3J? |
| cord-001385-rb5vwolt | Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain Computational design of peptides that target transmembrane helices Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling Location, location, location: is membrane partitioning everything when it comes to innate immune activation? |
| cord-015958-68dmza13 | Are we ready for pandemic influenza? |
| cord-007237-8y7218oj | I. Data analysis Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system Hedman K. Persistence of human parvovirus B19 in human tissues Prolonged activation of virusspecific CD8+ T cells after acute B19 infection Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis Parvovirus B19 and chronic arthritis- causal or casual association? |
| cord-004395-erqmbi2b | Vaccine design for H5N1 based on B- and T- cell epitope predictions Methods for prediction of peptide binding to MHC molecules: a comparative study Induction of broad cross- subtype- specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques First- in- human randomized controlled trial of mosaic HIV-1 Immunogens delivered via a modified Vaccinia Ankara vector Analysis of the history and spread of HIV-1 in Uganda using phylodynamics Mapping HLA- A2, −A3 and-B7 supertype- restricted T- cell epitopes in the ebolavirus proteome Enhancing in silico protein- based vaccine discovery for eukaryotic pathogens using predicted peptide- MHC binding and peptide conservation scores Discovering a vaccine against neosporosis using computers: is it feasible? |
| cord-016283-b6yywn9f | Worth a try in extensively drug- resistant tuberculosis? |
| cord-008672-luoxomif | How then may these results contribute to the care of HIV- infected patients with chronic diarrhoea in areas with limited diagnostic and microbiological facilities? |
| cord-010699-mfe1oajn | Different HPV Profiles in Oropharyngeal Carcinomas-Why? |
| cord-011064-1d3v87km | Why do some HIV- infected individuals generate neutralizing antibody breadth, while others do not? |
| cord-017227-66dx2dkv | The use of liver grafts from donors with bacterial meningitis Intrathoracic organ transplantation from donors with meningitis: a single- center 20-year experience Donors with positive blood culture: could they transmit infections to the recipients? |
| cord-009446-8keu2uay | Lack of N regions in antigen receptor variable region genes of TdT- deficient lymphocytes Hierarchy and extremes in selections from pools of randomized proteins Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization IMGT, the international ImMunoGeneTics database OLGA: Fast computation of generation probabilities of B- and T- cell receptor amino acid sequences and motifs High- throughput immune repertoire analysis with IGoR Inferring processes underlying B- cell repertoire diversity Genetic measurement of memory B- cell recall using antibody repertoire sequencing How many different clonotypes do immune repertoires contain? |
| cord-010689-d2qn1doq | The question that arises is why does the R- enantiomer have higher inhibitory activity than the S- enantiomer? |
| cord-016690-3gsq724l | CT image demonstrations of HIV- seropositive tuberculosis and their relationship with CD4+ T- lymphocyte count Positron emission tomography of 18FDG uptake in localized pulmonary infl ammation Penicilliosisde Rhizomys sinensis Accumulation of nuclear mitochondrial DNA in the frontal cortex cells of patients with HIVassociated neurocognitive disorders Imaging fi ndings of AIDS complicated with pulmonary rhodococcus equi infection and correlated with pathology Pulmonary toxoplasmosis? |
| cord-004827-bnf3mvaf | ( Samuel Roberts Noble Foundation, Ardmore OK) asked"What determines the quasispecies population size? |
| cord-004827-bnf3mvaf | The question arose: how can one recognize if a calculated fold is real? |
| cord-004501-guiy89x8 | Up to now we have concluded that current antiviral therapy has not yet achieved the ideal shape and efficiency and also that the complex biological barriers are major obstacles, but can we critically say that nanotechnology could be the identified solution? |
| cord-004501-guiy89x8 | Viral pneumonia La Revue de Médecine Interne Viral myocarditis Viral infections in type 1 diabetes mellitus- Why the β cells? |
| cord-001532-kz3b01wq | Autophagy is involved in antiviral activity of pentagalloylglucose( PGG) against Herpes simplex virus type 1 infection in vitro Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes Nelfinavir: a magic bullet to annihilate cancer cells? |
| cord-001532-kz3b01wq | The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma- associated herpesvirus replication in vitro Anti- HIV drugs for cancer therapeutics: back to the future? |
| cord-004247-lagv3tp7 | The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses? |
| cord-004247-lagv3tp7 | Where Are We Standing Now? |
| cord-016313-n4ewq0pt | Neuroprotective effect of combined hypoxia- induced VEGF and bone marrowderived mesenchymal stem cell treatment Complete knockdown of CCR5 by lentiviral vector- expressed siRNAs and protection of transgenic macrophages against HIV-1 infection Speci fi c transduction of HIV- susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization Stem cells and reprogramming: breaking the epigenetic barrier? |
| cord-016313-n4ewq0pt | TGF{beta}/ TNF{alpha}-mediated epithelial- mesenchymal transition generates breast cancer stem cells with a claudin- low phenotype Genetically engineered mesenchymal stem cells: applications in spine therapy Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and bone Notch signaling as gatekeeper of rat acinar- to- beta- cell conversion in vitro Transplantation of human bone marrow- derived mesenchymal stem cells promotes Will there be a live- attenuated HIV vaccine available for human safety trials by the year 2000? |
| cord-002746-qn34eyul | The A- rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA Various regulatory sequences are deprived of their uniqueness by the universal rule of TA/ CG deficiency and TG/ CT excess Selection against CpG dinucleotides in lentiviral genes: a possible role of methylation in regulation of viral expression Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? |
| cord-002746-qn34eyul | distinct biological states Circularization of the HIV-1 RNA genome RNA interactions in the 5′ region of the HIV-1 genome Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription Nucleotide composition as a driving force in the evolution of retroviruses What can AIDS virus codon usage tell us? |
| cord-021382-10omkpwl | The Biological Basis Point- of- care rapid tests for HIV antibodies Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? |
| cord-003715-deqiets2 | : What Makes a Killer? |
| cord-003715-deqiets2 | Given that nearly all HIV-1 in the human bloodstream seems to be selected to bind CD4 weakly, why would this be preferable? |
| cord-018545-fk17n2bx | what treatments are effective for the management of shock in severe dengue? |
| cord-018785-tcr5xlf8 | Should we treat asymptomatic bacteriuria after renal transplantation? |
| cord-015376-z739ifu5 | Identification of critical determinants on ACE2 for SARS- CoV entry and development of a potent entry inhibitor Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry Human Coronavirus hCoV-229E enters susceptible cells via the endocytic pathway Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-015376-z739ifu5 | This bioinformatic analysis of drug/ enzyme docking provides interesting insights on the use of HIV-1 protease inhibitors as lead compounds for development of 3Clpro inhibitors Old drugs as lead compounds for a new disease? |
| cord-018864-c1r2n17o | 36 S. Pöhlmann and M.J. Tremblay Can a significant contribution of DC- SIGN to DC interactions with HIV-1, and thus to sexual transmission of HIV-1, be disregarded in the light of these results? |
| cord-015372-76xvzvdg | Can any of the cognitive assessments help to predict behavioural dysfunction.'? |
| cord-015372-76xvzvdg | This is the first Irish Report of PSP and a most remarkable use of saxitoxin(?) |
| cord-021872-rhi7hi9m | A review of the last 20 years Susceptibility of feline immunodeficiency virus/ human immunodeficiency virus type 1 reverse transcriptase chimeras to non- nucleoside RT inhibitors Clinical aspects of feline immunodeficiency and feline leukemia virus infection Is AZT/3TC therapy effective against FIV infection or immunopathogenesis? |
| cord-010845-pakh49dy | The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries Cardiac surgery capacity in sub- Saharan Africa: quo vadis? |
| cord-010845-pakh49dy | What Is New? |
| cord-013336-42thiglv | A comparison of respondent- driven and venue- based sampling of female sex workers in Liuzhou Sampling studies to estimate the HIV prevalence rate in female commercial sex workers HIV testing in a high- incidence population: is antibody testing alone good enough? |
| cord-013336-42thiglv | Learn more biomedcentral.com/submissions Ready to submit your research Ready to submit your research? |
| cord-000868-vnwpzsu8 | ( DOC) GB virus C transmission by blood products Prevalence of GB virus type C/ hepatitis G virus RNA and of anti- E2 in individuals at high or low risk for blood- borne or sexually transmitted viruses: evidence of sexual and parenteral transmission GB virus type C interactions with HIV: the role of envelope glycoproteins The GB viruses: a review and proposed classification of GBV- A, GBV- C( HGV), and GBV- D in genus Pegivirus within the family Flaviviridae G- pers creepers, where'd you get those papers? |
| cord-000868-vnwpzsu8 | A reassessment of the literature on the hepatitis G virus GB virus type C/ Hepatitis G virus Sequence and genomic organization of GBV- C: a novel member of the flaviviridae associated with human non- A- E hepatitis Molecular cloning and disease association of hepatitis G virus: a transfusiontransmissible agent Isolation of novel virus- like sequences associated with human hepatitis Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins Humoral immune response to the E2 protein of hepatitis G virus is associated with longterm recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors Age- dependent acquisition of hepatitis G virus/ GB virus C in a nonrisk population: detection of the virus by antibodies GB virus C/ hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus- infected patients? |
| cord-000868-vnwpzsu8 | However, it is tempting to speculate whether in vivo the intact E2 ectodomain is able to reach the gp41 disulfide loop in a peptide- like manner? |
| cord-017506-t86v3zw3 | How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? |
| cord-017506-t86v3zw3 | In fl uence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition? |
| cord-022521-r72jtoso | : What is the current treatment and what are the challenges? |
| cord-012503-8rv2xof7 | : a baseline analysis Are negative affective states associated with HIV sexual risk behaviors? |
| cord-012503-8rv2xof7 | The control of confounding by intermediate variables Measuring depression over time or not? |
| cord-003764-141u6ax7 | How Far From Clinical Use? |
| cord-003764-141u6ax7 | The structural basis for membrane binding and pore formation by lymphocyte perforin DNA vaccines and apoptosis: to kill or not to kill? |
| cord-003764-141u6ax7 | What if? |
| cord-006260-ux32zanj | How should this influence prescribing? |
| cord-006260-ux32zanj | Influence Prescribing? date: 2012- 09- 17 journal: |
| cord-006260-ux32zanj | [ 27] Do n't keep taking the tablets? |
| cord-018070-js9vvsud | : Are there any sex workers in China? |
| cord-018070-js9vvsud | Why develop and support women's organizations in providing legal aid in China? |
| cord-002757-upwe0cpj | : can we retain the clinical use of mold- active antifungal azoles? |
| cord-002757-upwe0cpj | Contribution of Working Groups I, II and III to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change Impact of climate change in the epidemiology of vector- borne diseases in domestic carnivores Impact of climate change on human infectious diseases: empirical evidence and human adaptation Climate change and health: global to local influences on disease risk Climate change and mosquito- borne disease Climate of origin affects tick( Ixodes ricinus) host- seeking behavior in response to temperature: implications for resilience to climate change? |
| cord-002757-upwe0cpj | The burden of co- infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub- saharan Africa Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? |
| cord-010310-jqh75340 | A weekly Australian community online survey of influenza- like illness in Flutracking weekly online community survey of influenza- like illness annual report Mobility assessment of a rural population in the Netherlands using GPS measurements Generating GPS activity spaces that shed light upon the mobility habits of older adults: A descriptive analysis What can global positioning systems tell us about the contribution of different types of urban greenspace to children's physical activity? |
| cord-010310-jqh75340 | Inferencing human spatiotemporal mobility in greater Maputo via mobile phone big data mining GPS tracking in neighborhood and health studies: A step forward for environmental exposure assessment, a step backward for causal inference? |
| cord-010310-jqh75340 | What types of contacts are important for the spread of infections? |
| cord-034036-1wigu3i3 | : what's new? |
| cord-013481-3zwq67do | Could IFNβ have distinct biological effects that are likely not due to other IFN- Is? |
| cord-013481-3zwq67do | Which ISGs are responsible for the discordant effects of IFN- Is at distinct phases of infection with persistent viruses? |
| cord-013481-3zwq67do | e.g., IFNα2 for HIV-1 infection) achieve the same in vivo effect as that of more potent IFN- Is( e.g., IFNα14)? |
| cord-004986-en7taikk | Approximativement 30? |
| cord-004986-en7taikk | et certains auteurs sceptiques sugg6rent que ces diarrh6es seraient dues? |
| cord-004986-en7taikk | inf6rieur? |
| cord-034714-6e37yylk | Front Immunol 8:577 Low signal intensity in U- fiber identified by susceptibility- weighted imaging in two cases of progressive multifocal leukoencephalopathy Natalizumabassociated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases Inflammatory natalizumab- associated PML: baseline characteristics, lesion evolution and relation with PML- IRIS MRI pattern in asymptomatic natalizumab- associated PML PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab- associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML- IRIS manifestation? |
| cord-027859-citynr6c | : what determines the epidemic in developing societies? |
| cord-026112-58sa5z03 | Antiretroviral drug resistance mutations in naïve Islamic Republic of Iran AIDS Progress Report HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment- naive, sexually infected individuals Epidemiological distribution and genotype characterization of the hepatitis C virus among HIV patients in Kashan High prevalence of HCV coinfection in HIV- infected individuals in Shiraz, Islamic Republic of Iran Sexually transmitted hepatitis C infection: the new epidemic in MSM? |
| cord-017439-0c6ohmmg | Relative mean squared error and cost considerations in choosing group size for group testing to estimate infection rates and probabilities of disease transmission Reducing the cost of HIV antibody testing Experimenal design and sample size determination for testing synergism in drug combination studies based on uniform measures Estimating ordered binomial proportions with the use of group testing More powerful likelihood ratio tests for isotonic binomial proportions Estimation of the proportion of vectors in a natural population of insects Screening tests: Can we get more by doing less? |
| cord-017439-0c6ohmmg | So, are cost considerations no longer important for drug discovery? |
| cord-017439-0c6ohmmg | Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost efficiency models What is synergy? |
| cord-017675-in9r33ww | Do human rights matter to health? |
| cord-017675-in9r33ww | HIV Risk Behavior? |
| cord-017675-in9r33ww | How much revenue will a pharmaceutical company generate in each of the following scenarios? |
| cord-013442-kjfk7hq6 | Am Factfinder HIV care outcomes among Hispanics or Latinos with diagnosed HIV infection- United States Understanding the association between socioeconomic status and physical health: do negative emotions play a role? |
| cord-013442-kjfk7hq6 | Can cultural competency reduce racial and ethnic health disparities? |
| cord-013442-kjfk7hq6 | In: The Health of Sexual Minorities Stigma, discrimination and the health of illicit drug users Driving while brown: A proposal for ending racial profiling in emerging Latino communities Locus of control and anti- immigrant sentiment in Canada, the United States, and the United Kingdom Immigration policies and social determinants of health: Is immigrants'health at risk? |
| cord-018040-k0h5ejjt | Statements like"What message are we sending to our elementary students when we inoculate them for a sexually transmitted disease in the third grade?" |
| cord-018040-k0h5ejjt | What may be the mechanism of higher immunogenicity exhibited by particulate antigens compared to soluble ones and does the size of these particles matter? |
| cord-018040-k0h5ejjt | Who's afraid of Gardasil? |
| cord-016704-99v4brjf | A changing scene? |
| cord-016704-99v4brjf | Human normal immunoglobulin( HNIG), 500 mg, deep intramuscular in gluteal muscle should be used in the following circumstances: • Has the detainee traveled to Africa, South East Asia, the Indian subcontinent, Central/ South America, or the Far East in the last 6- 12 months? |
| cord-016704-99v4brjf | The White Plague: down and out, or up and coming? |
| cord-023854-w8kx5n8k | Diagnose einer RSV- Infektion basiert auf der klinischen Symptomatik, auf dem zeitlichen Hintergrund( Winterhalbjahr? |
| cord-023854-w8kx5n8k | bekannte RSV- Epidemie?) |
| cord-025172-qg3jxgch | Does HIV influence outcomes after trauma? |
| cord-025172-qg3jxgch | Estimated HIV incidence and prevalence in the United States World Health Organization( WHO) Assessing the impact of HIV status on injury outcomes: a multicenter study of trauma patients in Rwanda Human immunodeficiency virus infection in trauma patients: where do we stand? |
| cord-032438-cpoalxyd | Emerging perspectives in implementation research can help position researchers to offer findings that are maximally interpretable in other implementing contexts that differ by geographical( urban vs rural), economic( Kenya vs Mozambique), and social factors- what do these perspectives suggest for future research that aims to influence execution of the HIV response? |
| cord-255697-trig04hd | How long do nosocomial pathogens persist on inanimate surfaces? |
| cord-029450-4rnrq78l | An evolutionary conserved fuel for inflammaging The immunology of COVID-19: is immune modulation an option for treatment? |
| cord-029450-4rnrq78l | Why is hyperglycaemia worsening COVID-19 and its prognosis? |
| cord-017070-05vlz5dn | Neutralizing antibodies in patients with severe acute respiratory syndrome- associated coronavirus infection Antibody responses against SARS- coronavirus and its nucleocaspid in SARS patients Development of a safe neutralization assay for SARS- CoV and characterization of S- glycoprotein SARS corona virus peptides recognized by antibodies in the sera of convalescent cases S protein of severe acute respiratory syndrome- associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys Treating severe acute respiratory syndrome with hyperimmune globulins SARS: what have we learned? |
| cord-017070-05vlz5dn | The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus Nipah viral encephalitis or Japanese encephalitis? |
| cord-017070-05vlz5dn | The prospects for vaccines against HIV-1: more than a field of long- term nonprogression? |
| cord-017070-05vlz5dn | and the hMAb combination 4E10/2F5/2G12 Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design Identifying epitopes of HIV-1 that induce protective antibodies Antibodies: can they protect against HIV infection? |
| cord-048351-4y8ghcpq | Leuk Lymphoma Guillain- Barre syndrome associated with immune reconstitution Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis Varicella zoster as a manifestation of immune restoration disease in HIV- infected children Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma Immune reconstitution inflammatory syndrome in HIV- infected patients with disseminated histoplasmosis Hepatitis C virus- associated hepatitis following treatment of HIV- infected patients with HIV protease inhibitors: an immune restoration disease? |
| cord-048351-4y8ghcpq | Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease? |
| cord-017782-dtveihrj | How can we resolve the issue of two HIV serology tests taken at separate times in the same subject being false positive? |
| cord-017782-dtveihrj | What is the effect of life expectancy with late treatment initiation for HIV disease? |
| cord-017782-dtveihrj | What lessons can we learn from these cases? |
| cord-017782-dtveihrj | Would an earlier diagnosis by 1 year and assuming institution of ART then, affected the outcome as to lifespan and quality of life? |
| cord-017600-4e7mw041 | Do patients with cerebral malaria have cerebral edema? |
| cord-017600-4e7mw041 | Is cryptococcal meningoencephalitis in the tropics a distinct entity? |
| cord-017600-4e7mw041 | Is methyl prednisolone useful in acute transverse myelitis? |
| cord-017600-4e7mw041 | Strongyloides stercoralis hyperinfection syndrome; how often is it missed? |
| cord-022141-yxttl3gh | At this point, we must ask,"What is the carrying capacity of the earth?" |
| cord-022141-yxttl3gh | Can countries that are poisoning their environments do a turn around to save their citizens from grief? |
| cord-022141-yxttl3gh | Have we reached it at 7 billion given the billions who are today under served in developing and less developed countries? |
| cord-259748-x7dq1sy4 | interferon response reduces microglial reactivity and neuroinflammation Modulation of the immune system by UV radiation: more than just the effects of vitamin D? |
| cord-255690-xc4bxin4 | chloroquine based ARV regimen combined with hydroxyurea and lamivudine: a new economical triple therapy Therapeutic potential of chloroquine added to zidovudine plus didanosine for HIV-1 infected children Mother- tochild transmission of HIV-1: timing and implications for prevention Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-005882-iodfgzjf | ( World Health Organization Is the development of a new tuberculosis vaccine possible? |
| cord-005882-iodfgzjf | A Modeling Study A waxy tale by Mycobacterium tuberculosis Intracelluar models of Mycobacterium tuberculosis infection Mycobacterium tuberculosis: the indigestible microbe CD8 T cells in tuberculosis CD1 and tuberculosis gamma/ delta and other unconventional T lymphocytes: What do they see and what do they do? |
| cord-005882-iodfgzjf | Could AIDS and tuberculosis vaccines be given together? |
| cord-005882-iodfgzjf | Die Schutzimpfung gegen Tuberkulose mit"BCG Immune control of HIV-1 after early treatment of acute infection Guidelines for using antiretroviral agents among HIV- infected adults and adolescents Can Population Differences Explain the Contrasting Results of the Mwanza, Rakai, and Masaka HIV/ Sexually Transmitted Disease Intervention Trials?: |
| cord-005882-iodfgzjf | How can immunology contribute to the control of tuberculosis? |
| cord-021668-33zfio0u | ■ Did the person attend parties where large amounts or alcohol and/or drugs were consumed( e.g.,"spring break"in the USA)? |
| cord-021668-33zfio0u | ■ Did the person travel to countries where sex workers are readily available? |
| cord-021668-33zfio0u | ■ If the traveler is strongly suspected of having an STD, did he/ she visit a destination where chancroid, granuloma inguinale( GI), or lymphogranuloma venereum( LGV)( L serovars of Chlamydia trachomatis) is prevalent? |
| cord-021668-33zfio0u | ■ Was the person traveling without his/ her spouse/ family and therefore outside his/ her usual social structure? |
| cord-262143-s01jrtbb | Biomedical research; what gets funded where? |
| cord-254190-bxfne94u | the complex pathobiology of HIV- associated neurocognitive disorders? |
| cord-254190-bxfne94u | vaccines Humanized mice: are we there yet? |
| cord-253997-imwjoecx | where are we and where are we going? |
| cord-261287-l4649du3 | a randomised controlled trial of pegylatedinterferona-2b plus ribavirin vs interferona-2b plus ribavirin as primary treatment of chronic hepatitis C in HIV co- infected patients Is an'À la Carte'combination Interferon Alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? |
| cord-029416-738t6rk1 | How do private general practitioners manage tuberculosis cases? |
| cord-029416-738t6rk1 | Rather than aiming to capture this type of population structure, we asked the question:'What are the population- level implications of reducing TB incidence amongst a defined cohort( of household contacts) in the population?'. |
| cord-029416-738t6rk1 | Treatment Short- Course strategy in Indonesia: a cross- sectional study Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? |
| cord-260496-s2ba7uy3 | Such genomic divergences both maintain viral specificity and allow the emergence of new families raising the question: are these divergences selected by the specificity or are they specificityselectors while maintaining the viral integrity? |
| cord-104491-uu2rbtem | We posed an audacious question: Should n't HIV testing be a mandatory part of obstetric care? |
| cord-104491-uu2rbtem | Where Have All the “ AIDS Babies ” Gone? |
| cord-030368-6z99rm0a | Country- wide HIV incidence study complementing HIV surveillance in Germany Two drugs or three? |
| cord-030368-6z99rm0a | Wie hoch ist das Infektionsrisiko für den Chirurgen? |
| cord-030368-6z99rm0a | gelöstes Problem oder versteckte Gefahr? |
| cord-103662-a4ok5wqc | Are Associated with a Decreased Risk of Progression to AIDS- Related Complex or AIDS Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control Preferential CTL targeting of Gag is associated with relative viral control in long- term surviving HIV-1 infected former plasma donors from China Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 Cell- mediated anti- Gag immunity in pharmacologically induced functional cure of simian AIDS: a'bottleneck effect'? |
| cord-103662-a4ok5wqc | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
| cord-260191-0u0pu0br | an die Surveillance neu auftretender Infektionskrankheiten gerecht? |
| cord-262076-b5u5hp2r | confer HIV-1 resistance Human immunodeficiency virus type 1 escapes from RNA interference- mediated inhibition Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters Human immunodeficiency virus type 1 escape from RNA interference HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome RNA interference as an antiviral approach: targeting HIV-1 Silencing of HIV-1 with RNA interference: a multiple shRNA approach Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment Can hammerhead ribozymes be efficient tools to inactivate gene function? |
| cord-016075-ind62t53 | A prospective study Differential patterns of mental disorders among the homeless in Madrid( Spain) and Los Angeles( USA) Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population Are rates of psychiatric disorders in the homeless population changing? |
| cord-016075-ind62t53 | Do the homeless get a fair deal from general practitioners? |
| cord-016075-ind62t53 | Does homelessness have a sizeable effect on population health? |
| cord-016075-ind62t53 | The Megacity Saga: Democracy and Citizenship in This Global Age Seceding from Responsibility? |
| cord-016075-ind62t53 | The housing/ health relationship: what do we know? |
| cord-011855-0vetk6jd | In particular, we consider what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension when alternative affordable and accessible supplies are unavailable? |
| cord-011855-0vetk6jd | Is there an obligation to provide medicines to non- trial participants? |
| cord-011855-0vetk6jd | Should the health facilities be encouraged to procure a greater supply of medicines to facilitate the research? |
| cord-011855-0vetk6jd | Should the research be conducted in realworld conditions where medicines supply for hypertension and diabetes is patchy? |
| cord-011855-0vetk6jd | Should the research programme purchase the medicines for participants to enable the research to run smoothly? |
| cord-025628-9611eglg | : what are the needs for diagnosis, treatment and control? |
| cord-025628-9611eglg | Leishmaniasis vaccine: where are we today? |
| cord-025628-9611eglg | Macrophage polarization in bacterial infections Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms Interleukin 10 secretion in relation to human IL-10 locus haplotypes Microsatellite alleles and single nucleotide polymorphisms( SNP) combine to form four major haplotype families at the human interleukin-10( IL-10) locus Interleukin-10 and the interleukin-10 receptor Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century How effective are the 6 European Society of Immunodeficiency warning signs for primary immunodeficiency disease? |
| cord-261830-5o5epn6v | What makes them different? |
| cord-004575-b0t6bsya | Erwächst HIV- positiven Menschen eine andere oder besondere moralische Verantwortung? |
| cord-004575-b0t6bsya | HIV- positiv: Fertig mit Sex? |
| cord-004575-b0t6bsya | Is there a special responsibility of HIV- positive people? |
| cord-004575-b0t6bsya | ein Leben mit dem bis auf weiteres unausrottbaren Virus einstellen können?" |
| cord-004575-b0t6bsya | key: cord-004575-b0t6bsya authors: Staub, Roger title: Haben HIV- Positive eine besondere Verantwortung?: |
| cord-004575-b0t6bsya | und wie legen wir diese still? |
| cord-254194-962vynwk | A hazardous threat to the environment and human health? |
| cord-254194-962vynwk | Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? |
| cord-018646-fqy82sm6 | ( or Ebola Reemergent?). |
| cord-018646-fqy82sm6 | Ebola Déjà vu? |
| cord-018646-fqy82sm6 | Plagues& wars: the'Spanish flu'pandemic as a lesson from history Pandemic versus epidemic influenza mortality: a pattern of changing age distribution Contagion and chaos Expressionist portraits Is the 1918 influenza pandemic over? |
| cord-018646-fqy82sm6 | The origin of quarantine Lessons from the history of quarantine, from plague to influenza A. Emerging Infectious Diseases CDC: Remembering the 1918 influenza pandemic Molecular virology: was the 1918 flu avian in origin? |
| cord-018646-fqy82sm6 | Was SARS a mental health catastrophe? |
| cord-263157-8jin6oru | However, an important question arose from these pioneer studies: is the virion- associated incoming genomic viral RNA targeted by RNAi? |
| cord-021990-a8ku5rke | Did the person attend parties where large amounts of alcohol and/ or drugs were consumed( e.g.,"spring break"in the USA)? |
| cord-021990-a8ku5rke | Did the person travel to countries where sex workers are readily available? |
| cord-021990-a8ku5rke | If the traveler is strongly suspected of having an STD, did he/ she visit a destination where chancroid, granuloma inguinale( GI), or lymphogranuloma venereum( LGV)( L serovars of Chlamydia trachomatis) is prevalent? |
| cord-021990-a8ku5rke | Was the person traveling without his/ her spouse/ family and therefore outside his/ her usual social structure? |
| cord-032504-tmohg1mj | How soon after infection with HIV does the risk of tuberculosis start to increase? |
| cord-032504-tmohg1mj | Immunity to tuberculosis Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection Early Changes by( 18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques Digitally barcoding Mycobacterium tuberculosis reveals in vivo infection dynamics in the macaque model of tuberculosis Protective immunity against tuberculosis: what does it look like and how do we find it? |
| cord-032504-tmohg1mj | The macrophage in HIV-1 infection: from activation to deactivation? |
| cord-263645-wupre5uj | What is functional and what is junk? |
| cord-000130-dqqcajjd | Can we do better, quicker? |
| cord-000130-dqqcajjd | Can we optimally spend our way out of the HIV/ AIDS epidemic? |
| cord-000130-dqqcajjd | Can we spend our way out of the AIDS epidemic? |
| cord-000130-dqqcajjd | Can we then seize the moment and halt this epidemic now? |
| cord-000130-dqqcajjd | Can we work together to build a World Halting AIDS Model( WHAM) that would permit us to estimate the quickest way to halt HIV/ AIDS, monitor our success, and adjust our strategy as we go? |
| cord-000130-dqqcajjd | authors: Smith?, Robert J; Gordon, |
| cord-251939-dvbua4pf | Coverage of Selected Services for HIV/ AIDS Prevention, Care and Support in Low and Middle- income Countries in Interventions to reduce HIV/ AIDs stigma: what have we learned? |
| cord-251939-dvbua4pf | So, why are the responses to the prospective'storm'low, slow, and fragmented? |
| cord-251939-dvbua4pf | Why is there little appre- ciation among the leaders that the disease might take a heavy toll if left unchecked? |
| cord-255075-6azu6k3h | A one- size- fits- all flu vaccine? |
| cord-255075-6azu6k3h | What's the point? |
| cord-264050-6zpw6itb | What is a host? |
| cord-257553-479x7av6 | 95 Cluster of cases of severe acute respiratory syndrome among Toronto healthcare workers after implementation of infection control precautions: a case series Which preventive measures might protect health care workers from SARS? |
| cord-257553-479x7av6 | Early treatment improves outcomes in acute hepatitis C virus infection: a meta- analysis Two drugs or three? |
| cord-104162-fe51v2pt | Does the comparative method rule? |
| cord-104162-fe51v2pt | Is conservation necessarily a good indicator of likely therapeutic success? |
| cord-104162-fe51v2pt | The heart of the HIV RNA packaging signal? |
| cord-260422-z22t57ju | a cysteine- rich peptide mimics the normal metal- linked dimer interface Fuzzy complexes: a more stochastic view of protein function HIV-1 Tat, apoptosis and the mitochondria: a tubulin link? |
| cord-017887-pj6pal35 | Does the NMR structure, solved in the absence of Ca 2+ and inhibitors, represent the open or closed state of the channel( if the two states exist)? |
| cord-017887-pj6pal35 | How strong is the Ca 2+ selectivity of p7? |
| cord-017887-pj6pal35 | In the cases of the flu HA and HIV gp41, for example, new experiments need to be designed to address questions such as,"Does the TMD interact with the fusion domain in the hemifusion stage in which the two domains are presumably in close proximity?" |
| cord-017887-pj6pal35 | Or was p7 developed as a general, unspecific cation channel for the purpose of dissipating membrane potential? |
| cord-017887-pj6pal35 | and"Does the TMD play a role in facilitating the conversion from the hemifusion to the pore formation? |
| cord-260476-whfyczcj | The ESCRT-0 component HRS is required for HIV-1 Vpu- mediated BST-2/ tetherin down- regulation Guanylate binding protein( GBP) 5 is an interferon- inducible inhibitor of HIV-1 infectivity Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses Regulation of virus release by the macrophage- tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: A Vpu- like factor? |
| cord-263965-i8yutik6 | Why wo n't the WHO call the coronavirus by its name, SARS- CoV-2? |
| cord-001079-v01vwu00 | , TDF? |
| cord-001079-v01vwu00 | : what's new? |
| cord-001079-v01vwu00 | Grupo de Estudio del SIDA 04/98 Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus- infected patients: a randomized trial by the CIOP Study Group Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4? |
| cord-001079-v01vwu00 | In a small study in Thailand, a higher dose of fluconazole( 800 mg/ day) combined with AmB- D( 0.7 mg/ kg/ day) was more effective than monotherapy with AmB- D alone or a regimen of AmB- D? fluconazole( 400 mg/ day). |
| cord-001079-v01vwu00 | Other combination therapies( e.g. fluconazole? |
| cord-001079-v01vwu00 | is prophylaxis still indicated? |
| cord-001079-v01vwu00 | results of an open, randomized, multicenter clinical trial Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon- gamma production in the presence of Toxoplasma gondii antigens Restoration of Toxoplasma gondii- specific immune responses in patients with AIDS starting HAART Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel Restoration of cytomegalovirusspecific CD4? |
| cord-264986-glm2qcuz | A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web- based cross- sectional survey Psychological status of surgical staff during the COVID-19 outbreak Vicarious traumatization in the general public, members, and non- members of medical teams aiding in COVID-19 control COVID-19, telemedicine, and patient empowerment in HIV care and research Challenges to HIV care and psychological health during the COVID-19 pandemic among people living with HIV in China Provider burnout and fatigue during the COVID-19 pandemic: lessons learned from a high- volume intensive care unit Ecological models of human development Still misused after all these years? |
| cord-252433-0e9lonq4 | But how do viruses use noncoding RNAs to promote their replication? |
| cord-252433-0e9lonq4 | So which factors are required for the export of cellular mRNAs? |
| cord-252433-0e9lonq4 | So, why is this uncapped viral mRNA translated more efficiently than capped cellular mRNAs? |
| cord-252433-0e9lonq4 | mRNAs reach the cytoplasm? |
| cord-017012-yl0vanuh | Acute glomerulonephritis associated with varicella infection Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis Nephrotic syndrome associated with varicella infection Epstein- Barr virus- associated acute interstitial nephritis: infection or immunologic phenomenon? |
| cord-017012-yl0vanuh | Different pathohistological presentations of acute renal involvement in Hantaan virus infection: report of two cases Clinical characteristics of haemorrhagic fever with renal syndrome in children Prospects for treatment of viral haemorrhagic fever with ribavirin, a broad spectrum antiviral drug Lassa fever: effective therapy with ribavirin Human infection with highly pathogenic H5N1 influenza virus Renal insufficiency on presentation of bird flu infection: is it correlated to outcome? |
| cord-017012-yl0vanuh | Does antimicrobial therapy of streptococcal pharyngitis or pyoderma alter the risk of glomerulonephritis? |
| cord-017012-yl0vanuh | Impact of antibiotics on expression of virulence? |
| cord-017012-yl0vanuh | Philadelphia Schistosomal specific nephropathy leading to end- stage renal failure Is glomerulopathy due to schistosomiasis mansoni disappearing? |
| cord-017012-yl0vanuh | the balance right Comparison of three fluid solutions for resuscitation in dengue shock syndrome Epidemiology and clinical features of Crimean- Congo haemorrhagic fever in Southern Africa Viral hemorrhagic fever- induced acute kidney injury Hantavirus: an increasing problem? |
| cord-104490-t42eccng | A natural follow- up question would be; how have these educational commitments and interventions affected health outcomes so far? |
| cord-104490-t42eccng | Consequently, we ask: how exactly have global education efforts to improve health performed so far? |
| cord-104490-t42eccng | What was the effect of the West African Ebola outbreak on health programme performance, and did programmes recover? |
| cord-104490-t42eccng | Why then are educational efforts still failing to address the health challenges of young girls and women, as we have observed in the HIV/ AIDS epidemic and, most recently, the EVD crisis[ 12]? |
| cord-033558-lcgo1tiy | Frühzeitig Kontakt mit tropenmed BB: auf Eosinophilie achten( Helminthiasis?) |
| cord-033558-lcgo1tiy | Meldung wann und wohin? |
| cord-033558-lcgo1tiy | Senioren?) |
| cord-033558-lcgo1tiy | i m Erw.-Alter u. bei Kindern? |
| cord-033558-lcgo1tiy | • Reiseart, Reisedauer, Zielland, Zahl u. Alter der Mitreisenden( Kinder? |
| cord-271241-w1q46y63 | Can We Contain the COVID-19 Outbreak With the Same Measures as for SARS? |
| cord-000065-6c3zb3g4 | Among 1,000 health workers, how many want to provide care and treatment for HIV- infected patients? |
| cord-000065-6c3zb3g4 | HMU Managing AIDS stigma Critical delays in HIV testing and care: the potential role of stigma Interventions to Reduce HIV/ AIDS Stigma: What Have We Learned? |
| cord-000065-6c3zb3g4 | How can we have a good attitude toward them?" |
| cord-000065-6c3zb3g4 | If they will be trained, who will train them?" |
| cord-000065-6c3zb3g4 | Support groups? |
| cord-000065-6c3zb3g4 | There is no benefit to save the life of patients in the late period, so how could we be enthusiastic?" |
| cord-000065-6c3zb3g4 | Why do n't we provide PMTCT and paediatric treatment at the same facility? |
| cord-004600-5lhnzzvg | -vereinbar? |
| cord-004600-5lhnzzvg | 2, Abs. 1 GG[ 11]? |
| cord-004600-5lhnzzvg | An epidemic like any other? |
| cord-004600-5lhnzzvg | HIV- Infektion betroffenen Menschen? |
| cord-004600-5lhnzzvg | National HIV Prevention Conference Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA Routine testing: are we ready to throw human rights out of HIV testing policy? |
| cord-004600-5lhnzzvg | an-trotz der Präventionsarbeit? |
| cord-004600-5lhnzzvg | gesundheitlichen Folgen in derzeitiger Auslegung akzeptabel? |
| cord-271188-ewlxy5po | Does venesection reduce HIV viral load in patients with hereditary haemochromatosis? |
| cord-257272-4q52p1pd | 61, 629- 632 personal subscription to trends in CELL BIOLOGY? |
| cord-257272-4q52p1pd | Env? |
| cord-257272-4q52p1pd | How can virus bud into endocytlc organelles? |
| cord-276870-gxtvlji7 | Covid-19-a once- in- a- century pandemic? |
| cord-008530-yni0poh9 | : what chemokine is that? |
| cord-008530-yni0poh9 | A novel CXC chemokine PBSF/ SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection Induction of IP-10 chemokine promoter by measles virus: comparison with interferon- gamma shows the use of the same response element but with differential DNA- protein binding profiles Molecular cloning, functional expression, and signaling characteristics of a C- C chemokine receptor Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? |
| cord-008530-yni0poh9 | Do chemokines mediate leukocyte recruitment in post- traumatic CNS inflammation? |
| cord-008530-yni0poh9 | How does CNS chemokine expression contribute to the pathogenesis of neuroinflammatory disease states? |
| cord-008530-yni0poh9 | Inflammatory cytokines in the brain: does the CNS shape immune responses? |
| cord-008530-yni0poh9 | Modulating chemokines: more lessons from viruses Neuroinvasion of simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/ microglia and intrathecal immune activation Dynamic regulation of a- and~-chemokine expression in the central nervous system during mouse hepatitis virus- induced demyelinating disease Murine coronavirus infection: a paradigm for virus- induced demyelinating disease A central role for CD4+ T- cells and RANTES in virus- induced central nervous system inflammation and demyelination Chemokine receptors in the human brain and their relationship to HIV infection CXCR-4( Fusin), a co- receptor for the type 1 human immunodeficiency virus( HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1 A novel chemokine receptor- like protein, functions as a fusion cofactor for both macrophage- tropic and T cell line- tropic HIV-1 Chemokine receptors: keys to AIDS pathogenesis? |
| cord-008530-yni0poh9 | Tropical spastic paraparesis: a model of virus- induced, cytotexic T- cell- mediated demyelination? |
| cord-275859-ix8du1er | If the local stability of 3- 4 bp is sufficient to determine frameshift efficiency, why does the HIV-1 frameshift site stem- loop contain 11 Watson- Crick base pairs? |
| cord-027860-s97hdhh6 | ( Do I have cold sores? |
| cord-027860-s97hdhh6 | Do I have genital herpes? |
| cord-027860-s97hdhh6 | How should this change the way I live my life?). |
| cord-027860-s97hdhh6 | The lesions are most Who to Screen? |
| cord-027860-s97hdhh6 | The question,"Do you regularly use condoms?"has little relevance to infection control for many sexual practices. |
| cord-268901-7cm6m1ol | How flexible are fleximer nucleobases? |
| cord-264699-l8db5gll | Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy Metabolic complications associated with antiretroviral therapy Metabolic disorders among HIV- infected patients treated with protease inhibitors: a review HIV- associated lipodystrophy syndrome Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS- related insulin resistance/ lipodystrophy syndrome? |
| cord-264699-l8db5gll | The hypothalamic- pituitary- adrenal axis and immune- mediated inflammation Effectiveness of prolonged glucocorticoid treatment in acute respiratory distress syndrome: the right drug, the right way? |
| cord-018721-othar2uv | : what are the causal factors and can it be avoided? |
| cord-018721-othar2uv | Infektionen transverse myelitis Is methyl prednisolone useful in acute transverse myelitis? |
| cord-018721-othar2uv | New understandings on the pathophysiology of bacterial meningitis Innate immunity to pneumococcal infection of the central nervous system depends on toll- like receptor( TLR) 2 and TLR4 Protein expression pattern in experimental pneumococcal meningitis Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? |
| cord-018721-othar2uv | The long- term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors Viral encephalitis: familiar infections and emerging pathogens Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fl uid of patients with herpes simplex virus encephalitis Poliomyelitis- like syndrome associated with Epstein- Barr virus infection Nipah virus Infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis Harrison's Neurology in Clinical Medicine Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? |
| cord-018721-othar2uv | The spectrum of neuromyelitis optica Myelopathy but normal MRI: where next? |
| cord-018721-othar2uv | parasite entry and eff ects on sleep and synaptic functions Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient Posterior reversible encephalopathy syndrome in neuro- malaria Everyday and exotic foodborne parasites Helminth infections of the central nervous system occurring in Southeast Asia and the Far East Central nervous system infections as a cause of an altered mental status? |
| cord-265146-j0n3a4m6 | A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant Asia and Africa: on different trajectories? |
| cord-259925-g28sx9qu | Are pangolins the intermediate host of the 2019 novel coronavirus( SARS- CoV-2)? |
| cord-259925-g28sx9qu | Health Care News Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein The epidemic emergence of HIV: what novel enabling factors were involved? |
| cord-259925-g28sx9qu | Will there be a cure for Ebola? |
| cord-285151-zynor0b2 | Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections? |
| cord-019347-tj3ye1mx | : This research addresses the following question: when stratifying by race, gender, age, metropolitan/ rural place of residence and comorbidity, do adults with asthma have fewer ED or unscheduled office visits for urgent asthma care if they: a) have an identified primary care provider, or b) have health insurance? |
| cord-019347-tj3ye1mx | Significant Rr6 pre beta-2-agonists and? |
| cord-019347-tj3ye1mx | The patient was treated with interferon? |
| cord-019347-tj3ye1mx | The question was if CD30 activity in cord blood and in 1-year- old children correlates with development or not of allergy? |
| cord-019347-tj3ye1mx | The question,"Do you have Delta Crud?"was added. |
| cord-018017-c8myq6bi | If infections are the greatest threat to human life, they should be critical drivers of evolution? |
| cord-018017-c8myq6bi | In fact, why study anything that is not the most highly impactful area? |
| cord-018017-c8myq6bi | Most prominent was, why study an area of science that has no significant impact? |
| cord-018017-c8myq6bi | On which disease should we focus? |
| cord-018017-c8myq6bi | This question demands a definition, what constitutes high impact? |
| cord-018017-c8myq6bi | What presents the greatest threat to human life today? |
| cord-018017-c8myq6bi | Why not? |
| cord-287754-dh6abx2t | Galanthus nivalis agglutinin( GNA)-related lectins: Traditional proteins, burgeoning drugs? |
| cord-278174-znc99yos | Is a recalled unit of plasma being thawed in the waterbath? |
| cord-031722-n5ja5oqw | ( CBOP-3MV) project Associations between neighborhood problems and sexual behaviors among black men who have sex with men in the deep south: the MARI study Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV Can money prevent the spread of HIV? |
| cord-031722-n5ja5oqw | : where are the boys? |
| cord-031722-n5ja5oqw | Brief report: racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13- 29 years living with diagnosed HIV infection Predictors and profiles of antiretroviral therapy adherence among African American adolescents and young adult males living with HIV Multiple dimensions of stigma and health related factors among young Black men who have sex with men Triply cursed': racism, homophobia and HIV- related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young Black gay men HIV stigma experienced by young men who have sex with men( MSM) living with HIV infection Are HIV seroconversions among young men who have sex with men associated with social network proximity to recently or longterm HIV- infected individuals? |
| cord-031722-n5ja5oqw | The effect of high rates of bacterial sexually transmitted infections on HIV incidence in a cohort of black and white men who have sex with men in The high risk of an HIV diagnosis following a diagnosis of syphilis: a population- level analysis of New York City men Human immunodeficiency virus diagnosis after a syphilis, gonorrhea, or repeat diagnosis among males including non- men who have sex with men: what is the incidence? |
| cord-031722-n5ja5oqw | What's PrEP?: |
| cord-031722-n5ja5oqw | but how do we improve implementation in adolescent sexual and reproductive health care? |
| cord-017412-1avevzya | A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice Familial clustering of pulmonary nontuberculous mycobacterial disease Infection with Scedosporium apiospermum and S. prolificans Cross- reactivity among fungal allergens: a clinically relevant phenomenon? |
| cord-017412-1avevzya | CD8+ T lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease Exposure to Alternaria alternata in US homes is associated with asthma symptoms Prospective study of transbronchial biopsies in the management of heart- lung and single lung transplant patients Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease Principles of antibiotic treatment of community- acquired pneumonia in the outpatient setting Bacterial infection and the pathogenesis of COPD Infectious etiology of acute exacerbations of chronic bronchitis Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? |
| cord-017412-1avevzya | Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario |
| cord-017412-1avevzya | So if the lung is generally sterile, why do some individuals become chronically colonized? |
| cord-017412-1avevzya | The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis Bacterial diversity in human subgingival plaque Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Viruses as precipitants of asthma symptoms Viral infections, atopy, and asthma: is there a causal relationship? |
| cord-017412-1avevzya | What can comparative genomics tell us about species concepts in the genus Aspergillus? |
| cord-017412-1avevzya | What organisms colonize the lungs? |
| cord-288982-63ddlh20 | World Health Organization Laboratory systems and services are critical in global health: time to end the neglect? |
| cord-274080-884x48on | Molecular mechanism of divalentmetal- induced activation of NS3 helicase and insights into Zika virus inhibitor design HCV infection by cell- to- cell transmission: choice or necessity? |
| cord-274080-884x48on | Novel ESCRT functions in cell biology: spiraling out of control? |
| cord-254187-dcdc6sqi | : cord-254187-dcdc6sqi authors: Kimball, AM; Thant, Myo title: “ What, me worry? ” |
| cord-254187-dcdc6sqi | Global business surveybusiness and AIDS: commitment and action? |
| cord-254187-dcdc6sqi | The global epidemic has shown its inexorable nature in community after"What, me worry?" |
| cord-254187-dcdc6sqi | Why such complacency? |
| cord-254187-dcdc6sqi | community, country after country; will it now be business after business? |
| cord-271970-i35pic5o | A user's guide to genetic screens HIV-1 and interferons: who's interfering with whom? |
| cord-271970-i35pic5o | epithelium Inhibition of human immunodeficiency virus( HIV) replication by HIV- trans- activated alpha 2-interferon Somatic expression of LINE-1 elements in human tissues Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition Complex interplay between HIV-1 Capsid and MX2-independent IFNα- induced antiviral factors HIV-1 uncoats in the nucleus near sites of integration A sensitive and specific enzyme- based assay detecting HIV-1 virion fusion in primary T lymphocytes Specific inhibition of viral protein synthesis in HIV- infected cells in response to interferon treatment Detection of 2019 novel coronavirus( 2019-nCoV) by real- time RT- PCR Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus Am I ready for CRISPR? |
| cord-023884-etkhrgxp | How can these be addressed? |
| cord-023884-etkhrgxp | Is home treatment of malaria a better option? |
| cord-023884-etkhrgxp | List six factors that contribute to the worsening of the global problem of malaria? |
| cord-023884-etkhrgxp | What are artemisinin- based combination treatments( ACTs) and what are the advantages of their use in the treatment of malaria? |
| cord-023884-etkhrgxp | What are the challenges of community delivery of malaria treatment through existing primary healthcare systems? |
| cord-023884-etkhrgxp | What should be the role of Roll Back Malaria initiative in global malaria control? |
| cord-022535-08hqmwlg | Durchgemachte Infektionskrankheiten? |
| cord-022535-08hqmwlg | Frühere Impfungen, Auftreten von Impfreaktionen? |
| cord-022535-08hqmwlg | Immunschwäche,-defekt? |
| cord-022535-08hqmwlg | Impfanamnese • Allgemeiner Gesundheitszustand? |
| cord-022535-08hqmwlg | Reiseapotheke wird bestimmt durch Reiseart, Reisedauer, Zielland, Zahl und Alter der Mitreisenden( Kinder? |
| cord-022535-08hqmwlg | Senioren?) |
| cord-022535-08hqmwlg | das zuständige Gesundheitsamt gemeldet Meldung wann und wohin? |
| cord-022128-r8el8nqm | A unique intra- molecular fidelity- modulating mechanism identified in a viral RNA- dependent RNA polymerase Defective or effective? |
| cord-022128-r8el8nqm | Coxsackievirus B3 mutator strains are attenuated in vivo A single- nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production Is sex necessary for the proliferation and transmission of Pneumocystis? |
| cord-022128-r8el8nqm | Linking RNA sequence, structure, and function on massively parallel highthroughput sequences Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad- spectrum antivirals? |
| cord-022128-r8el8nqm | Pnemocystis genetic variability: cryptic biological species or clonal near- clades? |
| cord-022128-r8el8nqm | Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population Replication slippage involves DNA polymerase pausing and dissociation Genome instability: a conserved mechanism of ageing? |
| cord-022128-r8el8nqm | Ribavirin resistance in hepatitis C virus replicon- containing cell lines conferred by changes in the cell line or mutations in the replicon RNA Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription Transfection- mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment Low- fidelity polymerases of alphaviruses recombine at higher rates to overproduce defective interfering particles Mechanisms of retroviral mutation Reproductive clonality in protozoan pathogens ─ truth or artefact? |
| cord-022128-r8el8nqm | reveals the dynamic nature of viral genome evolution Molecular Basis of Virus Evolution Functional and genetic plasticities of the poliovirus genome: quasi- infectious RNAs modified in the 5'-untranslated region yield a variety of pseudorevertants Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces? |
| cord-284385-ster02o9 | Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors Single- cell RNA- seq identifies a PD-1 hi ILC progenitor and defines its development pathway COVID-19 Dashboard by the center for systems science and engineering( CSSE) at Johns Hopkins University( JHU) Covid-19: risk factors for severe disease and death Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019( COVID-19) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China CoViD-19 immunopathology and immunotherapy A rapid fatal evolution of coronavirus Disease-19 in a patient with advanced lung cancer with a long- time response to nivolumab State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: when common sense is not enough Do checkpoint inhibitors compromise the cancer patients'immunity and increase the vulnerability to COVID-19 infection? |
| cord-284385-ster02o9 | current insights Can immune checkpoint inhibitors keep JC virus in check? |
| cord-279828-es498qul | Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-279828-es498qul | When less is better Why Are n't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019( COVID-19)? |
| cord-016718-cxn1ewfw | Do you remember how I distrusted and doubted you when we met for the first time? |
| cord-016718-cxn1ewfw | Does n't it reflect prejudice ingrained in our values? |
| cord-016718-cxn1ewfw | I think that only when we create a better recovery? |
| cord-016718-cxn1ewfw | She asked;'Who is paying attention to the people who are in fear? |
| cord-016718-cxn1ewfw | Then why do n't I use my last time to make friends and contribute to the society to build a better afterlife? … |
| cord-016718-cxn1ewfw | Who does n't want to live healthily and happily? |
| cord-016718-cxn1ewfw | environment and cultural? |
| cord-016718-cxn1ewfw | … I wonder why a patient tries so hard to try to prove his innocence? |
| cord-284128-3obc5k5u | Italy Healthcare is not universal if undocumented migrants are excluded Is forced migration a barrier to treatment success? |
| cord-284128-3obc5k5u | What is required to end the AIDS epidemic as a public health threat by 2030? |
| cord-267182-ctvnmjsl | A hypothesis about the possible dispersion of the mutation by the Vikings in historical times Frequencies of 32 base pair deletion of the( Δ32) allele of the CCR5 HIV-1 co- receptor gene in Caucasians: a comparative analysis More about the Viking hypothesis of origin of the Δ32 mutation in the CCR5 gene conferring resistance to HIV-1 infection Host genetic effect on tuberculosis susceptibility in Chinese Uyghur NRAMP1, VDR, HLA- DRB1, and HLA- DQB1 gene polymorphisms in susceptibility to tuberculosis among the Chinese Kazakh population: a casecontrol study Innate immune gene polymorphisms in tuberculosis Host genome polymorphisms and tuberculosis infection: what we have to say? |
| cord-267182-ctvnmjsl | HIV infection Immunogenetics of HIV disease Immunogenetic basis of HIV-1 infection, transmission and disease progression Identifying recent adaptations in large- scale genomic data Human genetic susceptibility to intracellular pathogens Human genetic susceptibility to infectious disease Host genomic influences on HIV/ AIDS Host genetics of HIV acquisition and viral control Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? |
| cord-267182-ctvnmjsl | What did we learn from the genome- wide association study for tuberculosis susceptibility? |
| cord-269222-g2ibmo75 | Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection Bacterial vaginosis( BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? |
| cord-269222-g2ibmo75 | The vaginal microbiome: new information about genital tract flora using molecular based techniques Vaginal microbiome of reproductive- age women Lactobacillus iners: friend or foe? |
| cord-284523-lknyehsa | A 2( sPLA 2): friends or foes? |
| cord-284523-lknyehsa | Are they actors in antibacterial and anti- HIV resistance? |
| cord-268776-yfq9oky5 | Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease Body mass index and the risk of stroke in men Neuronal pathways for the propagation of herpes simplex virus type 1 from one retina to the other in a murine model Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain Activation of mitochondrial ATP- dependent potassium channels protects neurons against ischemia- induced death by a mechanism involving suppression of Bax translocation and cytochrome c release Pesticides and parkinsonism: is there an etiological link? |
| cord-268776-yfq9oky5 | The role of excitotoxicity in ALS- what is the evidence? |
| cord-268776-yfq9oky5 | induce beta- amyloid precursor protein changes in mouse brain Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age- associated diseases in Danish centenarians: is there a link? |
| cord-285430-o086q2qa | Current trends recommendations for assisting in the prevention of perinatal transmission of human T lymphotropic virus type III/ lymphadenopathy- associated virus and acquired immunode!Ciency syndrome Free formula milk for infants of HIV- infected women: blessing or curse? |
| cord-285430-o086q2qa | The cost of not breastfeeding: global results from a new tool Does breastfeeding protect against substantiated child abuse and neglect? |
| cord-284608-ba7wq52t | An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring Incidence of human papillomavirus( HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral- induced carcinoma? |
| cord-018440-qugmnolo | How much does fear of"exposure"via broken confidentiality impact a patient's initiative to get tested for diseases such as HIV? |
| cord-018440-qugmnolo | Is public health more important than an individual's health and rights? |
| cord-018440-qugmnolo | Nonjudgmentally asking a patient"do you have sex with men, women, or both?"is probably the best way to obtain such sexual history information during the medical interview. |
| cord-018440-qugmnolo | Question for thought and discussion: When should patient confidentiality be broken, even if it is against the patient's wishes? |
| cord-018440-qugmnolo | Questions for thought and discussion: What are the obligations of the medical resident for reporting the positive HIV and syphilis test results? |
| cord-018440-qugmnolo | Should HIV testing ever be anonymous or confidential? |
| cord-018440-qugmnolo | Who do these results get reported to? |
| cord-018440-qugmnolo | Who notifies the sexual partners of patients who test positive for sexually transmitted infections? |
| cord-274663-zyzgk2z3 | Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs TDP-43: multiple targets, multiple disease mechanisms? |
| cord-286711-nr6vnl9h | What's in the name? |
| cord-023669-3ataw6gy | A randomized, controlled trial Anidulofungin: A new echinocandin with a novel profi le Combination antifungal therapy for invasive aspergillosis Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? |
| cord-023669-3ataw6gy | An evidence- based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients Effi cacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients Antifungal therapy in patients with fever and neutropeniamore rational and less empirical? |
| cord-023669-3ataw6gy | How often does it mimic Pneumocystis carinii pneumonia? |
| cord-023669-3ataw6gy | How should a patient with AIDS- associated PCP be managed if there is no improvement, or if there is deterioration, after 5 to 10 days of therapy? |
| cord-023669-3ataw6gy | Posttransplant microbiological surveillance Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? |
| cord-023669-3ataw6gy | Should patients with AIDS- related PCP be intubated and provided with mechanical ventilation? |
| cord-023669-3ataw6gy | Specifically, if a patient has a CD4+ T lymphocyte count of 400 cells/µL while receiving HAART and that patient's CD4+ T lymphocyte count was 50 cells/µL before HAART, is that patient at greater risk for developing an opportunistic infection than another patient whose current CD4+ T lymphocyte count is 400 cells/µL but whose nadir before HAART was 250 cells/µL? |
| cord-023143-fcno330z | *? |
| cord-023143-fcno330z | , Cara Wilsont, Kelledy Mansons, Michael Wyands, Bruce Walker?, Ronald C. Desrosiers |
| cord-023143-fcno330z | However, productive virus replication is minimized by antiviral CD8 T cells which suppress( kill?) |
| cord-023143-fcno330z | PrP genes were used to demonstrate that the"specie9 bank?' |
| cord-023143-fcno330z | The interferons( IFNs) a n? a family of cytokines whose functions include the protection of cells against viral infection. |
| cord-023143-fcno330z | Thes? |
| cord-023143-fcno330z | ofthe influenza HA protein from this second promoter in baby hamster kidney( BHK) cells was approximately 50?? |
| cord-023143-fcno330z | ofthe influenza HA protein from this second promoter in baby hamster kidney( BHK) cells was approximately 50?? |
| cord-297530-7zbvgvk8 | : do we need more sites, more sequences, or more loci? |
| cord-265699-0socw0hp | -Where do you draw the line? |
| cord-265699-0socw0hp | Dendrimers with tetrabenzoporphyrin cores: Near infrared phosphors for in vivo oxygen imaging Dendrimers for theranostic applications Dendrimer- protein interactions versus dendrimer- based nanomedicine Dendrimers as drug carriers: Applications in different routes of drug administration Dendrimers as drug delivery vehicles: Non- covalent interactions of bioactive compounds with dendrimers Association of chemotherapeutic drugs with dendrimer nanocarriers: An assessment of the merits of covalent conjugation compared to noncovalent encapsulation Dendrimers for gene delivery- a potential approach for ocular therapy? |
| cord-265699-0socw0hp | Reality or utopia? |
| cord-265699-0socw0hp | Where should we invest our resources and efforts? |
| cord-264225-vzcfeh7t | Chiang Mai HEPS Working Group New insights into HIV-1 specific cytotoxic T- lymphocyte responses in exposed, persistently seronegative Kenyan sex workers Cervical HIV- specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV HIV vaccine development in the aftermath of the STEP study: re- focus on occult HIV infection? |
| cord-264225-vzcfeh7t | The Clustering of Infected SIV Cells in Lymphatic Tissue Glycerol monolaurate prevents mucosal SIV transmission Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection Heterogeneity and plasticity of T helper cells Cellular heterogeneity: do differences make a difference? |
| cord-286719-1xjmlwqr | Cytomegalovirus: pathogen, paradigm, and puzzle International consensus guidelines on the management of cytomegalovirus in solid organ transplantation Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns Is HCMV a tumor promoter? |
| cord-292830-gcfx1095 | ; could statins fill gap? |
| cord-292830-gcfx1095 | A DNA transfection system for generation of influenza A virus from eight plasmids Pleiotropic mechanisms of ribavirin antiviral activities Emerging virus diseases: can we ever expect the unexpected? |
| cord-252039-732z92dd | Are any drugs available that can cure or safely treat persons once they've become infected? |
| cord-252039-732z92dd | But what can we say about the public health responses that were undertaken in the years following the 1918- 1919 influenza pandemic, after the immediate threat had passed? |
| cord-252039-732z92dd | Do we have a test that can accurately diagnose infection? |
| cord-252039-732z92dd | How long will it take for scientists to develop an effective vaccine that can prevent disease acquisition? |
| cord-252039-732z92dd | Trust for America's Health Simple, effective but out of reach? |
| cord-252039-732z92dd | What can history teach us about successful responses to past infectious disease pandemics? |
| cord-252039-732z92dd | Why? |
| cord-275677-hbv49e01 | : are we there yet? |
| cord-275677-hbv49e01 | AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co- receptor Molecular biology of cancer- associated fibroblasts: can these cells be targeted in anti- cancer therapy? |
| cord-275677-hbv49e01 | An example is the emergence and selection of HIV subtype C virus in India, which contains multiple NF- kB( sites?) and strengthens the promoters of the virus. |
| cord-293857-o8rlqsq5 | : pharmacokinetic and pharmacodynamic interactions between AEDs Discontinuation of phenytoin and carbamazepine in patients receiving felbamate Effects of felbamate on the pharmacokinetics of phenobarbital Efavirenzstill first- line king? |
| cord-286219-qcx5ehnh | What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin- mediated receptor regulation? |
| cord-016829-37i1bn9m | : Why are Donors not Working Together? |
| cord-016829-37i1bn9m | A Response to Joseph Hanlon's Recent Article, Donor Concern Over IMF Cap on Aid Increases AIDS: Free Access to Treatment, a Public Health Necessity or an Economic Heresy? |
| cord-016829-37i1bn9m | Are we spending too much on HIV? |
| cord-016829-37i1bn9m | The Evolving HIV Epidemic: What Have We Learned Since the MAP Began? |
| cord-016829-37i1bn9m | The New International Aid Architecture: New Players, New Challenges Strengthening Partnerships in HIV Monitoring and Evaluation: How Joint Missions Build and Strengthen Partnerships to Support the Realization of National M&E systems Global Fund Responsiveness to Faith- based Organizations IMF must Adapt and Downsize or die Socioeconomic obstacles to HIV prevention and treatment in developing countries: The roles of the international monetary fund and the World bank Funding the Response to AIDS: Why are Donors not Working Together? |
| cord-016829-37i1bn9m | What is Business Doing? |
| cord-016829-37i1bn9m | Why are Donors not Working Together? |
| cord-016829-37i1bn9m | Why are Donors not Working Together? |
| cord-016829-37i1bn9m | Why are Donors not Working Together? |
| cord-016829-37i1bn9m | Why are Donors not Working together? |
| cord-048467-1dus0u4m | And, finally, how is the SLR to be determined, and which of the infectious diseases would then exceed this SLR? |
| cord-048467-1dus0u4m | Can"presumed consent"justify the duty to treat infectious diseases? |
| cord-048467-1dus0u4m | For instance, how wise is it to assume that at the time of choosing their future profession the HCW was fully aware of the risks involved with such work? |
| cord-048467-1dus0u4m | Furthermore, if they were aware of, and fully appreciated, the risks prior to deciding on a particular profession, would they have even chosen that profession in the first place? |
| cord-048467-1dus0u4m | How appropriate is it to describe the healthcare provider's responsibility and duty as stemming from their'consent'? |
| cord-048467-1dus0u4m | The role of psychosocial assessment and support in occupational exposure management Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis b virus to health- care and public- safety workers Duty to treat or right to refuse? |
| cord-048467-1dus0u4m | how possible is it to satisfy all these conditions? |
| cord-273324-xhpv783y | Ensuring quality and access for malaria diagnosis: how can it be achieved? |
| cord-273324-xhpv783y | a systematic review Are Treponema pallidum specific rapid and point- of- care tests for syphilis accurate enough for screening in resource limited settings? |
| cord-273324-xhpv783y | ® for tuberculosis detection in HIV- positive populations: An opportunity for systems strengthening Advances in tuberculosis diagnostics: the Xpert MTB/ RIF assay and future prospects for a point- of- care test Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines The impact of the roll- out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town Drug- resistant tuberculosis: time for visionary political leadership Implementation of Xpert MTB/ RIF for routine point- of- care diagnosis of tuberculosis at the primary care level Evaluation of diagnostic tests: dengue Innovative and new approaches to laboratory diagnosis of Zika and Dengue: a meeting report Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? |
| cord-269759-1n1oo6wc | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
| cord-269759-1n1oo6wc | The next big threat to global health? |
| cord-295494-wal0gtrs | How does it kill? |
| cord-295494-wal0gtrs | Why is HIV rarely transmitted by oral secretions? |
| cord-278156-zd039ohv | Is the protein/ lipid hydrophobic matching principle relevant to membrane organization and functions? |
| cord-278156-zd039ohv | T lymphocytes Is the fluid mosaic( and the accompanying raft hypothesis) a suitable model to describe fundamental features of biological membranes? |
| cord-278156-zd039ohv | What may be missing? |
| cord-278156-zd039ohv | phosphoinositides Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion HIV entry: a game of hide- and- fuse? |
| cord-291577-nf80kih2 | A molecular docking study A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-302321-6x7hyald | In- person health care as option B Virtually perfect? |
| cord-253182-s60vzf3q | ( in Chinese) Tuberculosis and Aging_ A Global Health Problem Lifestyle factors related to mortality and survival: a mini- review Development of Pharmacotherapies for the Treatment of Sarcopenia Gendered support to older parents: do welfare states matter? |
| cord-253182-s60vzf3q | Is Neighborhood Green Space Associated With Less Frailty? |
| cord-253182-s60vzf3q | The primary health- care system in China Catastrophic health expenditure and rural household impoverishment in China: what role does the new cooperative health insurance scheme play? |
| cord-253182-s60vzf3q | The well- being of community- dwelling near- centenarians and centenarians in Hong Kong: a qualitative study Challenges of population ageing: putting frailty as a cornerstone of health and social care systems Combating frailty and sarcopenia in aging populations: switching to a more positive paradigm Elder- Friendly Service Delivery Models Validating the SARC- F: a suitable community screening tool for sarcopenia? |
| cord-253182-s60vzf3q | What can we learn from China's health system reform? |
| cord-253182-s60vzf3q | Why is Old- care Industry Unable to be Prosperous? |
| cord-253182-s60vzf3q | shame and health- related quality of life among older, HIV- positive adults Association between depressive symptoms and sarcopenia in older Chinese community- dwelling individuals Gray Matter Age Prediction as a Biomarker for Risk of Dementia Use and prescription of antibiotics in primary healthcare settings in China Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 Melancholy or mahjong? |
| cord-297612-swc2pitd | What lessons it might teach us? |
| cord-300968-dtaasxk1 | Inhibiting severe acute respiratory syndrome- associated coronavirus by small interfering RNA Old drugs as lead compounds for a new disease? |
| cord-264408-vk4lt83x | ( l- sIGN) is a receptor for severe acute respiratory syndrome coronavirus Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route Phenotypic changes in langerhans'cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? |
| cord-264408-vk4lt83x | A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection recent progress in henipavirus research: molecular biology, genetic diversity, animal models Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever sArs vaccines: where are we? |
| cord-264408-vk4lt83x | A simple technique for infection of mosquitoes with viruses; transmission of Zika virus Human papillomavirus research: do we still need animal models? |
| cord-264408-vk4lt83x | An unusual hantavirus outbreak in southern Argentina: person- to- person transmission? |
| cord-264408-vk4lt83x | emerg sArs: what have we learned? |
| cord-295099-ghc85pf5 | Ammonium ions improve the survival of glutaminestarved hybridoma cells Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique Development of a new yeast surface display system based on Spi1 as an anchor protein Passive immunization with the anti- HIV-1 human monoclonal antibody( hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12 Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric Evaluation of a novel multi- immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region Improved efficiency of EBV transformation of B- lymphocytes Single cell sorting and cloning Isolation of human monoclonal antibodies by mammalian cell display Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies? |
| cord-302530-pp6bl941 | filovirus filament length explain the emergence of ebola virus in mammals? |
| cord-302403-kahi8cbc | Is this tuberculosis, toxoplasmosis, cryptococcosis, or viral or bacterial infection? |
| cord-259233-smmhhroe | Cold Spring Harbor Perspectives in Late budding domains and host proteins in enveloped virus release Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? |
| cord-259233-smmhhroe | Could CD4 capture by CD8+ T cells play a role in HIV spreading? |
| cord-259233-smmhhroe | Exosomes and retroviruses: the chicken or the egg? |
| cord-259233-smmhhroe | Herpesviruses remodel host membranes for virus egress Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses ORF1a- encoded replicase subunits are involved in the membrane association of the arterivirus replication complex Kunjin virus: an Australian variant of West Nile? |
| cord-259233-smmhhroe | Trojan exosomes riding the Trojan horse? |
| cord-259233-smmhhroe | Virus assembly and plasma membrane domains: which came first? |
| cord-259233-smmhhroe | and what is its purpose? |
| cord-303189-ktl4jw8v | The interferon response to intracellular DNA: why so many receptors? |
| cord-304214-66nxk4e8 | convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
| cord-011903-zqt6vu6d | In most times, you keep quiet and when they ask you'what happened, why are you hurt?' cord-011903-zqt6vu6d It's not going to be dark forever, things will be right … but what I can say? … |
| cord-011903-zqt6vu6d | A lack of emotional support from partners/ fathers of children also contributed to stress and depression amongst young mothers:"Where does the stress go? … |
| cord-011903-zqt6vu6d | Can social support buffer the impact of stigma? |
| cord-011903-zqt6vu6d | Experiencing violence negatively impacted AGYW self- esteem and self- worth:"It has to do with how you perceive yourself, he sees me as not good enough then maybe you will find that boyfriend that hits you, he is the one that you want to stay with because you think where else will you find another boyfriend? … |
| cord-011903-zqt6vu6d | Getting involved in transactional relationships, compounded by a sense of shame and fear of social judgement, also led to depression and suicidal ideation:"Most girls in the community, they get into those( transactional) relationships, to a point that it damages them … they end up being depressed …'Why are you doing this and that to me in front of people?' |
| cord-011903-zqt6vu6d | It's not planned, but is it okay? |
| cord-011903-zqt6vu6d | One young woman described how she wanted to terminate her pregnancy but was told it was already too late to do so, and how this unwanted pregnancy caused her stress:"I had stress … I only realised when I was 4 months 2 days that I was pregnant … if I had realised this earlier, I was going to do an abortion … then I asked the doctor'Is there any other way I can do an abortion?'… |
| cord-011903-zqt6vu6d | What is the relevance of mental health to HIV/ AIDS care and treatment programs in developing countries? |
| cord-011903-zqt6vu6d | he embarrassed me in front of people, tomorrow how will people look at me?'"( 19- 24 years, NW). |
| cord-304188-1nm1tbig | Papers of particular interest, published within the annual period of review, have been highlighted as: Immune stimulation systemic inflammation Safety fewer side effects? |
| cord-273777-qb0vp9gr | An In Vitro Study Fertility and infertility: Definition and epidemiology Anaerobes and Bacterial Vaginosis in Pregnancy: Virulence Factors Contributing to Vaginal Colonisation Risks associated with bacterial vaginosis in infertility patients: A systematic review and meta- analysis Bacterial vaginosis and infertility: Cause or association? |
| cord-273777-qb0vp9gr | Healthy human gut phageome Dysbiosis in inflammatory bowel disease: A role for bacteriophages? |
| cord-273777-qb0vp9gr | Vaginal bacterial phaginosis? |
| cord-273777-qb0vp9gr | cord-273777-qb0vp9gr authors: Happel, Anna- Ursula; Varsani, Arvind; Balle, Christina; Passmore, Jo- Ann; Jaspan, Heather title: The Vaginal Virome — Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes? |
| cord-305195-e41yfo89 | With these evolving technologies in mind, it is timely to ask: Is the world able to control viral diseases more effectively? |
| cord-297257-lzybfwc2 | Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry[ v1; ref status: awaiting peer review Evaluation of Ebola virus inhibitors for drug repurposing Lack of protection against Ebola virus from chloroquine in mice and hamsters Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure Persistent immune activation in chronic HIV infection: do any interventions work? |
| cord-297257-lzybfwc2 | early HIV infection predicts subsequent CD4+ T- cell changes independent of viral load Relationship between T cell activation and CD4+ T cell count in HIV- seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy Immune activation and HIV persistence: considerations for novel therapeutic interventions Effects of chloroquine on viral infections: an old drug against today's diseases? |
| cord-297257-lzybfwc2 | interferon: implication for T- cell activation Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: a possible mechanism for therapeutic modulation of T cells A cure for AIDS: a matter of timing? |
| cord-287286-4l963z2q | Are these changes in gene expression a result of a virus- host interaction disruption? |
| cord-287286-4l963z2q | But why are such changes occurring at a low frequency in infected populations? |
| cord-287286-4l963z2q | But why do only a few HPV infections result in malignancy? |
| cord-287286-4l963z2q | If the immature virus contains an incomplete shell, how is the virus released from the cell? |
| cord-307817-2vy28i4m | Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity Structure- activity relationship studies on clinically relevant HIV-1 NNRTIs Non- nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections Next- generation integrase inhibitors: where to after raltegravir? |
| cord-302928-nnly9ju8 | cancer Assisted evolution enables HIV-1 to overcome a high TRIM5α- imposed genetic barrier to rhesus macaque tropism Editorial: endogenous viral elementslinks between autoimmunity and cancer? |
| cord-302928-nnly9ju8 | first? |
| cord-022888-dnsdg04n | /CRTAM on gd T cells? |
| cord-022888-dnsdg04n | As the results show, could there not be a direct relationship between the HLA system and the development of SA or TBC, or in contrast, was the first patient missdiagnosed of TBC being a good prognosis SA? |
| cord-022888-dnsdg04n | Could Carabin play a role of negative regulator of B cell function? |
| cord-022888-dnsdg04n | How is the IGSF4-CRTAM axis regulated in T cells? |
| cord-022888-dnsdg04n | a one- year prospective birth cohort study PC09/16 TO WHAT EXTENT T- SPOT.TB COULD BE USED IN THE DIAGNOSIS OF TUBERCULOSIS IN CHILDREN EXPOSED TO TB INFECTION? |
| cord-309489-ubf55eux | Polio: The Final Assault? |
| cord-027678-k64whepc | : how do they differ from those in seasonal influenza? |
| cord-027678-k64whepc | Are there host factors that explain the failure( e.g. obstruction of bronchus by a foreign body or tumour, inadequate host response)? |
| cord-027678-k64whepc | Are there other organisms? |
| cord-027678-k64whepc | Has a complication developed( e.g. empyema, superinfection, bronchiolitis obliterans organising pneumonia, metastatic abscess)? |
| cord-027678-k64whepc | Has the patient got pneumonia? |
| cord-027678-k64whepc | Is the fever a drug fever? |
| cord-027678-k64whepc | Is the organism resistant to the drug being given? |
| cord-027678-k64whepc | Is the right drug being given in an adequate dose by the right route? |
| cord-027678-k64whepc | re-)bronchoscopy( is the diagnosis correct?), treat co- pathogens and consider a short course of high- dose i.v. methylprednisolone Fungi are rare but important causes of pneumonia. |
| cord-306050-y8i8759c | gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research Ready to submit your research? |
| cord-270399-yfko8mpc | COVID-19 Should COVID-19 concern nephrologists? |
| cord-270399-yfko8mpc | Why and to what extent? |
| cord-270399-yfko8mpc | implications for albuminuria in diabetes IL-6, and SARS- CoV-2( COVID-19) infection: may all fit together? |
| cord-300793-tuq8z6gm | The challenge of emerging and re- emerging infectious diseases Environmental and social influences on emerging infectious diseases: past, present and future Mortality trends and setbacks: global convergence or divergence? |
| cord-300793-tuq8z6gm | The injection century: massive unsterile injections and the emergence of human pathogens Mortality before and after HIV infection in the complete UK population of haemophiliacs Transmission of West Nile virus through blood transfusion in the United States in 2002 Transmission of West Nile virus from an organ donor to four transplant recipients Cell and molecular biology of simian virus 40: implications for human infections and disease SV40 in human cancers- an endless tale? |
| cord-300793-tuq8z6gm | What have we learnt from SARS? |
| cord-265600-lnik974k | Can this happen also for DC- SIGN and L- SIGN? |
| cord-265600-lnik974k | Can variations in the gene encoding DC- SIGN and L- SIGN be associated with vertical transmission of HIV-1? |
| cord-265600-lnik974k | Friend or foe? |
| cord-265600-lnik974k | So, what are these likely factors in breast milk, and how do they act in protection against the infection caused by HIV-1? |
| cord-265600-lnik974k | Thus, one can wonder: How is the contact between native virus- bound infected cells with the fetal cells expressing receptors for HIV-1? |
| cord-265600-lnik974k | Why does this happen? |
| cord-269194-b1wlr3t7 | Are treatment options available? |
| cord-269194-b1wlr3t7 | For how long will the patient need to be on therapy? |
| cord-269194-b1wlr3t7 | Simple amplification- based assay: A nucleic acid- based point- of- care platform for HIV-1 testing HIV-1 viral load blips are of limited clinical significance HIV cure and eradication: How will we get from the laboratory to effective clinical trials? |
| cord-269194-b1wlr3t7 | Transducers Quantitation of mRNA by the polymerase chain reaction Prehistoric eye disease( trachoma?) |
| cord-269194-b1wlr3t7 | What treatment regimen should be prescribed? |
| cord-031907-ilhr3iu5 | Extracellular Vesicle- based liquid biopsy in Acute Myeloid Leukaemia: a reliable source of residual disease biomarkers? |
| cord-278876-il7g78w1 | Characterization of the human papillomavirus( HPV) integration sites into genital cancers Lethal mutagenesis of hepatitis C virus induced by favipiravir Virus and host factors affecting the clinical outcome of bluetongue virus infection Ongoing clinical trials of human immunodeficiency virus latency- reversing and immunomodulatory agents Is virology dead? |
| cord-278876-il7g78w1 | Is microcephaly among some neonates just the tip of the neurological iceberg? |
| cord-278876-il7g78w1 | When and how should infants be tested for possible congenital Zika infection? |
| cord-278876-il7g78w1 | Why does the overall risk of microcephaly and other birth defects seem to differ in other parts of Latin America and the Caribbean, compared to Brazil? |
| cord-278876-il7g78w1 | straight or cocktail? |
| cord-286574-t9z2ynt5 | Active surveillance based on MDR gram- negative pathogens? |
| cord-286574-t9z2ynt5 | Epidemiology and management of mucormycosis and invasive aspergillosis: are there lessons to be learned? |
| cord-286574-t9z2ynt5 | What is the proper volume of resuscitating fluid and how to monitor are also important issues we should have interest? |
| cord-286574-t9z2ynt5 | What to use in the clinical practice? |
| cord-297135-mg2qs3b6 | An opportunity lost: HIV infections associated with lack of a national needle- exchange programme in the USA Who need protecting? |
| cord-297135-mg2qs3b6 | Scenarios from the Asian Epidemic Model Do needle exchange programmes increase the spread of HIV among injection drug users? |
| cord-297135-mg2qs3b6 | The role of injecting drug use and sexual transmission in the Russian Federation, China and India Is antiretroviral therapy modifying the HIV epidemic? |
| cord-310931-5165078t | What is the outcome of location- based targeted tuberculosis screening based on universal genotyping? |
| cord-292740-b4cdj96q | Universal epitopes of influenza virus hemagglutinins? |
| cord-292740-b4cdj96q | back to the pre- antibiotic and passive prophylaxis era? |
| cord-292740-b4cdj96q | labialis HSV-2 specific serology should be offered routinely to antenatal patients Neonatal herpes simplex infection Herpes simplex virus Treatment of Herpes simplex virus infections with topical antiviral agents Antiviral Therapy of HSV-1 and-2 Association between cervical shedding of herpes simplex virus and HIV-1 Herpes simplex virus type 2 vaccines: new ground for optimism? |
| cord-263438-9ra94uda | At the end of the victory over SARS, the nagging question therefore remains: even after the impressive efforts at rearmament since 1992, how prepared is the international community for upcoming emerging diseases? |
| cord-263438-9ra94uda | For example, should priority be given to those diseases for which the human immune response gives grounds for optimism thaton the basis of historical experience-a safe and effective vaccine can be developed( e.g. influenza and dengue)? |
| cord-263438-9ra94uda | Have we been forever changed? |
| cord-263438-9ra94uda | Or should other strategies be followed with respect to diseases for which the human immune response makes the development of a vaccine a far more arduous and unpredictable endeavor( e.g. cholera and malaria)? |
| cord-263438-9ra94uda | The Surgeon General's Report on Health Promotion and Disease Prevention Health, Human Rights, and the New War on the Poor Infections and Inequalities: The Modern Plagues Could a tuberculosis epidemic occur in London as it did in New York? |
| cord-263438-9ra94uda | What could possibly have led to such overweening confidence in the power of science, technology, and civilization to vanquish communicable disease? |
| cord-263438-9ra94uda | Will we be ready when it returns? |
| cord-274019-dao10kx9 | But has the, field of evolutionary epidemiology quite reached its full potential? |
| cord-274019-dao10kx9 | But what can we do if we have no knowledge regarding a particular organism or population? |
| cord-274019-dao10kx9 | Does it take too long to publish research? |
| cord-274019-dao10kx9 | Moreover, as the techniques and methods advance, are the infrastructures in place for global cooperation and immediate response following the presentation of a potentially more complex story? |
| cord-274019-dao10kx9 | What is Syndromic Surveillance? |
| cord-274019-dao10kx9 | Why do RNA viruses recombine? |
| cord-314528-5yq95giq | Strict specificity for high- mannose type N- glycans and primary structure of a red alga Eucheuma serra lectin Removal of two high- mannose N- linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate- binding agent griffithsin High- mannose N- glycan- specific lectin from the red alga Kappaphycus striatum( carrageenophyte) Purification, primary structure, and biological activity of the high- mannose N- glycan- specific lectin from cultivated Eucheuma denticulatum Algal lectins as potential HIV microbicide candidates Prediction of subcellular locations of proteins: where to proceed? |
| cord-303165-ikepr2p2 | How many cases of a disease are enough to justify an intervention? |
| cord-303165-ikepr2p2 | What is the"New Public Health"? |
| cord-303165-ikepr2p2 | Who will keep the public healthy? |
| cord-306972-alyyju5x | How does stigma affect people living with HIV? |
| cord-305394-wwabxlgr | COVID-19: Shining the Light on Africa Tackling COVID-19: Can the African continent play the long game? |
| cord-305394-wwabxlgr | What does this data mean for the rest of Africa? |
| cord-312332-rwmuucsp | Do cellular RBPs participate in viral particle assembly? |
| cord-266294-ua22udlc | Are disulfiram- like reactions associated with abacavir- containing antiretroviral regi mens in clinical practice? |
| cord-266294-ua22udlc | Does it still have a role? |
| cord-266294-ua22udlc | Is acyclovir involved? |
| cord-266294-ua22udlc | Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team Efficacy and safety of tenofovir double- dose in treatment- experi enced HIV- infected patients: the TENO PLUS study Castillo Muñoz A, toxicity in HIV- infected subjects: a rando- Baños Roldán U, Artacho Criado S. Analisis mized, controlled study Increased haemoglobin A2 percentage in HIV infection: disease or treatment? |
| cord-266294-ua22udlc | Rôle de l'acy clovir? |
| cord-266294-ua22udlc | a pharmacokinetics, efficacy and safety review Once- daily dosing of nevirapine in HAART Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV- infected patients concurrently receiving nevirapine- based antiretroviral therapy and fluconazole Phar macokinetics of darunavir( TMC114) and atazanavir during coadministration in HIVnegative, healthy volunteers Alo pecia associated with ritonavir- boosted ata zanavir therapy Pharmacokinetic interaction between rifampicin and ritonavir- boosted atazanavir in HIV- infected patients Increased incidence of cutaneous mycoses after HAART initiation: a benign form of immune reconstitution disease? |
| cord-282675-s4zmffj3 | : Is there a relationship? |
| cord-282675-s4zmffj3 | Are Scores on English and French Versions of the PHQ-9 Comparable? |
| cord-282675-s4zmffj3 | Overworked? |
| cord-282675-s4zmffj3 | Precarious sleep? |
| cord-282675-s4zmffj3 | Will COVID-19 be a litmus test for post- Ebola sub- Saharan Africa? |
| cord-282675-s4zmffj3 | the eye of the crocodile 2020 Was SARS a mental health catastrophe? |
| cord-295290-hs5ntlok | An AIDS- related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV- l Protection from experimental autoimmune thyroiditis conferred by a monoclonal antibody to T- cell receptor from a cytotoxic hybridoma specific for thyroglobulin Immunization with a synthetic T- cell receptor Vregion peptide protects against experimental autoimmune encephalomyelitis Arthritis induced by a T- lymphocyte clone that responds to Mycobucterium tuberculosis and to cartilage proteoglycans Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis Inhibition of antigen- induced lymphocyte proliferation by Tat protein from HIV- l Adoptive transfer of EAE- like lesions from rats with coronavirus- induced demyelinating encephalomyelitis HIV- l gpl20-mediated immune suppression and lymphocyte destruction in the absence of viral infection Networks of automata and biological organization HIV and HLA similarity HIVinfected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells MHC- restricted depletion of human myetin basic protein- reactive T cells by T cell vaccination Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphocytic retrovirus Virus- triggered AIDS: a T- cellmediated immunopathology? |
| cord-295290-hs5ntlok | Does the HIV envelope induce a chronic graft- versus- hostlike disease? |
| cord-295290-hs5ntlok | No lights, no camera, just facts Loss of envelope antigens of HTLV- III/ LAV, a factor in AIDS pathogenesis? |
| cord-295290-hs5ntlok | The panergic amnesia hypothesis T cell vaccination of HIV- seropositives: a therapeutic test for the autoimmune component of AIDS Preface, in"Theories of immune networks Introduction to immune networks Paradoxical effects of suppressor T cells in the onset of adjuvant arthritis: neural network analysis Can AIDS be prevented by T- cell vaccination? |
| cord-292286-ygomb3oi | Computational screen and experimental validation of anti- influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine Molecular docking of potential inhibitors for influenza H7N9 Quercetin: bioflavonoids as part of interferon- free hepatitis C therapy? |
| cord-292286-ygomb3oi | Further studies indicated that baicalin can directly induce IFN- c production in human CD4? |
| cord-292286-ygomb3oi | T cells and CD8? |
| cord-292286-ygomb3oi | The green tea catechin, epigallocatechin gallate inhibits Chikungunya virus infection Colonic metabolites of berry polyphenols: the missing link to biological activity? |
| cord-292286-ygomb3oi | show anti- Mayaro virus activity Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin- neuraminidase Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins(?) |
| cord-291063-de7v4e5s | Are viral- encoded microRNAs mediating latent HIV-1 infection? |
| cord-291063-de7v4e5s | LNA- mediated microRNA silencing in non- human primates Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses Silencing of microRNAs in vivo with'antagomirs Specificity, duplex degradation and subcellular localization of antagomirs Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? |
| cord-291063-de7v4e5s | Silencing Viral MicroRNA as a Novel Antiviral Therapy? |
| cord-291063-de7v4e5s | The properties and functions of virus encoded microRNA, siRNA, and other small noncoding RNAs Small RNAs: delivering the future Lentivirusmediated antagomir expression for specific inhibition of miRNA function Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? |
| cord-291063-de7v4e5s | ammunition to target miRNAs implicated in human disease? |
| cord-317990-61is0hgm | No signs of coronavirus? |
| cord-268712-rxdw553c | A bio- psychosocial evolutionary view of the role of the traumatic stress response in the emergence of pathology and/or growth Assessing spiritual growth and spiritual decline following a diagnosis of cancer: Reliability and validity of the spiritual transformation scale A better world or a shattered vision? |
| cord-268712-rxdw553c | A cross validation study that extends the generality of"benefit finding"in cancer patients with chronic disease Posttraumatic stress disorder in response to HIV infection Psychosocial and sociodemographic correlates of benefit- finding in men treated for localised prostate cancer Still stable after all this …? |
| cord-268712-rxdw553c | Can crisis lead to personal life transformation? |
| cord-268712-rxdw553c | Construing benefits from adversity: Adaptational significance and dispositional underpinnings Medical illness and positive life change: Can crisis lead to personal life transformation? |
| cord-268712-rxdw553c | Positive changes in the aftermath of crisis Posttraumatic growth in prostate cancer survivors and their partners Is finding something good in the bad always good? |
| cord-268712-rxdw553c | Temporal comparison in coping with severe and chronic disease Posttraumatic growth and group- based interventions for persons dealing with cancer: What have we learned so far? |
| cord-268712-rxdw553c | The problem in using fixed- effects models of meta- analysis on realworld data Is the meta- analysis of correlation coefficients accurate when population effect sizes vary? |
| cord-316789-nb4437qs | What tasks can be solved at this stage? |
| cord-304794-z2kx314h | Dr Jekyll or Mr Hyde? |
| cord-304794-z2kx314h | The Bloom's syndrome helicase unwinds G4 DNA Genome- wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability Human papillomavirus G- quadruplexes Spectrum of Epstein- Barr virus- associated diseases Role for G- quadruplex RNA binding by Epstein- Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment G- quadruplexes regulate Epstein- Barr virus- encoded nuclear antigen 1 mRNA translation Targeting G- quadruplexes in gene promoters: a novel anticancer strategy? |
| cord-304794-z2kx314h | The guanine- quadruplex aptamer 93del inhibits HIV-1 replication ex vivo by interfering with viral entry, reverse transcription and integration Cellular uptake of ODNs in HIV-1 human- infected cells: a role for viral particles in DNA delivery? |
| cord-009269-6fs0f4b7 | ( As We Now Use the Word)?', Unpublished manuscript Disease and Globalized Anarchy: Theoretical Perspectives on the Pursuit of Global Health |
| cord-009269-6fs0f4b7 | : Is universal access to antiretroviral drugs an emerging international norm? |
| cord-009269-6fs0f4b7 | Can Ministries of Health Support Primary Health Care? |
| cord-009269-6fs0f4b7 | How has this new norm emerged and why has it emerged now? |
| cord-009269-6fs0f4b7 | Is It Losing Its Influence? |
| cord-009269-6fs0f4b7 | Mahler, during the promotion of Health for All by 2000, held the same position as Lee, so what explains the difference? |
| cord-009269-6fs0f4b7 | The Global Compact: Shifting the Politics of International Development? |
| cord-009269-6fs0f4b7 | They answer the question'who am I?' |
| cord-009269-6fs0f4b7 | Versus PHC? |
| cord-009269-6fs0f4b7 | What explains the difference? |
| cord-009269-6fs0f4b7 | What prevented the norm of universal primary health care from being adopted and internalized by the international community? |
| cord-009269-6fs0f4b7 | Which Norms Matter? |
| cord-297125-la20vi9j | : are we a threat to each other? |
| cord-297125-la20vi9j | People's republic of China Future vaccines for a globalized world First Blue Bell ice cream, now Sabra hummuswhy all the food recalls lately? |
| cord-297125-la20vi9j | Why is big pharma getting out of antibacterial drug discovery? |
| cord-297125-la20vi9j | impacts of river discharge and aquaculture activities Does the recent growth of aquaculture create antibiotic resistance threats different from those associated with land animal production in agriculture? |
| cord-285505-8norumv6 | : What opportunity exists for a better nucleoside/ nucleotide to treat hepatitis C? |
| cord-285505-8norumv6 | In contrast, there was far less protection in clinical trials-why? |
| cord-285505-8norumv6 | Is it possible that raltegravir is inducing a single round of HIV replication, to give an increase in HIV circles? |
| cord-285505-8norumv6 | What is the role of T- cell responses? |
| cord-316534-ep7ezoko | The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? |
| cord-264159-e9071tyv | Apart from basic science discovery, how do these insights affect clinical practice in infectious disease? |
| cord-264159-e9071tyv | Do they share similar features that might be reasons for their susceptibility of infection? |
| cord-264159-e9071tyv | Furthermore, how are host cells'phenotypes influenced by infection individually and temporally? |
| cord-264159-e9071tyv | How do the states of infected cells affect pathogen replication and infection outcome? |
| cord-264159-e9071tyv | How does this preference arise? |
| cord-264159-e9071tyv | Why are certain people more susceptible to infections? |
| cord-264159-e9071tyv | Why are some infected individuals asymptomatic or display only mild symptoms? |
| cord-264159-e9071tyv | Why are there differences in terms of disease progression and outcomes among patients? |
| cord-318570-wj7r6953 | Do You Need a DBS Test? |
| cord-318570-wj7r6953 | app- based multiplex, point- of- care screening strategy for HIV and related coinfections affect timely quality antenatal screening of rural Indian women? |
| cord-319609-y0gdjn64 | long- term surviving hemophiliacs HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV- infected long term nonprogressors Progression of HIV to AIDS: a protective role for HLA- B27? |
| cord-289443-46w52de3 | TLR4/ MD-2 Signatures of positive selection in Toll- like receptor( TLR) genes in mammals Mass extinctions, biodiversity and mitochondrial function: are bats'special'as reservoirs for emerging viruses? |
| cord-289443-46w52de3 | The Causes of Evolution( Longmans, Green,& Co,1932) Revenge of the phages: defeating bacterial defences Genomic variability as a driver of plant- pathogen coevolution? |
| cord-289443-46w52de3 | The dashed arrows and'?'indicate steps that lack clear molecular definition or are only inferred. |
| cord-289443-46w52de3 | Why then is human TRIM5 so highly inefficient against HIV-1? |
| cord-313617-hh7lccet | A molecular docking study Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? |
| cord-313617-hh7lccet | The Time Is Now to End the HIV Epidemic Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? |
| cord-314560-rswa5zdn | The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Long- term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti- HIV shRNA, anti- CCR5 ribozyme, and a nucleolar- localizing TAR decoy Antibody mediated in vivo delivery of small interfering RNAs via cell- surface receptors Inhibition of HIV-1 by lentiviral vectortransduced siRNAs in T lymphocytes differentiated in SCID- hu mice and CD34 C progenitor cell- derived macrophages Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer Plasmacytoid dendritic cells in immunity Sequence- dependent stimulation of the mammalian innate immune response by synthetic siRNA Noise amidst the silence: offtarget effects of siRNAs? |
| cord-314560-rswa5zdn | cord-314560-rswa5zdn authors: Manjunath, N.; Kumar, Priti; Lee, Sang Kyung; Shankar, Premlata title: Interfering antiviral immunity: application, subversion, hope? |
| cord-327324-4c4a4bfz | Are there inferences that can be made from this very detailed study of susceptibility to tuberculosis conferred by diabetes? |
| cord-316273-vo6j8zb0 | In vivo evolution of HIV-1 co- receptor usage and sensitivity to chemokine- mediated suppression Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV- binding site? |
| cord-316273-vo6j8zb0 | the Ebola virus glycoprotein Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? |
| cord-326833-boxgt4kb | National AIDS Control Organization| MoHFW| GoI Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-317277-rr9zue4l | They might be giants: does syncytium formation sink or spread HIV infection? |
| cord-317277-rr9zue4l | Viral extracellular biofilms: a novel spreading trick of viruses? |
| cord-321773-5fw9abzl | Why, how, when? |
| cord-318272-spt0oea0 | CAF01, promotes long- lived Mycobacterium tuberculosis- specific T- cell responses in human A triple co- culture model of the human respiratory tract to study immune- modulatory effects of liposomes and virosomes The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1 Immune responses induced by nano- self- assembled lipid adjuvants based on a monomycoloyl glycerol analogue after vaccination with the Chlamydia trachomatis major outer membrane protein Cubosomes: the next generation of smart lipid nanoparticles? |
| cord-318272-spt0oea0 | In vivo gold nanoparticle delivery of peptide vaccine induces anti- tumor immune response in prophylactic and therapeutic tumor models Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo Multicopy multivalent'glycopolymer- stabilized gold nanoparticles as potential synthetic cancer vaccines Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvant Single- walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor- associated antigens Immunisation of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein Silica vesicle nanovaccine formulations stimulate long- term immune responses to the bovine viral diarrhoea virus E2 protein Lipopeptide- coated iron oxide nanoparticles as potential glycoconjugate- based synthetic anticancer vaccines A visible codelivery nanovaccine of antigen and adjuvant with self- carrier for cancer immunotherapy Effect of preexisting neutralizing antibodies on the anti- tumor immune response induced by chimeric human papillomavirus virus- like particle vaccines Room temperature stable PSPA- based nanovaccine induces protective immunity Reversal of autoimmunity by boosting memory- like autoregulatory T cells Peptide- MHC- based nanovaccines for the treatment of autoimmunity: a"one size fits all"approach? |
| cord-299754-tgexahwd | Do TRIM proteins function as hubs connecting different signaling pathways or different systems? |
| cord-299754-tgexahwd | For example, how many TRIMs act as autophagic receptors and what are their specific targets? |
| cord-299754-tgexahwd | How is the autophagic role of TRIMs integrated with the other functions of TRIMs, including regulation of gene expression and pro- inflammatory signaling? |
| cord-299754-tgexahwd | I interferons in infectious disease Are the IKKs and IKK- related kinases TBK1 and IKK- epsilon similarly activated? |
| cord-299754-tgexahwd | What is the interplay between the E3 ligase activity of TRIMs and precision autophagy? |
| cord-293379-c4qdmkw5 | Does HIV variation matter? |
| cord-293379-c4qdmkw5 | Lentivirus tropism and pathogenesis Are RNA viruses adapting or merely changing? |
| cord-293379-c4qdmkw5 | Who would have thought a few years ago that men imbued with their traditional social customs would readily come forward to take part in randomized controlled trials of adult circumcision? |
| cord-293379-c4qdmkw5 | Will the drop in AIDS mortality owing to antiretroviral therapy( Fig. 1) be maintained so that people on treatment can expect a normal life span? |
| cord-306701-hs9cfdsu | Health Access and Quality based o mortality from causes amenable to personal healthcare in 195 countries and territories, 1990- 2015: a novel analysis from the Global Burden of Disease Study What will become of me if they take this away? |
| cord-306701-hs9cfdsu | It is astounding that the 2017 ratio for SADC was lower than the ratio experienced in OECD member states 30 years prior, a period during which there was no widespread use of ART or secondary prophylaxis against opportunistic infections? |
| cord-306701-hs9cfdsu | What is required to end the AIDS epidemic as a public health threat by 2030? |
| cord-328287-3qgzulgj | Tb and diabetes mellitus, hiv and metabolic syndrome, and the impact of globalization Cancer risk in people infected with human immunodeficiency virus in the united states Hepatocellular cancer in hiv- infected individuals: tomorrow's problem? |
| cord-296309-i1mpov7k | 3 Control for stochastic sampling variation and qualitative sequencing error in next generation sequencing Tales from the crypt and coral reef: the successes and challenges of identifying new herpesviruses using metagenomics Human cancers and mammalian retroviruses: should we worry about bovine leukemia virus? |
| cord-296309-i1mpov7k | We will discuss the strengths, weaknesses and technical challenges of different viral WGS methods Why sequence whole genomes? |
| cord-296309-i1mpov7k | What does the future hold? |
| cord-296309-i1mpov7k | Why do we need deep sequencing? |
| cord-296309-i1mpov7k | benefit health now Clinical management of HIV-1 resistance HIV-1 genotypic drug resistance testing: digging deep, reaching wide? |
| cord-308916-6p2qutc5 | GAVI, the vaccine alliance World Health Organization perspectives on the contribution of the global alliance for vaccines and immunization on reducing child mortality Maternal immunization Effectiveness of maternal influenza immunization in mothers and infants Influenza vaccination of pregnant women and protection of their infants Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality? |
| cord-308916-6p2qutc5 | Should ultrasound be included in the initial assessment of respiratory patients? |
| cord-308916-6p2qutc5 | what works and at what cost? |
| cord-309242-ilsupfl8 | Why is an article about global health included in a special issue on health in the USA? |
| cord-330581-g5r2b043 | Role of immune activation HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels Tumor necrosis factor- a induced expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein Macrophage activation and HIV infection: can the Trojan horse turn into a fortress? |
| cord-294366-swwz4kzd | Anamnestic response to administration of purified non- adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with longterm non- protective antibody titres The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine( 7VPnC) concurrently administered with a combination DTaP- IPV- Hib vaccine Vaccines in the public eye Preparing for the Next Pandemic WHO's attempts to eradicate polio are thwarted in Africa and Asia Spread of vaccinederived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine Long- term excretion of vaccine- derived poliovirus by a healthy child Bacillus Calmette- Guerin shares with virulent Mycobacterium tuberculosis the capacity to subvert monocyte differentiation into dendritic cell: implication for its efficacy as a vaccine preventing tuberculosis Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macrophages BCG- different strains, different vaccines? |
| cord-294366-swwz4kzd | And can new and refined approaches succeed where more conventional approaches appear to have failed? |
| cord-294366-swwz4kzd | Can successful vaccines teach us how to induce efficient protective immune responses? |
| cord-294366-swwz4kzd | In this complex but increasingly focussed environment of vaccine development, are there opportunities for new solutions for vaccine design? |
| cord-294366-swwz4kzd | The key question addressed here is, with all our research and understanding, have we reached a new echelon in vaccine development, that of rational design? |
| cord-326744-eled2tgo | a more illuminating question is what is the trajectory of COVID-19 cases nationally in overwhelmingly non- Hispanic white counties since the reopening of the economy? |
| cord-310867-78cx3o29 | : what works? |
| cord-310867-78cx3o29 | Can we measure HIV/ AIDS- related stigma and discrimination? |
| cord-310867-78cx3o29 | Key Programmes to Reduce Stigma and Discrimination and Increase Access to Justice in National HIV Responses Self- stigma among concealable minorities: conceptualization and unified measurement Interventions to reduce HIV/ AIDS stigma: what have we learned? |
| cord-304251-dohglrm1 | -a reality in near future? |
| cord-304251-dohglrm1 | : a singlecenter series of 67 patients and review of clinical outcome and trends Chikungunya: a potentially emerging epidemic? |
| cord-304251-dohglrm1 | Viruses: are they really culprits for periodontal disease? |
| cord-331879-w7008uyy | Health and Human Rights Mental health, drug use and sexual risk behavior among gay and bisexual men? |
| cord-306111-wn1gxhk9 | A longitudinal study Reconstitution of opsonizing activity by infusion of mannan- binding lectin( MBL) to MBL- deficient humans Human plasma- derived mannose- binding lectin: a phase I safety and pharmacokinetic study An assay for the mannan- binding lectin pathway of complement activation Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA Inherited deficiency of mannan- binding lectin- associated serine protease 2 Deficiency of the mannan- binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship L- ficolin in children with recurrent respiratory infections Mannan- binding lectin insufficiency in children with recurrent infections of the respiratory system Human mannose- binding lectin in immunity: friend, foe, or both? |
| cord-306111-wn1gxhk9 | AIDS Human mannose- binding protein gene is regulated by interleukins, dexamethasone and heat shock Modulatory effect of mannose- binding lectin on cytokine responses: possible roles in HIV infection Low mannose- binding lectin serum concentrations in HIV long- term nonprogressors? |
| cord-306111-wn1gxhk9 | Mannan- binding lectin enhances susceptibility to visceral leishmaniasis Dual role of mannan- binding protein in infections: another case of heterosis? |
| cord-333405-ji58jbct | The origins of acquired immune deficiency viruses: where and when? |
| cord-277818-8w15dz20 | A risk to patients and health care workers Disease transmission by inefficiently sanitized anesthetizing apparatus Contamination, disinfection, and cross- colonization: are hospital surfaces reservoirs for nosocomial infection? |
| cord-277818-8w15dz20 | Anesthesia practice- a vector of infection? |
| cord-277818-8w15dz20 | Preventing the transmission of pathogenic microbes during anesthesia Infection control and anesthesia: lessons learned from the Toronto SARS outbreak Fecal patina in the anesthesia work area Intensive care unit environments and the fecal patina: a simple problem? |
| cord-277818-8w15dz20 | Reducing surgical site infections at a pediatric academic medical center Drug allergies in the surgical population Is there cross- reactivity between penicillins and cephalosporins? |
| cord-277818-8w15dz20 | do anesthesiologists practice proper infection control precautions? |
| cord-277818-8w15dz20 | the cost effectiveness of using varicella vaccine in healthcare workers Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits A survey of policies at children's hospitals regarding immunity of healthcare workers: are physicians protected? |
| cord-315687-stgj6olw | Naturally SIV- infected sooty mangabeys: are we closer to understanding why they do not develop AIDS? |
| cord-315687-stgj6olw | The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection? |
| cord-325300-wawui0fd | What is a reasonable explanation of the occurrence; is there a previous pattern, with the present episode a recurrence or new event? |
| cord-325300-wawui0fd | What steps are needed to prevent spread and recurrence of the disease? |
| cord-303208-4bui0ioe | 11 What are we learning? |
| cord-303208-4bui0ioe | Is the policy- making system highly centralised( one decision centre) or decentralised( multiple decision centres)? |
| cord-303208-4bui0ioe | Is the policy- making system relatively open or relatively closed to innovations? |
| cord-303208-4bui0ioe | Who might become the early adopters and serve as models or opinion leaders for others in the system? |
| cord-303208-4bui0ioe | Who would provide what sort of reward to political leaders for implementing HIV services for IDUs? |
| cord-338594-wft7yy6j | The role of NK cells in HIV-1 protection: autologous, allogeneic or both? |
| cord-324984-ojrpsdt9 | , in patients infected with HIV-1 Chemokine control of West Nile virus infection Virological and immunological response to antiretroviral regimens containing maraviroc in HIV type 1-infected patients in clinical practice: role of different tropism testing results and of concomitant treatments Intensification of a raltegravir- based regimen with maraviroc in early HIV-1 infection Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates( S)-methyl-1-piperazinyl]-4-methylpiperidine( Sch-417690/ Sch- D), a potent, highly selective, and orally bioavailable CCR5 antagonist Pharmacokinetics and short- term safety of 873140, a novel CCR5 antagonist, in healthy adult subjects An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-Fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H- imidazo[4, 5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide( PF-232798) Is PF-232798 a possible successor to maraviroc? |
| cord-324984-ojrpsdt9 | molecular chaperone inhibitors: are we there yet? |
| cord-332093-iluqwwxs | The history and medical consequences of rubella Vaccination against rubella and measles: quantitative investigations of different policies Congenital rubella syndrome: progress and future challenges Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review: How does herd immunity work? |
| cord-337720-kmwft059 | We Missing? |
| cord-334855-s0ci3r8w | en Emerging virus diseases: Can we ever expect the unexpected? |
| cord-325936-rwxg187r | 2020; www.theco vidch allen ge.org Coronavirus: would you volunteer to be exposed? |
| cord-325936-rwxg187r | Why are n't people living with HIV at higher risk for developing severe coronavirus disease 2019( COVID-19)? |
| cord-324056-cvvyf3cb | Global governance in health-do historical experiences of industrialized countries teach any lessons? |
| cord-324056-cvvyf3cb | The International bank for reconstruction and development/ the world bank Millennium development goals for health: what will it take to accelerate progress? |
| cord-333622-0ddutmdd | Could a change in viral pathogenicity overcome this delicate balance between host and virus, or could progressive weakening of the CD4 T cell response by slow virus turnover gradually allow the virus to escape the combined effector mechanisms of the HIV- specific cell- mediated and humoral immune responses? |
| cord-329361-0mpbau1b | An siRNA- based microbicide protects miRNA and HIV: promises and mice from lethal herpes simplex virus 2 infection Anti- viral RNA silencing: do we look like plants? |
| cord-329361-0mpbau1b | Progress towards in vivo use of siRNAs gene by systemic administration of modified siRNAs Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing Retrovirus vectors: toward the plentivirus? |
| cord-330698-9t24jo8s | HIV and mature dendritic cells: trojan exosomes riding the Trojan horse? |
| cord-330698-9t24jo8s | lessons from Epstein- Barr virus Direct immunosuppressive effects of EBV- encoded latent membrane protein 1 Functional inactivation of EBV- specific T- lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy Exosomes containing glycoprotein 350 released by EBV- transformed B cells selectively target B cells through CD21 and block EBV infection in vitro EBV- gp350 confers B- cell tropism to tailored exosomes is a neo- antigen in normal and malignant B cells- a new option for the treatment of B- CLL Identification of virus- encoded microRNAs Epstein- Barr virus microRNAs are evolutionarily conserved and differentially expressed The viral and cellular microRNA targetome in lymphoblastoid cell lines Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen- induced arthritis Human tumor virus utilizes exosomes for intercellular communication Polarized secretion of lysosomes at the B cell synapse couples antigen extraction to processing and presentation Exosomes and retroviruses: the chicken or the egg? |
| cord-331673-xv1tcugl | Far from Clinical Use? |
| cord-331673-xv1tcugl | Hypericin- Loaded Graphene Oxide Protects Ducks against a Novel Duck Reovirus Graphene- Based"Hot Plate"for the Capture and Destruction of the Herpes Simplex Virus Type 1 Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? |
| cord-027242-7qq82j2f | , ansteckende Erkrankungen? |
| cord-027242-7qq82j2f | Allergien? |
| cord-027242-7qq82j2f | Allgemeiner Gesundheitszustand? |
| cord-027242-7qq82j2f | Dauermedikation? |
| cord-027242-7qq82j2f | Durchgemachte Infektionskrankheiten? |
| cord-027242-7qq82j2f | Gesundheitszustand/"Fitness"? |
| cord-027242-7qq82j2f | Gravidität? |
| cord-027242-7qq82j2f | Immunschwäche,-defekt? |
| cord-027242-7qq82j2f | Immunsuppression? |
| cord-027242-7qq82j2f | Impfstatus? |
| cord-027242-7qq82j2f | Impfungen, Auftreten von Impfreaktionen? |
| cord-027242-7qq82j2f | Reiseapotheke wird bestimmt durch Reiseart, Reisedauer, Zielland, Zahl und Alter der Mitreisenden( Kinder? |
| cord-027242-7qq82j2f | Senioren?) |
| cord-338654-ma9ayu80 | Are HIV/ AIDS conspiracy beliefs a barrier to HIV prevention among African Americans? |
| cord-291534-c6cjxq07 | A potential issue with using defensins as a topical antiviral treatment is that, despite CHDPs( including defensins) being required for in vitro anti- HIV activity of vaginal fluid from healthy women, defensins may also cause immune activation and subsequent loss of CD4? |
| cord-291534-c6cjxq07 | Both down- regulate the co- receptor CXCR4 expression( but not CCR5) on the surface of CD4? |
| cord-291534-c6cjxq07 | Gene structure and developmental expression Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract Neisseria gonorrhoeae- induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission Paneth cell defensins: endogenous peptide components of intestinal host defense Mouse neutrophils lack defensins Strain- specific polymorphisms in Paneth cell alpha- defensins of C57BL/6 mice and evidence of vestigial myeloid alpha- defensin pseudogenes Antibacterial activity and specificity of the six human{ alpha}-defensins Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? |
| cord-291534-c6cjxq07 | In addition b- defensins are described as having a range of immunomodulatory properties, including chemotaxis of CD4? |
| cord-291534-c6cjxq07 | Initial studies on retrocyclins found no direct inactivation of HIV-1, but demonstrated strong inhibition of proviral DNA formation and protection of primary human CD4? |
| cord-291534-c6cjxq07 | LL-37 has been shown to inhibit the replication of a range of HIV-1 isolates in primary CD4? |
| cord-291534-c6cjxq07 | Of these, RC100 was found to inhibit primary CD4? |
| cord-291534-c6cjxq07 | a- Defensins have been demonstrated to directly inactivate HIV-1, with the observation of reduced cytopathogenicity in a CD4? |
| cord-291534-c6cjxq07 | dendritic and T cell CCR6 Human beta- defensin-3 promotes wound healing in infected diabetic wounds beta- Defensins: multifunctional modulators of infection, inflammation and more? |
| cord-318591-ssnlfjap | : what is the real role of respiratory viruses in severe community- acquired pneumonia? |
| cord-318591-ssnlfjap | Different pattern of viral infections and clinical outcomes in patient with acute exacerbation of chronic obstructive pulmonary disease and chronic obstructive pulmonary disease with pneumonia: respiratory viral infections in COPD patients Does viral co- infection influence the severity of acute respiratory infection in children? |
| cord-318591-ssnlfjap | The role of respiratory viral infections among children hospitalized for community- acquired pneumonia in a developing country Does virus- bacteria coinfection increase the clinical severity of acute respiratory infection?: |
| cord-330800-s91zfzfi | Molecular diagnosis of infectious diseases using cytological specimens Point- counterpoint: is the era of viral culture over in the clinical microbiology laboratory? |
| cord-330800-s91zfzfi | Where do we go from here? |
| cord-340619-3tjquzx8 | The enlightenment from two cases of asymptomatic infection with SARS- CoV-2: is it safe after 14 days of isolation? |
| cord-317037-1qydcc5e | : Are they close relatives? |
| cord-317037-1qydcc5e | A novel mechanism of generating extracellular vesicles during apoptosis via a beads- on- a- string membrane structure Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding? |
| cord-317037-1qydcc5e | Premises for the Therapeutic Use Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? |
| cord-317037-1qydcc5e | The chicken or the egg? |
| cord-322581-v96k4yxg | The impact of an intervention to change health workers'HIV/ AIDS attitudes and knowledge in Nigeria: a controlled trial Nurses knowledge, attitude and willingness to take care for HIV/ AIDS patients in Bhutan Challenges for future research: providing evidence for health- care education Moving nursing research forward towards a stronger impact on health care practice? |
| cord-322581-v96k4yxg | family or patient's first? |
| cord-322581-v96k4yxg | key: cord-322581-v96k4yxg authors: Mockiene, Vida; Suominen, Tarja; Välimäki, Maritta; Razbadauskas, Arturas; Caplinskas, Saulius; Martinkenas, Arvydas title: Nurses'willingness to take care of people living with human immunodeficiency virus/ acquired immunodeficiency syndrome( HIV/ AIDS) — does a teaching intervention make a difference? |
| cord-285898-rtqkvf63 | A case report and review of literature Chronic hepatitis B infection in pregnancy illustrated by a case of successful treatment with entecavir Maternal drug use in early pregnancy and infant cardiovascular defect Is erythromycin therapy teratogenic in humans? |
| cord-285898-rtqkvf63 | ORACLE Collaborative Group Antifungal therapy during pregnancy Is gentamicin ototoxic to the fetus? |
| cord-285898-rtqkvf63 | Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies Is praziquantel therapy safe during pregnancy? |
| cord-285898-rtqkvf63 | The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study Impact of malaria at the end of pregnancy on infant mortality and morbidity Is single- dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy? |
| cord-285898-rtqkvf63 | a case series presentation Can amodiaquine be used safely during pregnancy? |
| cord-285898-rtqkvf63 | case report and review of literature Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? |
| cord-285898-rtqkvf63 | does it cause hearing loss or nephrotoxicity in the infant? |
| cord-329482-haenltxn | COVID-19 situation reports Accelerate progress- sexual and reproductive health and rights for all: report of the Guttmacher- Lancet Commission Do family planning programs decrease poverty? |
| cord-339879-92esdjy9 | Interferon production by t4 coliphage Bacterial viruses as human vaccines? |
| cord-322915-zrjx31ev | : where did we go wrong? |
| cord-322915-zrjx31ev | The end of an era? |
| cord-322915-zrjx31ev | The future of cephalosporins business Infectious history Oceans: medicine chests of the future? |
| cord-322915-zrjx31ev | Where have all the antibiotic patents gone? |
| cord-334454-cqaado3u | Clinical aspects of feline retroviruses: A review Clinical aspects of feline immunodeficiency and feline leukemia virus infection Efficacy of antiviral chemotherapy for retrovirus- infected cats: What does the current literature tell us? |
| cord-334454-cqaado3u | Who's interfering with whom? |
| cord-332588-k4tghibp | : Can We Make a Diagnosis? |
| cord-332588-k4tghibp | Does anti- JCV therapy improve the prognosis of AIDS- related PML? |
| cord-332588-k4tghibp | World Health Organization Antimalarials- Are they effective and safe in rheumatic diseases? |
| cord-319116-2ts6zpdb | Elevated levels of G- quadruplex formation in human stomach and liver cancer tissues G- quadruplex- binding small molecules ameliorate C9orf72 FTD/ ALS pathology in vitro and in vivo G- quadruplex structures and their interaction diversity with ligands Structure, location and interactions of G- quadruplexes Telomere G- quadruplex as a potential target to accelerate telomere shortening by expanding the incomplete end- replication of telomere DNA Telomeric G- quadruplex architecture and interactions with potential drugs Human telomeric G- quadruplex: the current status of telomeric G- quadruplexes as therapeutic targets in human cancer Cell cycle regulation of G- quadruplex DNA structures at telomeres G- quadruplexes in human promoters: a challenge for therapeutic applications G4 DNA in ras genes and its potential in cancer therapy Small molecules targeting c- Myc oncogene: promising anti- cancer therapeutics Making sense of G- quadruplex and i- motif functions in oncogene promoters G- quadruplex structures in the human genome as novel therapeutic targets Targeting G- quadruplexes in gene promoters: a novel anticancer strategy? |
| cord-319116-2ts6zpdb | Targeting unimolecular G- quadruplex nucleic acids: a new paradigm for the drug discovery? |
| cord-319116-2ts6zpdb | radioresistance of D. radiodurans involves G4 DNA- mediated regulation Mapping and characterization of G- quadruplexes in Mycobacterium tuberculosis gene promoter regions G- quadruplexes in pathogens: a common route to virulence control? |
| cord-346557-s6c7d70y | How Might Social Distancing Impact Gay, Bisexual, Queer, Trans and Two- Spirit Men in Canada? |
| cord-341838-lkz8ro90 | Do people living with HIV experience greater age advancement than their HIV- negative counterparts? |
| cord-333730-qsx0m68e | An open pilot study On chikungunya acute infection and chloroquine treatment Confronting an influenza pandemic with inexpensive generic agents: can it be done? |
| cord-333730-qsx0m68e | Anti- malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model Influenza A/ H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? |
| cord-333730-qsx0m68e | inhibition with baricitinib in the treatment of autoinflammatory interferonopathies Baricitinib for COVID-19: a suitable treatment? |
| cord-340703-vtuy806l | Patient Prefer Adherence Scientific group on the assessment of osteoporosis at primary health care level Estimation of a population total under a"Bernoulli sampling"procedure Prevalence and risk factors for osteopenia/ osteoporosis in an HIV- infected male population Prevalence of osteoporosis and fractures in a migrant population from southern to northern Italy: a cross- sectional, comparative study Insulin/ IGF-1R, SIRT1, and FOXOs Pathways- An Intriguing Interaction Platform for Bone and Osteosarcoma Morphological and postural sexual dimorphism of the lumbar spine facilitates greater lordosis in females Calcium and vitamin D in human health: Hype or real? |
| cord-340703-vtuy806l | Phalangeal quantitative ultrasound: cheaper methods for screening and follow- up of bone pathologies in HIV- infected women? |
| cord-345342-04tvuj9f | A case report Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co- infection with HIV-1 and HCV Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
| cord-346314-o9fjpqaj | HIV-1 Tat fluctuations drive phenotypic diversity DEDD and DEDD2 associate with caspase-8/10 and signal cell death Chaperones and multitasking proteins in the nucleolus: networking together for survival? |
| cord-311559-vkb7a4cm | : How close are we to the target? |
| cord-311559-vkb7a4cm | Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-311559-vkb7a4cm | In line with this, one of the puzzling questions in the wake of this pandemic is"Does HIV infection increases the risk of getting and disease severity of COVID-19?. |
| cord-311559-vkb7a4cm | Japan A case of HIV and SARS- CoV-2 co- infection in Singapore HIV and SARS- CoV-2 co- infection: the diagnostic challenges of dual pandemics COVID-19 in an HIVpositive kidney transplant recipient A case series of five people living with HIV hospitalized with COVID-19 in COVID-19 in a patient with HIV infection Predisposition or protection? |
| cord-311559-vkb7a4cm | When less is better t people living with HIV at higher risk for developing severe coronavirus disease 2019( COVID-19)? |
| cord-311559-vkb7a4cm | modelling studies warn HIV services take a backseat to COVID-19 in Russia Living with HIV in the time of COVID-19: a glimpse of hope Public health, health systems and palliation planning for COVID-19 on an exponential timeline HIV care in times of the COVID-19 crisis- where are we now in Central and Eastern Europe? |
| cord-355439-eqtk51q3 | Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-342076-3a6aky7i | Jilin People's Publishers Quality assurance in the HIV/ AIDS laboratory network of China Joint United Nations Programme on HIV/ AIDS, World Health Organization Geneva: World Health Organization and Joint United Nations Programme on HIV Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? |
| cord-342076-3a6aky7i | The China Stigma Index Report Evaluation of effect of community- based HIV/ AIDS interventions among men who have sex with men in eighteen cities, China Which Chinese men who have sex with men miss out on HIV testing? |
| cord-340777-d1vwjqk6 | Should we fear resistance from tenofovir/ emtricitabine PrEP? |
| cord-340777-d1vwjqk6 | What Are Your Research's Implications toward Theory, Practice, or Policy? |
| cord-309900-4nln90jn | All teachers responded positively to the question:"What do you think the students learned from the module?" |
| cord-309900-4nln90jn | Does active learning work? |
| cord-309900-4nln90jn | Questions that were asked included"how was the contact with the coaches?" |
| cord-309900-4nln90jn | So what factors play a role in making an educational intervention effective in changing behavior? |
| cord-309900-4nln90jn | Where's the evidence that active learning works? |
| cord-309900-4nln90jn | and"what have the students learned during the project? |
| cord-309900-4nln90jn | issues related to the science apprenticeship camp Is peer interaction necessary for optimal active learning? |
| cord-327135-4c2flue4 | : do interferon lambda 3 polymorphisms predict the outcome of interferon- therapy in hepatitis B infection? |
| cord-327135-4c2flue4 | One more piece in the interleukin 28B gene puzzle? |
| cord-327135-4c2flue4 | So the question arises: is the IFN- λ4-generating SNP the sole functional SNP or the other SNPs regulating the expression of IFN- λ3 also have independent roles? |
| cord-327135-4c2flue4 | So, how does the expression of a functional IFN- λ4 in patients who get an acute HCV infection will lead them to become chronically infected? |
| cord-023168-cd7adns8 | Are there any other treatments I should give before making the decision to transfuse, such as intravenous replacement fluids or oxygen? |
| cord-023168-cd7adns8 | Can I minimize blood loss to reduce this patient's need for transfusion? |
| cord-023168-cd7adns8 | Can hematological parameters discriminate malaria from nonmalarious acute febrile illness in the tropics? |
| cord-023168-cd7adns8 | How much time do health services spend on antenatal care? |
| cord-023168-cd7adns8 | Is it HIV TTP or HIV- associated thrombotic microangiopathy? |
| cord-023168-cd7adns8 | Plateletmediated clumping of Plasmodium falciparuminfected erythrocytes is a common adhesive phenotype and is associated with severe malaria Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation Thrombopoietin in Plasmodium falciparum malaria Immunemediated thrombo- cytopenia of malaria Thrombocytopenia in malaria: who cares? |
| cord-023168-cd7adns8 | Thalassaemia intermedia Alpha- thalssemia Hemoglobin H disease and mental retardation: a new syndrome or a remarkable coincidence? |
| cord-023168-cd7adns8 | The Thalassaemia Syndromes Pathophysiology of beta thalassaemia-a guide to molecular therapies Beta- thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? |
| cord-023168-cd7adns8 | What are the risks of transmitting HIV, hepatitis, syphilis or other infectious agents through the blood products that are available for this patient? |
| cord-023168-cd7adns8 | What are the specific clinical or laboratory indications for transfusion in this patient? |
| cord-023168-cd7adns8 | What improvement in the patient's clinical condition am I aiming to achieve? |
| cord-023168-cd7adns8 | What works? |
| cord-023168-cd7adns8 | Why would the incidence of HIV- associated Hodgkin lymphoma increase in the setting of improved immunity? |
| cord-023168-cd7adns8 | can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? |
| cord-023168-cd7adns8 | deficiency Importance of folate in human nutrition Review of the magnitude of folate and vitamin B 12 deficiencies worldwide Red cell or serum folate? |
| cord-023168-cd7adns8 | there models for developing countries? |
| cord-338572-5ifc2lx6 | Co- infection of SARS- CoV-2 and HIV in a patient in Wuhan city A survey for COVID-19 among HIV/ AIDS patients in two districts of, China Wuhan Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-338572-5ifc2lx6 | Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
| cord-347992-coby2m6e | In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins Berzal- Herranz, A. RNA selection and evolution in vitro: powerful techniques for the analysis and identification of new molecular tools Aptamers: a new class of oligonucleotides in the drug discovery pipeline? |
| cord-354974-bh2expef | Do multiple concurrent infections in African children cause irreversible immunological damage? |
| cord-341503-3cvtoc2j | COVID-19 conspiracy theories: was SARS- CoV-2 made in a lab? |
| cord-341503-3cvtoc2j | Does discrimination breed mistrust? |
| cord-341503-3cvtoc2j | Whose responsibility is it to dismantle medical mistrust? |
| cord-333655-lylt7qld | I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate- binding agents against wild- type and mutant HIV-1 strains containing glycan deletions in gp120 Carbohydrate- binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? |
| cord-333655-lylt7qld | Lack of complex N- glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function Impact of mannose- binding lectin on susceptibility to infectious diseases Lectin- carbohydrate interactions: different folds, common recognition principles Noroviruses everywhere: has something changed? |
| cord-333655-lylt7qld | Mannan- binding lectin deficiency-Good news, bad news, does n't matter? |
| cord-354029-mp5r82g4 | Do the transitions to their recently described low pH forms( Bressanelli et al. 2004; Gibbons et al. 2004; Modis et al. 2004) mediate hemifusion or fusion pore opening? |
| cord-354029-mp5r82g4 | What about the mechanisms of the as yet unclassified viral fusion proteins? |
| cord-316904-g7dli0a8 | 112 Is there a role for leptin? |
| cord-316904-g7dli0a8 | As these cytokines do not appear to cross the blood- brain barrier in significant amounts, how can these cytokines be acting at the CNS level? |
| cord-316904-g7dli0a8 | What are mechanisms( and mediators) by which anorexia and hypermetabolism are produced? |
| cord-316904-g7dli0a8 | What, therefore, would be the cause for muscle wast- ing in AIDS? |
| cord-316904-g7dli0a8 | pilot studies Pentoxifylline therapy in HIV seropositive subjects with elevated TNF Pentoxifylline for treatment of cancer anorexia and cachexia? |
| cord-341298-mqpovrms | Molecular evidence of HIV-1 transmission in a criminal case Detecting biothreat agents: The laboratory response network Select agent regulations Aum Shinrikyo: Once and future threat? |
| cord-341298-mqpovrms | The 1990 Florida dental investigation Agroterrorism targeting livestock: A review with a focus on early detection systems Did bioweapons test cause a deadly smallpox outbreak? |
| cord-341298-mqpovrms | The Russian biological weapons program: Vanished or disappeared? |
| cord-350443-ca5avyjf | Back to the Future Prevention and treatment of infectious diseases in new millenium in China Syphilis among female sex workers in southwestern China: potential for HIV transmission Hidden epidemic of sexually transmitted diseases in China: crisis and opportunity Female sex workers in China: vectors of disease? |
| cord-350443-ca5avyjf | The influence of social and sexual networks in the spread of HIV and syphilis among men who have sex with men in Shanghai Relationship between syphilis and HIV infections among men who have sex with men in Beijing Strategies for implementing Health- Promoting Schools in a province in China Effect of foliar application of zinc, selenium, and iron fertilizers on nutrients concentration and yield of rice grain in China Epidemic of HIV infection and prevention research in Yunnan, 1989- 98 State council AIDS working committee office and UN themem group on HIV/ AIDS in China Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey High prevalence of risk behavior concurrent with links to other high risk populations: a potentially explosive HIV epidemic among men who have sex with men in Guangzhou Update on the HIV/ AIDS epidemic and response in China Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV? |
| cord-349358-leicos9j | Again, as with other drugs in development against HIV infection, we are confronted with the following major questions: what are the potential side effects from such an approach, and what would be the therapeutic dose window? |
| cord-349358-leicos9j | In other words, what would be the preferred delivery system to use in animals and later on in humans? |
| cord-350540-s6is9ndm | The hardest questions doctors may face: Who will be saved? |
| cord-350540-s6is9ndm | What'patient- centered'should mean: Confessions of an extremist Retention in HIV care among participants in the patient- centered hiv care model: a collaboration between community- based pharmacists and primary medical providers Is the quality of the patient- provider relationship associated with better adherence and health outcomes for patients with HIV? |
| cord-350540-s6is9ndm | Who wo n't? |
| cord-342936-43u7afl3 | A new C- type lectin similar to the human immunoreceptor DC- SIGN mediates symbiont acquisition by a marine nematode Mannose- binding lectin( MBL) and HIV Mannose- binding lectin: do we need it? |
| cord-342936-43u7afl3 | Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle Cyanovirin- N binds to the viral surface glycoprotein, GP1, 2 and inhibits infectivity of Ebola virus Safety concerns for the potential use of cyanovirin as a microbicidal anti- HIV agent in Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections Glycosylation and the immune system Dendritic- cell interactions with HIV: infection and viral dissemination Carbohydrate- binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? |
| cord-342936-43u7afl3 | The role of DC- SIGN and DC- SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? |
| cord-342936-43u7afl3 | What are the unique features of the CBA concept that differentiate this therapeutic approach from those that are currently available( BOX 2)? |
| cord-355475-kdubhh73 | A Systematic Review Oral Manifestations in Patients with COVID-19: A Living Systematic Review Oral lesions in patients with SARS- CoV-2 infection: could the oral cavity be a target organ? |
| cord-355475-kdubhh73 | Are they a true sign of COVID-19 disease? |
| cord-355475-kdubhh73 | Will there be oral toxicities or benefits of COVID-19 treatments particularly as treatments target the cytokine storm, a procoagulant state, and local and systemic activation of inflammation? |
| cord-355541-5sctqkwr | How, when and where is the efficacy of the different vaccines to be evaluated? |
| cord-355541-5sctqkwr | Neutralizing antibody- independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations HIV-1 neutralizing antibodies: how full is the bottle? |
| cord-355541-5sctqkwr | WHO The global alliance for vaccines and immunization: a millennial challenge Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? |
| cord-331289-02411gfv | A review on its molecular characteristics and role in medicine Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? |
| cord-331289-02411gfv | A single mutation in chikungunya virus affects vector specificity and epidemic potential Parvovirus transmission by blood products-a cause for concern? |
| cord-331289-02411gfv | Is the incidence and prevalence of inhibitors greater with recombinant products? |
| cord-331289-02411gfv | Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma- derived factor concentrates Human parvovirus B19 Viral pathogens Hepatitis E screening for blood donations: an urgent need? |
| cord-331289-02411gfv | Use and interpretation The reliability of HBV core antibody in serological screening for hepatitis B virus World Health Organisation( WHO) Laboratory diagnostics for hepatitis C virus infection Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment Hepatitis C diagnostics: clinical evaluation of the HCVcore antigen determination Transfusion- transmitted hepatitis E: is screening warranted? |
| cord-354790-xx6imhzb | Antibody- mediated immunomodulation: a strategy to improve host responses against microbial antigens Antiviral monoclonal antibodies: can they be more than simple neutralizing agents? |
| cord-354790-xx6imhzb | Intravenous immunoglobulin therapy: how does IgG modulate the immune system? |
| cord-354790-xx6imhzb | Which antibody functions are important for an HIV vaccine? |
| cord-312194-1jiaghrb | What do you know about the transmission of the virus? cord-312194-1jiaghrb What do you understand by being prepared to provide oral health care during the pandemic? |
| cord-312194-1jiaghrb | Why is this pandemic relevant to oral health care? cord-312194-1jiaghrb But at what cost? I'm not sure it is even working the way it should. cord-312194-1jiaghrb COVID-19 information for dental patients Member checking: a tool to enhance trustworthiness or merely a nod to validation? cord-312194-1jiaghrb How do we balance tensions between COVID-19 public health responses and stigma mitigation? cord-312194-1jiaghrb Interview questions included but were not limited to the following: 1)What do you know about the COVID-19 outbreak? |
| cord-312194-1jiaghrb | Is n't that the same history behind HIV back in the 80s, from slaughtering monkeys in the[ African] jungles, that was transmitted to us? |
| cord-312194-1jiaghrb | What will be the new normal for the dental industry? |
| cord-341155-3d64mso0 | Hepatitis C- contamination of toothbrushes: myth or reality? |
| cord-341155-3d64mso0 | The role of household contacts in the transmission of group A streptococci Salivary cytomegalovirus( CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus- seropositive patients Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo Ecology of Haemophilus influenzae and Haemophilus parainfluenzae in sputum and saliva and effects of antibiotics on their distribution in patients with lower respiratory tract infections Varicellazoster virus DNA level and facial paralysis in Ramsay Hunt syndrome Quantitation of varicella- zoster virus DNA in patients with Ramsay Hunt syndrome and zoster sine herpete Practice of feeding premasticated food to infants: a potential risk factor for HIV transmission Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa Saliva as a diagnostic tool for periodontal disease: current state and future directions Global burden and epidemiology of tuberculosis Epstein- Barr virus reactivation and upper- respiratory illness in elite swimmers Oral fluid, a substitute for serum to monitor measles IgG antibody? |
| cord-341155-3d64mso0 | The utility of whole saliva to detect the oral presence of periodontopathic bacteria Do periodontopathogens disappear after full- mouth tooth extraction? |
| cord-341155-3d64mso0 | report of two cases Oral Helicobacter pylori: can we stomach it? |
| cord-344084-z4t2wkgk | , the following question arose: does CCR5 have any clinically relevant influence on SARS- CoV-2 or other coronaviruses infections? |
| cord-344084-z4t2wkgk | : forgotten or ignored? |
| cord-344084-z4t2wkgk | An emerging interplay between extracellular vesicles and cytokines Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d- restricted NKT cells CCR5 in T cell- mediated liver diseases: what's going on? |
| cord-344084-z4t2wkgk | CCR5 polymorphism as a protective factor for hepatocellular carcinoma in hepatitis B virus- infected Iranian patients CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C Effects of the CCR5-Δ32 mutation on hepatitis C virus- specific immune responses in patients with haemophilia CC- chemokine receptor 5( CCR5) in hepatitis C-- at the crossroads of the antiviral immune response? |
| cord-344084-z4t2wkgk | Cells Chemokine receptors as important regulators of pathogenesis during arboviral encephalitis Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor Dengue haemorrhagic fever: a job done via exosomes? |
| cord-327461-ohgkgvry | Which testing do you prefer, facility- based testing or HIV self- testing?, etc. |
| cord-327461-ohgkgvry | Adverse events or IPV that happened on alters during distribution are determined from the question"Have you experienced any of the following IPV when received the HIVST kit from the index?". |
| cord-327461-ohgkgvry | Alters'experience and perception of HIVST are determined from total 20 question items, e.g."How difficult do you feel about completing HIV self- testing?","How many men did you have anal sex with after HIV selftesting?", |
| cord-327461-ohgkgvry | Alters'experience and perception of HIVST are determined from total 20 question items, e.g."How difficult do you feel about completing HIV self- testing?","How many men did you have anal sex with after HIV selftesting?", |
| cord-327461-ohgkgvry | High- risk sexual behavior, defined as unprotected sex, substance use, or multiple sexual partners, are determined from survey questions such as"How often do you wear a condom during anal sex?","In the past three months, how many sexual partners did you have?","In the past three months, have you used drugs before sex?", etc. |
| cord-327461-ohgkgvry | High- risk sexual behavior, defined as unprotected sex, substance use, or multiple sexual partners, are determined from survey questions such as"How often do you wear a condom during anal sex?","In the past three months, how many sexual partners did you have?","In the past three months, have you used drugs before sex?", etc. |
| cord-327461-ohgkgvry | High- risk sexual behavior, defined as unprotected sex, substance use, or multiple sexual partners, are determined from survey questions such as"How often do you wear a condom during anal sex?","In the past three months, how many sexual partners did you have?","In the past three months, have you used drugs before sex?", etc. |
| cord-347710-ff64y6ef | : where do we stand? |
| cord-347710-ff64y6ef | Hsp90 inhibitors: a potential treatment for latent EBV infection? |
| cord-347710-ff64y6ef | The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics The ins and outs of tubulin acetylation: more than just a post- translational modification? |
| cord-347710-ff64y6ef | diagnostic, prognostic, predictive, and treatment implications Altered states: selectively drugging the Hsp90 cancer chaperone Heat shock proteins promote cancer: it's a protection racket Heat shock proteins and cancer: intracellular chaperones or extracellular signalling ligands? |
| cord-341323-mw352rr1 | COVID-19: What implications for sexual and reproductive health and rights globally? |
| cord-341323-mw352rr1 | Experts offer ethical guidance Fair Allocation of Scarce Medical Resources in the Time of Covid-19 Community- based interventions that work to reduce HIV stigma and discrimination: results of an evaluation study in Thailand Stigma in health facilities: why it matters and how we can change it Combating HIV stigma in health care settings: what works? |
| cord-341323-mw352rr1 | The impact of HIV- related stigma on older and younger adults living with HIV disease: does age matter? |
| cord-341323-mw352rr1 | What implications does this scarcity of COVID-19 medical resources have on stigma towards older persons? |
| cord-341323-mw352rr1 | Who should be saved first? |
| cord-341323-mw352rr1 | this liability shift to other marginalized communities, such as undocumented immigrants, homeless persons, and others who experience barriers to testing and care[ 14]? |
| cord-332569-af8oq2d6 | And is the vaccine likely to be safe? |
| cord-332569-af8oq2d6 | But how do researchers even begin to define these risks and benefits before human clinical trials? |
| cord-332569-af8oq2d6 | Here all of the knowledge accumulated earlier is applied to specific medical questions such as: Will this vaccine protect a pregnant woman( and her baby) from Zika infection? |
| cord-332569-af8oq2d6 | How does the brain work? |
| cord-332569-af8oq2d6 | In human clinical studies, a fundamental question is,"Do the potential benefits of this treatment outweigh the potential risks?" |
| cord-332569-af8oq2d6 | The top 3 benefits of our human/ monkey research partnerships? |
| cord-332569-af8oq2d6 | What is the BRAIN initiative? |
| cord-349790-dezauioa | If applicable, is the statistical analysis and its interpretation appropriate? |
| cord-349790-dezauioa | Is the study design appropriate and is the work technically sound? |
| cord-349790-dezauioa | Is the study design appropriate and is the work technically sound? |
| cord-349790-dezauioa | Yes Are all the source data underlying the results available to ensure full reproducibility? |
| cord-349790-dezauioa | Yes Are the conclusions drawn adequately supported by the results? |
| cord-023017-k6edtg58 | ( I? |
| cord-023017-k6edtg58 | 12mmHg or by? |
| cord-023017-k6edtg58 | 12mmHg or? lo%), had a significantly lower probability of bleeding( P?O.Ol) and of requiring hospital admission because decompensations of cirrhosis, while survival probability was higher, both after acute and chronic beta- blocker administration. |
| cord-023017-k6edtg58 | 2) what are the risk factors of IR; 3) does IR play a role( and to what extent) in the occurrence of steatosis? |
| cord-023017-k6edtg58 | 20% in 38% of cases and decreased? lo% in 74%( P?O.OOl) after acute beta- blocker. |
| cord-023017-k6edtg58 | 4) is IR involved in the progression of fibrosis? |
| cord-023017-k6edtg58 | Control( 0.65 cellsltriad? |
| cord-023017-k6edtg58 | Hemodynamic responders( defining response as a decrease of HVPG to? |
| cord-023017-k6edtg58 | If CD34 numbers are adjusted for the total mononuclear cell counts then the increase in circulating stem cells between these two groups became even more apparent( 0.44? 0.34 and 4.98XlOX6 cellsll 24.8; p<0.05). |
| cord-023017-k6edtg58 | In patients with chronic hepatitis C, we adressed the following issues: 1) is IR the cause or consequence of steatosis and fibrosis? |
| cord-023017-k6edtg58 | Methods: Chronic liver injury was induced in rats by CC14 treatment( of the development of cirrhosis in Group 1( histopathology score of 3.7? |
| cord-023017-k6edtg58 | Our results suggest that: 1) A decrease of HVFG? |
| cord-023017-k6edtg58 | Overall, patients with PNF were older( 55.7 t 10 vs. 48.99 years, p=0.03) and had higher peak ALT levels( 141? 185 vs. 40 2 32 U/ L, p=0.04). |
| cord-023017-k6edtg58 | Studies dealing with the prevention of rebleeding have shown that hemodynamic response to pharmacological treatment of portal hypertension is adequate when the hepatic venous pressure gradient( HVPG) decreases to? |
| cord-023017-k6edtg58 | The HCV RNA was done by a PCR technique with a detectability cutoff of 50-copieslmb Results: Both randomized groups were similar at baseline without statistical significant difference, 190( 90%) were infected with genotype 4, mean age was 39.5 years? |
| cord-023017-k6edtg58 | The HVPG decreased? |
| cord-023017-k6edtg58 | The area of ASMA- positive cells was however significantly decreased by SSR 182289 from 3.83? 1.04 to 2.86 |
| cord-023017-k6edtg58 | The mean level of circulating apoptotic cells in Day 1 recipient PBMC was higher than healthy controls( 0.9% t-0.2 vs 0.2%? |
| cord-023017-k6edtg58 | Using ROC curve a decrease of HVPG? |
| cord-277417-f71jwdzj | A meta- analysis of trends in prognostic markers of HIV disease progression and transmission Association between the rate of CD4+ T cell decrease and the year of human immunodeficeny virus( HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study Is HIV-1 evolving to a less virulent form in humans? |
| cord-277417-f71jwdzj | A phylogenomic analysis of Marek's disease virus reveals independent paths to virulence in Eurasia and North America Immunity promotes virulence evolution in a malaria model Has the rate of progression to AIDS changed in recent years? |
| cord-277417-f71jwdzj | Can Ebola virus evolve to be less virulent in humans? |
| cord-277417-f71jwdzj | Can we read the future from a tree? |
| cord-277417-f71jwdzj | Convergent evolution of lysozyme sequences? |
| cord-277417-f71jwdzj | Did Zika virus mutate to cause severe outbreaks? |
| cord-277417-f71jwdzj | Globalization, land use, and the invasion of West Nile virus H5N1 influenza: a protean pandemic threat Are we ready for pandemic influenza? |
| cord-277417-f71jwdzj | Is there any consistent association between host- jumping and virulence such that predictions can be made about how virulence might evolve following emergence? |
| cord-277417-f71jwdzj | The human immunodeficiency virus Italian seroconversion study Is the virulence of HIV changing? |
| cord-277417-f71jwdzj | This paper provides an overview of the theory that there is a trade- off between virulence and transmissibility, highlighting areas in which the theory has been challenged and extended over the past 20 years Adaptive virulence evolution: the good old fitness- based approach Virulence and transmissibility of pathogens: what is the relationship? |
| cord-277417-f71jwdzj | Virological factors that increase the transmissibility of emerging human viruses Coevolution of hosts and parasites Evolution in Health and Disease Challenging the trade- off model for the evolution of virulence: is virulence management feasible? |
| cord-277417-f71jwdzj | What level of virulence is optimized by natural selection and why? |
| cord-277417-f71jwdzj | Why do RNA viruses recombine? |
| cord-277417-f71jwdzj | Will a virus become more or less virulent in a new host? |
| cord-277417-f71jwdzj | why they are not jacks of all trades? |
| cord-021966-5m21bsrw | > Having chosen an antigen and presentation system, what is the best way to produce it on a large scale? |
| cord-021966-5m21bsrw | A review of the Vaccine Adverse Event Reporting System database Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines Permanent brain damage and pertussis vaccination: is the end of the saga in sight? |
| cord-021966-5m21bsrw | Can a specific antigen( or antigens) be identified that represents the target of protective host immune responses? |
| cord-021966-5m21bsrw | Can the pathogen be grown in culture? |
| cord-021966-5m21bsrw | Even larger phase IIb studies can provide additional data on vaccine safety and immunogenicity in subjects generally representative of those for whom the vaccine might be recommended, but importantly, also provide the first opportunity to address to answer the question,'Does this vaccine work in humans?' |
| cord-021966-5m21bsrw | If natural immunity capable of preventing re- infection follows an initial infection with the pathogen, can a specific host immune effector mechanism( e.g., antibody, CD8 T- cell) be identified as the likely agent( or'correlate') of immune protection? |
| cord-021966-5m21bsrw | If so, can a threshold level of this specific immune correlate needed for protection from re- infection be defined? |
| cord-021966-5m21bsrw | If so, does the pathogen cause such a life- threatening disease that an attenuated version of the virus would face an impossible barrier for demonstration of safety? |
| cord-021966-5m21bsrw | If the infection occurs relatively rarely in an overall population, can a subset of the population be identified that has a higher risk of infection so as to accelerate the achievement of statistically significant protection? |
| cord-021966-5m21bsrw | If the protective immune response is mediated by antibodies, can the target antigen( be it a protein or polysaccharide) be produced in scalable quantities in a form that mimics its native structure so that it can effectively elicit antibody responses that can block the key functional role(s) of the target molecule in the pathogen lifecycle or otherwise lead to the clearance of an incipient pathogen infection? |
| cord-021966-5m21bsrw | Is immunity to a given antigen associated with protection against disease following re- exposure in the context of natural infection? |
| cord-021966-5m21bsrw | Is the antigen of interest sufficiently immunogenic on its own, or is augmentation of the desired immune response by conjugation to a specific carrier or addition of an adjuvant necessary to elicit a sufficient and sufficiently durable immune response in individuals in the target population for vaccination? |
| cord-021966-5m21bsrw | Is this subset sufficiently similar to the rest of the population to enable extrapolation of the clinical results to the broader target population as a whole? |
| cord-021966-5m21bsrw | Recent advances in the development of HIV-1 vaccines using replication- incompetent adenovirus vectors One step forward, two steps back-will there ever be an AIDS vaccine? |
| cord-021966-5m21bsrw | The MMR vaccination and autism controversy in United Kingdom 1998- 2005: inevitable community outrage or a failure of risk communication? |
| cord-021966-5m21bsrw | What are the major unmet medical and public health needs today? |
| cord-021966-5m21bsrw | What is known about the natural history and pathogenic mechanisms of the infection of interest? |
| cord-021966-5m21bsrw | What is the attack rate of the infection in the general population? |
| cord-021966-5m21bsrw | What is the most effective way to present the antigens of the pathogen of interest to the immune system? |
| cord-021966-5m21bsrw | What tests to evaluate vaccine immunogenicity will need to carried out on clinical samples obtained from participants in the clinical trials? |
| cord-021966-5m21bsrw | What types of potential safety concerns can be anticipated for the vaccine in question? |
| cord-021966-5m21bsrw | Will measurement of antibody titers, T- cell responses, pathogen presence and quantity, pathogen serotype, and any other parameter peculiar to the disease in question represent the primary criteria for vaccine effect? |
| cord-022633-fr55uod6 | All sites were asked:''Are psychiatric consults available in- person to the ED?'' |
| cord-022633-fr55uod6 | Does Implementation of a Therapeutic Hypothermia Protocol Improve Survival and Neurologic Outcomes in all Comatose Survivors of Sudden Cardiac Arrest? |
| cord-022633-fr55uod6 | Does the Addition of a Hands- Free Communication Device Improve ED Interruption Times? |
| cord-022633-fr55uod6 | Due to the Medication? |
| cord-022633-fr55uod6 | EMS 9- 1- 1 Protocols Predict ED Utilization for Pediatric Patients? |
| cord-022633-fr55uod6 | Has a doctor or other health professional every told you that you are overweight? |
| cord-022633-fr55uod6 | How often have you felt down, depressed or hopeless?' |
| cord-022633-fr55uod6 | In both surveys, physicians were asked to rate a list of 18 items in response to the question,''What is your current level of competence in each of the following aspects of work in EM?'' |
| cord-022633-fr55uod6 | Is the Australian Triage System a Better Indicator of Psychiatric Patients'Needs for Intervention than the ENA Emergency Severity Index Triage System? |
| cord-022633-fr55uod6 | Objectives: Is PRP helpful in acute ankle sprains in the the emergency department? |
| cord-022633-fr55uod6 | Objectives: To answer the following research question: are wounds closed via primary repair after the golden period at increased risk for infection? |
| cord-022633-fr55uod6 | Objectives: We assessed patients'perceptions about obesity as disease and patient communication with their providers through two questions: Do you believe your present weight is damaging to your health? |
| cord-022633-fr55uod6 | Over the last two weeks, how often have you had little interest in doing things? |
| cord-022633-fr55uod6 | Residents were asked:''What do you feel are your greatest strengths as a resident? |
| cord-022633-fr55uod6 | The Way Of The Future? |
| cord-022633-fr55uod6 | The question being asked: is the TBT still useful as a screening tool for patients with suspected mandibular fractures when compared to the new gold standard of HCT? |
| cord-323261-1of5ertf | After the Global Fund Investment in HIV/ AIDS programs: does it help strengthen health Systems in Developing Countries? |
| cord-323261-1of5ertf | Considering the regime type of the government, allowing the growth of local NGOs would in turn potentially attenuate the supremacy of the Chinese Communist Party( CCP) in ruling the country or erode the autonomy of the state, why the Chinese government tolerated, allowed, or even encouraged the growth of NGOs in fixing HIV/ AIDS problems, especially the epidemic has been viewed as a politically sensitive issue in China? |
| cord-323261-1of5ertf | How can one account for and understand the phenomenon? |
| cord-323261-1of5ertf | How is health a security issue? |
| cord-323261-1of5ertf | International Community Foundation Is China's new overseas NGO management law sounding the death knell for civil society? |
| cord-323261-1of5ertf | Politics, responses and issues Securitizing infectious disease Should HIV/ AIDS be securitized? |
| cord-323261-1of5ertf | The ethical dilemmas of linking HIV/ AIDS and security where are the links? |
| cord-323261-1of5ertf | United Nations General Assembly United Nations General Assembly AIDS and security: where are we now? |
| cord-323261-1of5ertf | key: cord-323261- 1of5ertf authors: Lo, Catherine Yuk- ping title: Securitizing HIV/ AIDS: a game changer in state- societal relations in China? |
| cord-330852-n7j0c4ne | ( Fig. 6.5D)? |
| cord-330852-n7j0c4ne | ( Patargias et al., 2006): is the p7 bundle just sensitive to protons but does not conduct them? |
| cord-330852-n7j0c4ne | How can a protein be defined as a channel? |
| cord-330852-n7j0c4ne | How does knowledge about the mechanism of function fit into this wish? |
| cord-330852-n7j0c4ne | Or is p7 also a proton conductor similar to M2? |
| cord-330852-n7j0c4ne | Or is the interaction with the host to be seen as a kind of"host based ligand"closing the channel while without the host protein the channel is open; or do other ligands trigger activity? |
| cord-330852-n7j0c4ne | What makes knowledge of the mechanism of function so important? |
| cord-330852-n7j0c4ne | With further analogy to M2, the question arises, can the protein also be built by less than the six units as it is proposed to date? |
| cord-332610-t99l3zii | How do emerging diseases come to be categorized as'emerging'? |
| cord-332610-t99l3zii | If certain populations have long been afflicted by these disorders, why are the diseases considered''new''or''emerging''? |
| cord-332610-t99l3zii | If this is the case, what is the concern over avian influenza? |
| cord-332610-t99l3zii | In his critical analysis of emerging infection, Farmer asks,''Emerging for whom?'' |
| cord-332610-t99l3zii | Is it simply because they have come to afflict more visible-read more''valuable''persons? |
| cord-332610-t99l3zii | Nor does it answer the question''what drives the overall worldwide trends in such problems?'' |
| cord-332610-t99l3zii | Should toxic shock syndrome be considered to be an emerging disease? |
| cord-332610-t99l3zii | The 1969 outbreak was publicized in the United States through the news media, perhaps because it was an'exotic'or newsworthy event, and once again, the social amplification of risk was responsible for exaggerated fears of'what if it spreads here?' |
| cord-332610-t99l3zii | not answer either the micro- scale questions such as''why is there an outbreak here, now, of this size, affecting these people?''nor does it answer the macro- questions such as''why are there more( or fewer) outbreaks this decade than last?'' |
| cord-332610-t99l3zii | not answer either the micro- scale questions such as''why is there an outbreak here, now, of this size, affecting these people?''nor does it answer the macro- questions such as''why are there more( or fewer) outbreaks this decade than last?'' |
| cord-337659-x4oywbrj | But, just how much of an improvement would that be? |
| cord-337659-x4oywbrj | In considering the gaps in the U.S. agriculture and food defense capabilities, the main question that must be addressed is: Exactly what level of security do the people of the USA want the agricultural industry to achieve, and our government to enforce, in terms of food safety and biosecurity? |
| cord-337659-x4oywbrj | Molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain-A conceptual shift Pandemic influenza: are we ready? |
| cord-337659-x4oywbrj | Or, will this threat diminish before it evolves into a more human- specific virus? |
| cord-337659-x4oywbrj | So, how can this be achieved? |
| cord-337659-x4oywbrj | So, how could this be improved? |
| cord-337659-x4oywbrj | This was considered an accidental outbreak, but what if it had been a deliberate attack? |
| cord-337659-x4oywbrj | Will this fine dividing line be crossed soon? |
| cord-016472-jj7fqcen | Ethical questions correctional health researchers must address include: • What procedures ensure that all incarcerated people involved in studies have been given the opportunity to give informed and voluntary consent to participate in the research? |
| cord-016472-jj7fqcen | Have the courts made a difference in the quality of prison conditions? |
| cord-016472-jj7fqcen | How best can we develop consistent frameworks for research so that clinical, practice, and policy decisions can be more evidence- based? |
| cord-016472-jj7fqcen | How can researchers ensure that participation in correctional health research studies will not lead to harm through disclosure of confidential medical or criminal justice information to third parties? |
| cord-016472-jj7fqcen | How do correctional health researchers balance their ethical responsibilities to the correctional officials who commission their work or provide access to inmates with their responsibility to inmates? |
| cord-016472-jj7fqcen | How does incarceration affect the health of the families and communities of incarcerated individuals? |
| cord-016472-jj7fqcen | How does incarceration itself affect the health of incarcerated populastions? |
| cord-016472-jj7fqcen | How does reentry affect the health of incarcerated populations? |
| cord-016472-jj7fqcen | How does the health of inmates differ from that of nonincarcerated populations? |
| cord-016472-jj7fqcen | Questions to discuss include: what are the most promising avenues of research to lead to short- and middle- term improvements in the health of incarcerated populations? |
| cord-016472-jj7fqcen | Research questions that need to be addressed in the coming decade include: How does incarceration influence socioeconomic, racial, and gender disparities in health in the United States? |
| cord-016472-jj7fqcen | Right or regression? |
| cord-016472-jj7fqcen | What are potential stable funding streams for this research? |
| cord-016472-jj7fqcen | What are the health and social characteristics of people in jail and prison? |
| cord-016472-jj7fqcen | What are the health effects of criminal justice policies and practices on the health of inmates? |
| cord-016472-jj7fqcen | What correctional research might be particularly beneficial both to the health of the incarcerated and to the larger health of the public? |
| cord-016472-jj7fqcen | What ethical responsibility do researchers have to bring the findings of their research in correctional settings to policy makers or others who can act on these finding? |
| cord-016472-jj7fqcen | What have we accomplished to date? |
| cord-016472-jj7fqcen | What is the impact of incarceration rates on the well- being of communities and populations? |
| cord-016472-jj7fqcen | What is the impact of interventions designed to care for or improve the health of incarcerated populations? |
| cord-016472-jj7fqcen | What level of individual or population benefits in correctional health research balances potential risks? |
| cord-016472-jj7fqcen | What research practices can guarantee that inmates have as much right to choose to participate in research as any other population? |
| cord-016472-jj7fqcen | What role can correctional health services play in reducing community incidence, prevalence, severity, or costs of conditions such as HIV infection, hepatitis C, diabetes, asthma, addiction, violence, depression, or lack of health insurance? |
| cord-016472-jj7fqcen | Who are the constituencies that will support a national research agenda on correctional health and how can these constituencies be organized into a coherent force? |
| cord-337458-dc90ecfe | A Tool for Malaria Diagnosis? |
| cord-337458-dc90ecfe | For instance, what are the physiochemical differences between high and low affinity egg groups? |
| cord-337458-dc90ecfe | If so, should two types of magnetic microspheres be used to ensure the Helmintex method captures all egg types present in a sample? |
| cord-337458-dc90ecfe | In other words, what changes can be made to the diagnostic test format that maintain the simplicity of lateral flow assays but will enable improved quantification, communication, and aggregation of test results? |
| cord-337458-dc90ecfe | Is there a biological difference between the two groups, such as egg maturity or surface antigen expression? |
| cord-337458-dc90ecfe | Newly Developed, Rapid Immunochromatographic Antigen Detection Tests Be Reliably Used for the Laboratory Diagnosis of Influenza Virus Infections? |
| cord-337458-dc90ecfe | What They Are and What They Are Not? |
| cord-337458-dc90ecfe | Why Is Trehalose an Exceptional Protein Stabilizer? |
| cord-337458-dc90ecfe | studies were performed on eggs isolated from livers of infected mice, but do these two egg populations appear in the urine or feces of infected humans? |
| cord-311679-m6poosn3 | Among 5700 Patients Hospitalized With COVID-19 in the Why Are n't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019( COVID-19)? |
| cord-311679-m6poosn3 | Do you feel you have access to HIV prevention strategies during the COVID-19 crisis?" |
| cord-311679-m6poosn3 | For participants living with HIV, questions were also asked regarding their access to HIV providers( e.g.,"Since the beginning of COVID-19 related social isolation in your country, by that or any other name, have you been able to see your HIV provider if you needed to?") and medication( e.g.,"Do special measures related to COVID-19 impact your ability to access or refill your HIV medicine?"), as well as on their perception of being vulnerable to COVID-19 due to their HIV status( e.g.,"Do you feel that you are more vulnerable to COVID-19 because you are living with HIV?"). |
| cord-311679-m6poosn3 | For participants living with HIV, questions were also asked regarding their access to HIV providers( e.g.,"Since the beginning of COVID-19 related social isolation in your country, by that or any other name, have you been able to see your HIV provider if you needed to?") and medication( e.g.,"Do special measures related to COVID-19 impact your ability to access or refill your HIV medicine?"), as well as on their perception of being vulnerable to COVID-19 due to their HIV status( e.g.,"Do you feel that you are more vulnerable to COVID-19 because you are living with HIV?"). |
| cord-311679-m6poosn3 | For participants living with HIV, questions were also asked regarding their access to HIV providers( e.g.,"Since the beginning of COVID-19 related social isolation in your country, by that or any other name, have you been able to see your HIV provider if you needed to?") and medication( e.g.,"Do special measures related to COVID-19 impact your ability to access or refill your HIV medicine?"), as well as on their perception of being vulnerable to COVID-19 due to their HIV status( e.g.,"Do you feel that you are more vulnerable to COVID-19 because you are living with HIV?"). |
| cord-311679-m6poosn3 | Participants were also asked about their HIV serostatus; membership to a racial or ethnic minority group( e.g., Do you consider yourself a member of an ethnic or racial minority?); immigrant status( e.g.,"Are you, or is one or more of your parents, a migrant to the country in which you currently live?"); and history of engaging in sex work( e.g.,"Have you ever engaged in sex work |
| cord-311679-m6poosn3 | Participants were also asked about their HIV serostatus; membership to a racial or ethnic minority group( e.g., Do you consider yourself a member of an ethnic or racial minority?); immigrant status( e.g.,"Are you, or is one or more of your parents, a migrant to the country in which you currently live?"); and history of engaging in sex work( e.g.,"Have you ever engaged in sex work |
| cord-311679-m6poosn3 | The survey assessed the impact of the COVID-19 pandemic on participants'economic status through questions regarding their employment status; ability to make ends meet( e.g.,"Thinking of your household's total monthly income, is your household able to make ends meet?"); income level( e.g.,"How much are you expecting your income to reduce because of the COVID-19 crisis?"); receipt of government financial assistance( e.g.,"Are you receiving any additional financial benefits from work or government because of the COVID-19 crisis?"); loss of health insurance coverage( e.g.,"Do you expect to lose your health insurance coverage because of the COVID-19 crisis?"); and food security( e.g.,"Since the COVID-19 crisis began, have you had to cut the size of your meals or skip meals because there was not enough money for food?"). |
| cord-311679-m6poosn3 | The survey assessed the impact of the COVID-19 pandemic on participants'economic status through questions regarding their employment status; ability to make ends meet( e.g.,"Thinking of your household's total monthly income, is your household able to make ends meet?"); income level( e.g.,"How much are you expecting your income to reduce because of the COVID-19 crisis?"); receipt of government financial assistance( e.g.,"Are you receiving any additional financial benefits from work or government because of the COVID-19 crisis?"); loss of health insurance coverage( e.g.,"Do you expect to lose your health insurance coverage because of the COVID-19 crisis?"); and food security( e.g.,"Since the COVID-19 crisis began, have you had to cut the size of your meals or skip meals because there was not enough money for food?"). |
| cord-311679-m6poosn3 | The survey assessed the impact of the COVID-19 pandemic on participants'economic status through questions regarding their employment status; ability to make ends meet( e.g.,"Thinking of your household's total monthly income, is your household able to make ends meet?"); income level( e.g.,"How much are you expecting your income to reduce because of the COVID-19 crisis?"); receipt of government financial assistance( e.g.,"Are you receiving any additional financial benefits from work or government because of the COVID-19 crisis?"); loss of health insurance coverage( e.g.,"Do you expect to lose your health insurance coverage because of the COVID-19 crisis?"); and food security( e.g.,"Since the COVID-19 crisis began, have you had to cut the size of your meals or skip meals because there was not enough money for food?"). |
| cord-311679-m6poosn3 | The survey assessed the impact of the COVID-19 pandemic on participants'economic status through questions regarding their employment status; ability to make ends meet( e.g.,"Thinking of your household's total monthly income, is your household able to make ends meet?"); income level( e.g.,"How much are you expecting your income to reduce because of the COVID-19 crisis?"); receipt of government financial assistance( e.g.,"Are you receiving any additional financial benefits from work or government because of the COVID-19 crisis?"); loss of health insurance coverage( e.g.,"Do you expect to lose your health insurance coverage because of the COVID-19 crisis?"); and food security( e.g.,"Since the COVID-19 crisis began, have you had to cut the size of your meals or skip meals because there was not enough money for food?"). |
| cord-311679-m6poosn3 | The survey assessed the impact of the COVID-19 pandemic on participants'economic status through questions regarding their employment status; ability to make ends meet( e.g.,"Thinking of your household's total monthly income, is your household able to make ends meet?"); income level( e.g.,"How much are you expecting your income to reduce because of the COVID-19 crisis?"); receipt of government financial assistance( e.g.,"Are you receiving any additional financial benefits from work or government because of the COVID-19 crisis?"); loss of health insurance coverage( e.g.,"Do you expect to lose your health insurance coverage because of the COVID-19 crisis?"); and food security( e.g.,"Since the COVID-19 crisis began, have you had to cut the size of your meals or skip meals because there was not enough money for food?"). |
| cord-311679-m6poosn3 | Will the global HIV response fail gay and bisexual men and other men who have sex with men? |
| cord-318363-1mv5j4w2 | : Is There a Generalized HIV Epidemic in Impoverished Urban Areas of the United States? |
| cord-318363-1mv5j4w2 | A multidimensional model of obsessive- compulsive disorder Do the daily experiences of healthy men and women vary according to occupational prestige and work strain? |
| cord-318363-1mv5j4w2 | Behavior, Research, and Therapy Socioeconomic status differences in vulnerability to undesirable life events Is anxiety sensitivity distinguishable from trait anxiety? |
| cord-318363-1mv5j4w2 | COVID-19: Risk of increase in smoking rates among England's 6 million smokers and relapse among England's 11 million ex- smokers Computer- delivered personalized feedback intervention for hazardous drinkers with elevated anxiety sensitivity: Study protocol for a randomized controlled trial Pandemics and violence against women and children Wider income gaps, wider waistbands? |
| cord-318363-1mv5j4w2 | Do negative beliefs about exposure therapy cause its suboptimal delivery? |
| cord-318363-1mv5j4w2 | How much anxiety is reasonable? |
| cord-318363-1mv5j4w2 | That is, do cleaning behaviors likewise decline or remain at elevated states thereby impacting diagnosis rates? |
| cord-318363-1mv5j4w2 | The Pediatric infectious disease journal Are the high smoking rates related to COVID-19 outbreaks? |
| cord-318363-1mv5j4w2 | The age of anxiety? |
| cord-318363-1mv5j4w2 | The relation of perceived and received social support to mental health among first responders: a meta- analytic review Intolerance of uncertainty and DSM-5 PTSD symptoms: Associations among a treatment seeking veteran sample Acceptance: A key to wellbeing in older adults? |
| cord-318363-1mv5j4w2 | Why do clinicians exclude anxious clients from exposure therapy? |
| cord-318363-1mv5j4w2 | a meta- analysis of treatment outcome and moderators Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? |
| cord-305085-bv7udg9k | : prospective cohort study from Durban Are HIVinfected women who breastfeed at increased risk of mortality? |
| cord-305085-bv7udg9k | A further report on cancer of the breast Repeated congenital infection with Toxoplasma gondii Is ingestion of milk associated bacteria by premature infants fed raw human milk controlled by routine bacteriologic screening? |
| cord-305085-bv7udg9k | Does breast feeding increase the child's risk of breast cancer? |
| cord-305085-bv7udg9k | HIV Infection in Newborns French Collaborative Study Group Clinical Virology Postpartum varicella vaccination: Is the vaccine virus excreted in breast milk? |
| cord-305085-bv7udg9k | How well will they work were they are needed most? |
| cord-305085-bv7udg9k | Ing et al 194 investigated the question,"Does the unsuckled breast have an altered risk for cancer? |
| cord-305085-bv7udg9k | Is breast milk collected at home suitable for raw consumption by neonates in Brizilian public neonatal intensive care units? |
| cord-305085-bv7udg9k | Morbidity in children born to women infected with human immunodeficiency virus in South Africa: Does mode of feeding matter? |
| cord-305085-bv7udg9k | Neonatal group B streptococcal infection related to breast milk Epidemiology of tuberculosis in the United States Probable transmission of brucellosis by breast milk Does discarding the first few milliliters of breast milk improve the bacteriological quality of bank breast milk? |
| cord-305085-bv7udg9k | New frontiers in an old dilemma Breastfeeding and the risk of life- threatening rotavirus diarrhea: Prevention or postponement? |
| cord-305085-bv7udg9k | Revised guidelines from CDC Detection of TT virus DNA and GB virus type C/ hepatitis G virus RNA in serum and breast milk: Determination of mother- to- child transmission Effects of hepatitis A and B in pregnancy on the mother and fetus Human immunodeficiency virus load in breast milk, mastitis and mother- to- child transmission of human immunodeficiency virus type 1 How contagious is vaccinia? |
| cord-305085-bv7udg9k | The yeast connection: is Candida linked to breastfeeding associated pain? |
| cord-305085-bv7udg9k | Which measures for which success? |
| cord-305085-bv7udg9k | Who should receive rifampin? |
| cord-354374-rtgjjglc | Does the T- cell repertoire expand following reconstitution to recognize'new'CMV antigens? |
| cord-354374-rtgjjglc | How can CMV indices be monitored to predict relapse in patients on HAART? |
| cord-354374-rtgjjglc | What are the immune consequences of retroviral rebound when HAART fails? |
| cord-354374-rtgjjglc | What are the specific immune mechanisms leading to disease resolution following HAART? |
| cord-354374-rtgjjglc | What are the specific immune mechanisms leading to disease resolution following HAART? |
| cord-354374-rtgjjglc | What is the significance of pathological change associated with'adenovirus colitis'? |
| cord-354374-rtgjjglc | What role do non- CMV enteric viruses, particularly adenovirus, have in HIV- related diarrhoea? |
| cord-354374-rtgjjglc | What role does HAART play in the control of non- CMV enteric virus infection? |
| cord-354374-rtgjjglc | When can secondary prophylaxis be discontinued in patients that respond to HAART? |
| cord-270726-w59fu9c9 | As treatment of HIV has improved, the increase in peripheral CD4? |
| cord-270726-w59fu9c9 | Clostridium difficile is more common in patients with advanced AIDS( CD4? |
| cord-270726-w59fu9c9 | Data from simian models with simian immunodeficiency virus[ 16] and from patients with HIV[ 13, 17, 18] show that within weeks of infection, the vast majority of mucosal lamina propria CD4? lymphocytes are depleted. |
| cord-270726-w59fu9c9 | Diarrhea- associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2? |
| cord-270726-w59fu9c9 | Further, despite the use of potent antiretroviral medications, HIV persists within GALT lymphocytes, even after repletion of CD4? |
| cord-270726-w59fu9c9 | Imodium A- D, and Imodium multi- symptom relief( loperamide and loperamide- simethicone) PA: McNeil Consumer Healthcare Crofelemer for the treatment of secretory diarrhea Efficacy and safety of crofelemer for noninfectious diarrhea in HIV- seropositive individuals( ADVENT trial): a randomized, double- blind, placebocontrolled, two- stage study Population pharmacokinetic( PK) analysis demonstrates no drug- drug interactions( DDI) between crofelemer, a novel treatment for noninfectious diarrhea in HIV? |
| cord-270726-w59fu9c9 | In addition to these pathogens, patients with HIV who are profoundly immunosuppressed, with a CD4? |
| cord-270726-w59fu9c9 | In addition, crofelemer has no known drug interactions with ART drugs, is minimally absorbed, and does not have a negative impact on the clinical immune parameters( e.g., HIV viral load and CD4? |
| cord-270726-w59fu9c9 | In support of this assertion, US historical data of HIV- infected patients with CD4? |
| cord-270726-w59fu9c9 | Laboratory tests should include comprehensive metabolic panel, complete blood count with cell differential, blood cultures, HIV viral load, and CD4? |
| cord-270726-w59fu9c9 | Mycobacterium avium complex( MAC) typically causes diarrhea in patients with AIDS with profoundly suppressed immune systems( i.e., CD4? |
| cord-270726-w59fu9c9 | T cell depletion and viral replication in SIV infection Primary HIV-1 infection is associated with preferential depletion of CD4? |
| cord-270726-w59fu9c9 | T cells but is overpopulated with CD8? |
| cord-270726-w59fu9c9 | T cells is seen in the periphery and likely reflects the greater expression of the CC chemokine receptor type 5( CCR5), which functions as the primary coreceptor for the majority of infective HIV strains, on mucosal CD4? |
| cord-270726-w59fu9c9 | T lymphocytes from effector sites in the gastrointestinal tract Mechanisms of gastrointestinal CD4? |
| cord-270726-w59fu9c9 | The expression of the chemokine receptor on these cells supports the entry of the virus, but their state of physiologic activation is responsible for enhanced HIV replication in the mucosal compartment and subsequent mucosal CD4? |
| cord-270726-w59fu9c9 | The mucosal immune system and HIV-1 infection Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissueinfiltrating lymphocytes Gastrointestinal tract as a major site of CD4? |
| cord-270726-w59fu9c9 | This depletion occurs well before any decrease in CD4? |
| cord-270726-w59fu9c9 | This reflects greater mucosal infiltration by activated CD8? |
| cord-270726-w59fu9c9 | Thus, in patients with chronic HIV infection, the mucosal environment contains a paucity of CD4? |
| cord-304157-u0mlee6u | : Implementation strategies from the African Health Initiative Can mHealth improve access to safe blood for transfusion during obstetric emergency? |
| cord-304157-u0mlee6u | Currently, which are the worst performing provinces, districts and faciliƟes needing more aƩenƟon? |
| cord-304157-u0mlee6u | How can emergency and essenƟal health services teams collaborate? |
| cord-304157-u0mlee6u | How do we maintain quality monitoring of exisƟng essenƟal services during emergency? |
| cord-304157-u0mlee6u | How do we maximize the potenƟal of web and mobile based technologies for service delivery? |
| cord-304157-u0mlee6u | How do we tap from resources outside the health systems and ensure mulƟsectoral collaboraƟon? |
| cord-304157-u0mlee6u | How do we Ɵmely integrate emergency responses with priority essenƟal services? |
| cord-304157-u0mlee6u | How will COVID-19 responses affect health system's delivery of essenƟal services? |
| cord-304157-u0mlee6u | No increased coronavirus risk for people with well- controlled HIV says WHO, but how will health systems cope? |
| cord-304157-u0mlee6u | What are the exisƟng gaps and strengths in essenƟal services( within each WHO building block)? |
| cord-304157-u0mlee6u | What emergency responses will be needed for COVID-19? |
| cord-304157-u0mlee6u | What is the current capacity of the health system to mobilize resources? |
| cord-304157-u0mlee6u | What makes health systems resilient against infectious disease outbreaks and natural hazards? |
| cord-304157-u0mlee6u | Which essenƟal services need to be prioriƟzed, postponed and suspended? |
| cord-304157-u0mlee6u | Which populaƟon group will be most affected? |
| cord-350569-dtxtjtfo | Does Christman, who criticises Frankfurtian theories of autonomy, provide a more realistic perspective? |
| cord-350569-dtxtjtfo | If indeed humans are self- rulers and rational players, why should social stigma prevent them from making self- rational and moral decisions in directing their own HIV medical therapy for their own good, and direct their lives as they deem fit? |
| cord-350569-dtxtjtfo | If to be autonomous is to be self- governing or self- directing or, in other words, to act on motives, values, and reasons that are one's own, then how can we restrict non- autonomous action to only false/ oppressive socialisation? |
| cord-350569-dtxtjtfo | Is this not conceptually and practically conflicting? |
| cord-350569-dtxtjtfo | Or there is n't a need to rethink because humans are, as Kantian and related notions of autonomy tell us, normatively and narratively sovereign selves? |
| cord-350569-dtxtjtfo | Therefore, does this temptation and pursuit to view ourselves as autonomous HIV testing decision- makers blind us to an observable reality that shows that as humans we are interdependent and inextricably social and socialised beings? |
| cord-350569-dtxtjtfo | Thus, can Killmister convincingly enumerate in what circumstances exactly an agent can enjoy this limited autonomy, circumstances which are excluded from the susceptibility to socialisation, internalisation, biological influences or environmental changes? |
| cord-350569-dtxtjtfo | Thus, should there be a need to rethink the personal autonomy 1 premising of informed consent requirements in HIV testing in most sub- Saharan African( SSA) countries, since informed consent requirements in HIV testing are mainly premised on personal autonomy? |
| cord-350569-dtxtjtfo | What about Christman's theory of autonomy which Killmister claims is more persuasive? |
| cord-350569-dtxtjtfo | Why should patients be declared and imputed with personal autonomy and yet at the same time blame the impact of social stigma on preventing potential HIV service- users from seeking medical attention? |
| cord-007890-bie1veti | ( 5?-GCAAGTTCTT- CAGCTTGTTT-3?). |
| cord-007890-bie1veti | ( 5?-TATTGCGCT- TAGAAAATTAA-3?) |
| cord-007890-bie1veti | ( hence, if we treat alcoholic cirrhosis patients with interferon could we have a favorable response?). |
| cord-007890-bie1veti | */does its aetiology matter? |
| cord-007890-bie1veti | And on the basis of which classification system should the two legs of such a trial be separated? |
| cord-007890-bie1veti | Can coins and paper currency transmit Bacillus anthracis? |
| cord-007890-bie1veti | Can varicella be eliminated by universal childhood vaccination? |
| cord-007890-bie1veti | Do the trials with interferon alfa for patients with HBV or HCV cirrhosis exhibit a favorable result due to the antiviral properties of interferon, or is interferon exhibiting anti- oncogenic potential?, and is HCC cytokine and hormone sensitive( view ongoing trials with somatostatine analogues versus HCC)? |
| cord-007890-bie1veti | Do the trials with interferon alfa for patients with HBV or HCV cirrhosis exhibit a favorable result due to the antiviral properties of interferon, or is interferon exhibiting anti- oncogenic potential?, and is HCC cytokine and hormone sensitive( view ongoing trials with somatostatine analogues versus HCC)? |
| cord-007890-bie1veti | Does their end in the stage of cirrhosis? |
| cord-007890-bie1veti | HBV Á/ HCV and liver carcinogenesis: where does the viral influence end? |
| cord-007890-bie1veti | How ethical is it to conduct a randomised trial where one leg of cirrhotic patients is left without antiviral therapy? |
| cord-007890-bie1veti | How much hope can be put on a drug that seems to be partly useless before its initiation? |
| cord-007890-bie1veti | In vivo activity of glycopeptides against S. aureus infection in a rabbit endocarditis model: is MIC predictive for in vivo efficacy? |
| cord-007890-bie1veti | Is progression towards HCC independent of the etiology of cirrhosis( since alcoholic cirrhosis also proceeds to HCC)? |
| cord-007890-bie1veti | Lactulose, a factor that decreases endotoxaemia, in obstructive jaundice? |
| cord-007890-bie1veti | Moreover, do viral proteins with oncogenic potential exist( the controversy over the recently discovered HBV protein is still, unresolved)? |
| cord-007890-bie1veti | Our experience suggests a promising role of lamivudine in the treatment of acute hepatitis B, but how long such therapy have to be practiced and in which patients? |
| cord-007890-bie1veti | These strains was genotypically characterized for the mec A gene presence by PCR method using the mec A 1- 5?-AAA ATC CAT GGT AAA GGT TGG C-3? and the mec A 2 Á/5?-AGT TCT GCA GTA CCG GAT TTG C-3? primers( GIBCO, BRL). |
| cord-007890-bie1veti | These strains was genotypically characterized for the mec A gene presence by PCR method using the mec A 1- 5?-AAA ATC CAT GGT AAA GGT TGG C-3? and the mec A 2 Á/5?-AGT TCT GCA GTA CCG GAT TTG C-3? primers( GIBCO, BRL). |
| cord-007890-bie1veti | Which patients with HBV or HCV cirrhosis are eligible for interferon treatment? |
| cord-007890-bie1veti | and of transconjugants and the amplification by PCR of the gene aac(6?)-aph(2?? |
| cord-007890-bie1veti | and of transconjugants and the amplification by PCR of the gene aac(6?)-aph(2?? |
| cord-007890-bie1veti | can the associated morbidity and mortality in this rare but deadly disease be reduced? |
| cord-022348-w7z97wir | And if so, what is the virus adapting to? |
| cord-022348-w7z97wir | Are They Adapting or Merely Changing? |
| cord-022348-w7z97wir | But if it were non- linear? |
| cord-022348-w7z97wir | Can quasispecies define a transient molecular clock? |
| cord-022348-w7z97wir | Conservative perhaps, but is there any suggestion that viruses are more or less so than other replicons? |
| cord-022348-w7z97wir | Could symptomatic infections reflect bottleneck transmission of those fitter clones with asymptomatic( subclinical) infection representing fitness- compromised clones? |
| cord-022348-w7z97wir | Does the VP1 gene of foot- and- mouth disease virus behave as a molecular clock? |
| cord-022348-w7z97wir | For outbred populations, is it in fact virulence? |
| cord-022348-w7z97wir | Given the inevitability of mutation, is it possible that over the aeons natural selection has selected for proteins that are robust, those that are capable of absorbing endless substitutions? |
| cord-022348-w7z97wir | How are innate and adaptive immune responses coupled and how are they influenced by genetic polymorphisms? |
| cord-022348-w7z97wir | How good are viruses as machines? |
| cord-022348-w7z97wir | How many rounds of infection are necessary to fix mutations? |
| cord-022348-w7z97wir | Is not fourth best in any large population remarkable? |
| cord-022348-w7z97wir | Might this finding suggest that the optimum is actually away from mass production? |
| cord-022348-w7z97wir | Problems arise transposing it to the in vivo situation, notably: 9 First and foremost: how does one determine fitness in vivo? |
| cord-022348-w7z97wir | Should such measurements score intrahost viral titres or transmission probabilities from an index case? |
| cord-022348-w7z97wir | We come to the basic question- to what extent is genetic variation exploited by an RNAvirus, if at all? |
| cord-022348-w7z97wir | What fraction of amino acid residues is necessary for function? |
| cord-022348-w7z97wir | What is the value of n? |
| cord-022348-w7z97wir | What might a viral species be? |
| cord-022348-w7z97wir | While they are fit enough to survive, are they the best possible? |
| cord-022348-w7z97wir | Why do they mutate rapidly yet remain phenotypically stable? |
| cord-022348-w7z97wir | Why is the evolution of RNA viruses so conservative? |
| cord-022348-w7z97wir | Why is this? |
| cord-022348-w7z97wir | Yet is that correct? |
| cord-022348-w7z97wir | Yet who can remember the name of any Olympic athlete who came in fourth? |
| cord-330970-6kkqoh7f | I wonder if they were head or body lice-is a wig hair or clothing? cord-330970-6kkqoh7f Can we now view this phenomenon in the same way as the lice, as one of the pair of parasites cospeciating with H. sapiens and the other jumping from non- ancestral archaic humans to the modern human lineage? cord-330970-6kkqoh7f Had this custom arisen to protect them from lice as Zinsser[ 1] suggests? cord-330970-6kkqoh7f Is it a coincidence that three human parasites acquired horizontally from great apes, namely pubic lice, HIV-1 and speculatively HSV-2, are sexually transmitted? cord-330970-6kkqoh7f Might vivax malaria have first adapted to H. erectus as an intermediate between monkeys and humans? cord-330970-6kkqoh7f Over to the microbiologists: What do the bacteria, viruses and fungi tell us? cord-330970-6kkqoh7f So how can humans harbor two clades of louse that diverged from each other over one million years ago, when that separation is tenfold older than the emergence of Homo sapiens? cord-330970-6kkqoh7f So was there duplication and separation of lice in the African anthropoid ape lineage, where they could have occupied separate ecological niches, rather as human head lice and pubic lice do today? cord-330970-6kkqoh7f So where did HSV-2 come from? cord-330970-6kkqoh7f Which came first, nakedness or pubic hair? cord-330970-6kkqoh7f Why do adult humans sport a thick bush of wiry pubic hair, uniquely among primates? cord-330970-6kkqoh7f to op pa ar ra as si it te es s?? cord-330970-6kkqoh7f to op pa ar ra as si it te es s?? cord-317213-vhprfb1o 13.1 pg/ ml Clinical/ real- world samples tested? cord-317213-vhprfb1o : what's new? cord-317213-vhprfb1o An electrochemical DNA hybridization detection assay based on a silver nanoparticle label HIV viral load monitoring in resource- limited regions: optional or necessary? cord-317213-vhprfb1o Cisplatin- tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? cord-317213-vhprfb1o Clinical/ real- world samples tested? cord-317213-vhprfb1o Clinical/ real- world samples tested? cord-317213-vhprfb1o Clinical/ real- world samples tested? cord-317213-vhprfb1o Clinical/ real- world samples tested? cord-317213-vhprfb1o Clinical/ real- world samples tested? cord-317213-vhprfb1o Clinical/ real- world samples tested? cord-317213-vhprfb1o ECM: LOD of 260 pg/ ml Clinical/ real- world samples tested? cord-317213-vhprfb1o LOD slightly varied between antigen types, ranging from 0.8 ng/ ml for HBV to 1.5 ng/ ml for HCV and HEV • same upper limit of linear range( 350 ng/ ml) Clinical/ real- world samples tested? cord-317213-vhprfb1o no amplification or enrichment required Assay time: 20 min Clinical/ real- world samples tested? cord-317213-vhprfb1o • 100 viral particles in 100 μl samples Clinical/ real- world samples tested? cord-317213-vhprfb1o • amplification using PCR Detection range: 10 2-10 5 cells Clinical/ real- world samples tested? cord-317213-vhprfb1o • amplification using PCR • dilution with TE buffer solution, followed by denaturation in boiling water bath Detection range: • 1 fM-10 nM of nuc gene • 10- 10 6 CFU ml −1 for real- world samples Clinical/ real- world samples tested? cord-324137-nau83mjv , are the plasmids of other bacteria also devoid of G4s? cord-324137-nau83mjv Are the differences in the density and distribution of G4s in pathogens influenced by the ecological relationship they share with the host? cord-324137-nau83mjv Are the prokaryotic ORFs devoid of G4s to cut down on the energy cost of resolution of G4 for translation? cord-324137-nau83mjv As in D. radiodurans, are the unique adaptations of other extremophiles regulated by G4s? cord-324137-nau83mjv Do G4s represent structural elements for conservation of energy in bacterial metabolism? cord-324137-nau83mjv Do the pathogenicity islands in bacterial genomes have unique G4 profiles? cord-324137-nau83mjv Does the presence of G4s as an additional level of coordinated gene control in operons also signify the same? cord-324137-nau83mjv In other words, are there differences in the genomic densities of G4s among parasites, symbionts, commensals, and mutualists? cord-324137-nau83mjv Is G4-mediated control of gene expression exercised only in the early stages of central dogma to conserve energy? cord-324137-nau83mjv Microbiol G- quadruplexes in pathogens: a common route to virulence control? cord-324137-nau83mjv Stability and kinetics of G- quadruplex structures High- throughput sequencing of DNA G- quadruplex structures in the human genome How long is too long? cord-324137-nau83mjv Supplemental information associated with this article can be found Do G4-unwinding helicases encoded by the host interact with G4s in pathogens during infection? cord-324137-nau83mjv and the ability of G4s to pause replication, are they selectively eliminated from extrachromosomal elements to minimize interference, if any, in vertical transmission? cord-324137-nau83mjv mRNA translation Is the Epstein- Barr virus EBNA-1 protein an oncogen? cord-324137-nau83mjv such host- microbe interactions doubleedged swords that help the host to defend some infections and prove to be detrimental in others? cord-355318-qm79gz8w : Insights into environmental resistance and its influence on the development of new antiseptic strategies Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: A possible source of hospital- acquired infections Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination How long do nosocomial pathogens persist on inanimate surfaces? cord-355318-qm79gz8w A retrospective analysis of influence of environmental/ air temperature and relative humidity on SARS- CoV-2 outbreak Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19, for cases reported globally up to 29th Is temperature reducing the transmission of COVID-19? High Temperature and high humidity reduce the transmission of COVID-19 Possible environmental effects on the spread of COVID-19 in China cord-355318-qm79gz8w Do latitude and ozone concentration predict COVID-2019 cases in 34 countries? cord-355318-qm79gz8w Does the pathogenesis of SARS- CoV-2 virus decrease at high- altitude? cord-355318-qm79gz8w Healthcare Reform and Poverty in Latin America Shortage of healthcare workers in developing countries- Africa Health- system reform and universal health coverage in Latin America Informal m- health: How are young people using mobile phones to bridge healthcare gaps in Sub- Saharan Africa? cord-355318-qm79gz8w The story behind the statistics Influenza seasonality in the tropics and subtropics- When to vaccinate? cord-355318-qm79gz8w Underlying causes and modeling theories Are meteorological parameters associated with acute respiratory tract Infections? cord-355318-qm79gz8w Understanding patterns of emergence and transmission Drivers of MERS- CoV transmission: What do we know? cord-355318-qm79gz8w What are the differences? cord-355318-qm79gz8w What do studies to date tell us? cord-355318-qm79gz8w Which metric of SARS- CoV-2 transmission to use as dependent variable is critical in addressing the central question,do environmental variables modulate the transmission of the virus? |
| cord-355318-qm79gz8w | Will coronavirus pandemic diminish by summer? |
| cord-023354-f2ciho6o | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023354-f2ciho6o | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023354-f2ciho6o | : will it become reality? |
| cord-023354-f2ciho6o | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023354-f2ciho6o | Against this background where should our attentions focus? |
| cord-023354-f2ciho6o | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023354-f2ciho6o | An ISO standard for blood transfusion? |
| cord-023354-f2ciho6o | Are transfusion guidelines evidence- based? |
| cord-023354-f2ciho6o | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023354-f2ciho6o | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023354-f2ciho6o | Is it a mutual decision making between physician and patient? |
| cord-023354-f2ciho6o | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023354-f2ciho6o | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023354-f2ciho6o | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023354-f2ciho6o | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023354-f2ciho6o | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023354-f2ciho6o | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023354-f2ciho6o | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023354-f2ciho6o | What is however the meaning of informed consent? |
| cord-023354-f2ciho6o | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023354-f2ciho6o | Who will hear it? |
| cord-023354-f2ciho6o | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023354-f2ciho6o | to apply which screening method? |
| cord-023354-f2ciho6o | your Trima ® can be? |
| cord-023346-8sqbqjm1 | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023346-8sqbqjm1 | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023346-8sqbqjm1 | : will it become reality? |
| cord-023346-8sqbqjm1 | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023346-8sqbqjm1 | Against this background where should our attentions focus? |
| cord-023346-8sqbqjm1 | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023346-8sqbqjm1 | An ISO standard for blood transfusion? |
| cord-023346-8sqbqjm1 | Are transfusion guidelines evidence- based? |
| cord-023346-8sqbqjm1 | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023346-8sqbqjm1 | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023346-8sqbqjm1 | Is it a mutual decision making between physician and patient? |
| cord-023346-8sqbqjm1 | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023346-8sqbqjm1 | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023346-8sqbqjm1 | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023346-8sqbqjm1 | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023346-8sqbqjm1 | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023346-8sqbqjm1 | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023346-8sqbqjm1 | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023346-8sqbqjm1 | What is however the meaning of informed consent? |
| cord-023346-8sqbqjm1 | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023346-8sqbqjm1 | Who will hear it? |
| cord-023346-8sqbqjm1 | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023346-8sqbqjm1 | to apply which screening method? |
| cord-023346-8sqbqjm1 | your Trima ® can be? |
| cord-015324-y44sfr0c | Can postnatal US diagnose significant PNU? |
| cord-015324-y44sfr0c | Crescentic Glomerulonephritis with Isolated C3 Deposits Associated to Complement Abnormalities: a New Entity? |
| cord-015324-y44sfr0c | Does ANH predict renal tract pathology in neonates? |
| cord-015324-y44sfr0c | Does sonographic quantification of the renal parenchyma allow estimation of isotopic renal function? |
| cord-015324-y44sfr0c | Drug Intake in the Background of Sudden Death? |
| cord-015324-y44sfr0c | Following Halothane Anesthesia in Young Child? |
| cord-015324-y44sfr0c | Generation of Oxidized Lipoproteins in Obstructive Nephropathy-Atherogenic or Fibrogenic? |
| cord-015324-y44sfr0c | How many neonates with ANH would need to be investigated to prevent one case of ESRF/ CRF? |
| cord-015324-y44sfr0c | How much Iron is Needed and how much is Toxic? |
| cord-015324-y44sfr0c | In order to improve long term outcome of these patients, increased awareness and an European( International?) |
| cord-015324-y44sfr0c | Is Repeated Urine Culture Essential after Antibiotic Therapy in UTI in Thai Children? |
| cord-015324-y44sfr0c | Is there a Role for Bisphosphonates in Pediatric Bone Disease? |
| cord-015324-y44sfr0c | Nephronophthisis and Joubert Syndrome: Converging on Convergent Extension? |
| cord-015324-y44sfr0c | Unilateral Renal Agenesis( URA): how Intensively do we Need to Investigate and Follow- up? |
| cord-015324-y44sfr0c | What exactly happened during arteriography in her left kidney, in order to provoke such ischemic injury, knowing that the left renal artery was not catheterized during arteriography and PTA? |
| cord-015324-y44sfr0c | What is the value of prophylactic antibiotics in infants with ANH? |
| cord-015324-y44sfr0c | When is the optimal time to screen infants postnatally? |
| cord-015324-y44sfr0c | Which Immunosuppression in Pediatric Transplantation? |
| cord-015324-y44sfr0c | Which imaging modalities are necessary to diagnose the cause of the HN? |
| cord-329890-wg23sa1u | Belief in effective HIV/ AIDS prevention"Is there an effective way of protecting yourself from AIDS"? |
| cord-329890-wg23sa1u | I ascertained perceived severity of HIV/ AIDS in terms of the respondents'subjective perception of the likelihood of death using the close- ended question"When you think about AIDS, how serious do you feel it is? |
| cord-329890-wg23sa1u | I include social constructs from the HBM and the SCT and some relevant contextual social factors, to explore the research question"What can we learn from the SARS experience about effective prevention of HIV/ AIDS"? |
| cord-329890-wg23sa1u | In the case of epidemics, competence is typically found at the community level and this brings us to the question of governance: how does a government deal with the health crisis represented by an infectious disease epidemic? |
| cord-329890-wg23sa1u | In the study of SARS, perceived susceptibility was ascertained through the question"How likely do you think it is for you to contract SARS"? |
| cord-329890-wg23sa1u | More specifically, why were the efforts to contain and prevent the spread of a new epidemic like SARS successful while it has taken 25 years so far to contain the spread of HIV/ AIDS and no effective solution is yet in sight? |
| cord-329890-wg23sa1u | Referring the respondents to the measures implemented to prevent the spread of SARS, they were asked their level of agreement( strongly agree to strongly disagree) with these statements:"People should be willing to make some personal sacrifices";"People have mostly been socially responsible";"If you did not develop symptoms of SARS after having close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days?";"If you did not develop symptoms of SARS after having non- close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days"? |
| cord-329890-wg23sa1u | Referring the respondents to the measures implemented to prevent the spread of SARS, they were asked their level of agreement( strongly agree to strongly disagree) with these statements:"People should be willing to make some personal sacrifices";"People have mostly been socially responsible";"If you did not develop symptoms of SARS after having close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days?";"If you did not develop symptoms of SARS after having non- close contact with someone diagnosed with SARS, would you agree to be quarantined for 10 days"? |
| cord-329890-wg23sa1u | The main research question is: what can we learn from the SARS experience about effective prevention of HIV/ AIDS? |
| cord-329890-wg23sa1u | The perceived severity of HIV/ AIDS was ascertained through the question"When you think about AIDS, how serious do you feel it is? |
| cord-329890-wg23sa1u | The perception of severity of SARS was measured by the question"If you have contracted SARS, what is the likelihood of survival"? |
| cord-329890-wg23sa1u | The public image of HIV/ AIDS was ascertained through one open- ended question about persons living with HIV/ AIDS:"What kind of people do you think are most likely to get AIDS"? |
| cord-329890-wg23sa1u | WHO global conference on severe acute respiratory syndrome( SARS)-where do we go from here? |
| cord-329890-wg23sa1u | What can we learn from the SARS experience about effective prevention of HIV/ AIDS? |
| cord-329890-wg23sa1u | What kind of people do you think are most likely to get HIV/ AIDS?" |
| cord-329890-wg23sa1u | When does the problem begin and when does it end and who is involved? |
| cord-329890-wg23sa1u | Would people's sense of susceptibility to these diseases and their severity contribute to that difference? |
| cord-023364-ut56gczm | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023364-ut56gczm | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023364-ut56gczm | : will it become reality? |
| cord-023364-ut56gczm | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023364-ut56gczm | Against this background where should our attentions focus? |
| cord-023364-ut56gczm | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023364-ut56gczm | An ISO standard for blood transfusion? |
| cord-023364-ut56gczm | Are transfusion guidelines evidence- based? |
| cord-023364-ut56gczm | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023364-ut56gczm | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023364-ut56gczm | Is it a mutual decision making between physician and patient? |
| cord-023364-ut56gczm | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023364-ut56gczm | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023364-ut56gczm | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023364-ut56gczm | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023364-ut56gczm | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023364-ut56gczm | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023364-ut56gczm | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023364-ut56gczm | What is however the meaning of informed consent? |
| cord-023364-ut56gczm | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023364-ut56gczm | Who will hear it? |
| cord-023364-ut56gczm | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023364-ut56gczm | to apply which screening method? |
| cord-023364-ut56gczm | your Trima ® can be? |
| cord-010092-uftc8inx | Can you confirm my genotype? cord-010092-uftc8inx Who is a blood donor recruiter?"was the topic of ABD- VII at 9- 11 March 2018. |
| cord-010092-uftc8inx | 4A- S18- 05 WHO IS SYPHILIS TESTING EXCLUDING? |
| cord-010092-uftc8inx | : IS IT TIME TO LABEL EACH UNIT WITH HB CONTENT? |
| cord-010092-uftc8inx | A donor was classified as"tired"if they responded"all the time"or"most of the time"to the question"how often do you feel that you lacked energy and strength?". |
| cord-010092-uftc8inx | ALL TOGETHER? |
| cord-010092-uftc8inx | Are we alone in the Universe? |
| cord-010092-uftc8inx | As a consequence, questions asked 30 years ago have changed: Today, molecular biologists looking at hundreds of newly discovered blood group alleles find themselves not being asked by serologists any more:"Can you confirm my serology?", but instead, pose their question to the experts for the blood group phenotype: |
| cord-010092-uftc8inx | But can we apply the metaphor as successfully into donating blood for research? |
| cord-010092-uftc8inx | Donors and Donation-Donor Adherence-are we doing the Right Thing? |
| cord-010092-uftc8inx | How can we start using this tool in unison with our existing tools to improve science and clinical practice in our respective( bio)medical fields? |
| cord-010092-uftc8inx | So is there a future for new anti- platelet agents? |
| cord-010092-uftc8inx | To evaluate self- rated health we used the well- validated single question:"How would you rate your health in general?". |
| cord-010092-uftc8inx | WHAT CAN WE LEARN FROM HOW ADVERSE EVENTS ARE DETECTED? |
| cord-010092-uftc8inx | What is the optimal balance between iron supplementation and prolongation of interdonation intervals? |
| cord-010092-uftc8inx | What then is the best approach to use? |
| cord-010092-uftc8inx | Where are we from? |
| cord-010092-uftc8inx | Where are we going? |
| cord-010092-uftc8inx | Will serologic typing be replaced by DNAbased typing? |
| cord-010092-uftc8inx | but how does this affect health? |
| cord-350571-6tapkjb6 | DI012: Wikipedia and medicines: who edits medicine articles on the English Wikipedia? |
| cord-350571-6tapkjb6 | Does a hospital formulary system impact timely medication administration and quality of inpatient care? |
| cord-350571-6tapkjb6 | From those who were treated by TMP/ SMX, following data were collected: age, gender, weight, doses, and indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | From those who were treated by TMP/ SMX, following data were collected: age, gender, weight, doses, and indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | From those who were treated by carbapenems, PIP/ TAZ or AMX AC, following data were collected: age, gender, weight, doses, indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | From those who were treated by carbapenems, PIP/ TAZ or AMX AC, following data were collected: age, gender, weight, doses, indications( probabilistic? documented? |
| cord-350571-6tapkjb6 | HP- PC015: Discharged patients: a problem for community pharmacists? |
| cord-350571-6tapkjb6 | HP- PC027: QT- prolongation in an acute psychiatric setting: fact or fiction? |
| cord-350571-6tapkjb6 | HP- PC068: Are hospital pharmaceutical staff educated on the criticality of thermosensitive drugs? |
| cord-350571-6tapkjb6 | HP- PC134: How the centralization of medicines manufacturing enable to generalize the pharmaceutical validation? |
| cord-350571-6tapkjb6 | Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression and Monte Carlo simulations: is it plausible? |
| cord-350571-6tapkjb6 | On the question''What is your general perception of the benefit of the clinical pharmacy service; for collaborating health professionals? |
| cord-350571-6tapkjb6 | Personal changes in drug regimen: dangerous for health system? |
| cord-350571-6tapkjb6 | The office of access to healthcare: how to optimize secured access to treatments? |
| cord-350571-6tapkjb6 | The open questions:''What disadvantages/ advantages have you experienced by the introduction of clinical pharmacist into multidisciplinary teams?''received 153/185 comments respectively. |
| cord-350571-6tapkjb6 | The research questions were: When comparing dicloxacillin with other antibiotics commonly used in children,( 1) is there a difference in the age of conversion from liquid to solid formulation and( 2) is there a difference in re- prescription rates on day 1 and 2 after the initial prescription? |
| cord-350571-6tapkjb6 | for the patient?''the total benefit was ranked 5.45 and 5.54 respectively( Scale from 0(''no benefit'') to 6(''beneficial to a very large extent''). |
| cord-002774-tpqsjjet | ( 2) does participation in drug treatment programs increase social capital?, and( 3) is there a significant difference among treatment modalities in affecting change in~ial capital? |
| cord-002774-tpqsjjet | ( 2) does participation in drug treatment programs increase social capital?, and( 3) is there a significant difference among treatment modalities in affecting change in~ial capital? |
| cord-002774-tpqsjjet | Die: How to Save our Children? |
| cord-002774-tpqsjjet | Findings suggest that HM have less access t? |
| cord-002774-tpqsjjet | How can we Measure this Elusive Goal? |
| cord-002774-tpqsjjet | How do AIDS mortality and fatality rates vary when related community characteristics, such as household income, ethnic mix, and geographic access to primary and ancillary HIV/ AIDS services are considered? |
| cord-002774-tpqsjjet | How has the widespread availability of HAART( after 1996) impacted AIDS outcomes at the community level? |
| cord-002774-tpqsjjet | However, as part of an ongoing study? |
| cord-002774-tpqsjjet | In June 2004, the Association of? |
| cord-002774-tpqsjjet | Moreover, there is n? basis for assessing the impact of the resultant initiatives to improve health~onditions amo~ g~o":1":1um ties settled in unplanned areas. |
| cord-002774-tpqsjjet | Nearly all participants( 97%) reported a history of contact with drug llt.lnnent services( methadone maintenance, rehabilitation clinics and judicial treatment), mental health car? |
| cord-002774-tpqsjjet | Since urban areas are more than the aggregation? |
| cord-002774-tpqsjjet | System for Homeless, HIV- infected Patients in NYC? |
| cord-002774-tpqsjjet | The increase m parnc1pat10n, the CHR mvolvement in the community, and the positive feedback from the agen? |
| cord-002774-tpqsjjet | The moot question in all the above observed development are: has the city rationally addressed it planning needs? |
| cord-002774-tpqsjjet | The principle research questions were: 1) What is the relationship between the locations of areas with concentrations of PL WA and the distribution of both primary and ancillary service providers? |
| cord-002774-tpqsjjet | The quesuon to be explore.cl 1~: If health care is available and accessible to one person, what makes it not available to all people? |
| cord-002774-tpqsjjet | The research questions were: What are the effects of homelessness on health? |
| cord-002774-tpqsjjet | Two research questions were investigated: are there spatial patterns to the events dis · tribution, and moreover, are these patterns overlapping across space? |
| cord-002774-tpqsjjet | What kind of supports are needed for homeless people to get off the street? |
| cord-002774-tpqsjjet | When the govern · ment withdrew from direct service provision as reform trends and donor advocacy suggested, how does it perform its new indirect role of managing relations with new direct health services providers in terms of regulating, enabling, and managing relations with these health services providers? |
| cord-002774-tpqsjjet | When/(calen · dar time), By 2, fisher exact and t were appliedxwhom( authors?). |
| cord-002774-tpqsjjet | Who and Why? |
| cord-002774-tpqsjjet | Why children die in Bangladesh? |
| cord-002774-tpqsjjet | _ contacts these women via? |
| cord-002774-tpqsjjet | a report of the efforts being made towards such a goal: The paper descr~ bes~ c~ se study? |
| cord-002774-tpqsjjet | and dent~ I hygiene t? |
| cord-002774-tpqsjjet | blocks, we considered a broad range of factors including evidence of homogeneity an~ heterogeneity( socmeconomic, ethnic, housing type, environmental) across blocks within and blocks ad1acent to a nei.ghborhood, and across the 36 sample neighborhoods; the potential for efficient recruit · ment of appropriate particip.ants( i.e. sufficient local pedestrian traffic); and boundaries used in reporting census data( s? |
| cord-002774-tpqsjjet | cQue tenemos para aprender de las"soluciones"que ellos mismos encuenrran a los usos problemat1cos? |
| cord-002774-tpqsjjet | dema~~a? |
| cord-002774-tpqsjjet | en estas comunidades? |
| cord-002774-tpqsjjet | t) does social capital predict parti~ ipating in treatment programs? |
| cord-002774-tpqsjjet | to all pama~~g? |
| cord-002774-tpqsjjet | ~i~ an~ s were recruited from drop in centres in 7 cities across |
| cord-002774-tpqsjjet | ~ts: In addmon to reporting process data and descriptions of the SIF users, we report on data indicating that the establishment of the SIF has been independently associated with reductions in public~': ° g~( p |
| cord-010119-t1x9gknd | Among all potential causes investigated, only the gel card lot number was associated with the number of"?"generated( table 1). |
| cord-010119-t1x9gknd | Assuming 30 seconds of technologist time per"?", we estimate that 13.6 hours were needed to resolve and update these results. |
| cord-010119-t1x9gknd | Can Texting Decrease Wastage? |
| cord-010119-t1x9gknd | Interference: More Than Just Kell? |
| cord-010119-t1x9gknd | Is Its Use Inappropriate? |
| cord-010119-t1x9gknd | Of 19,647 columns run as part of antibody screens, 1,633( 8.3%) columns generated"? |
| cord-010119-t1x9gknd | Patient 1 was a 29 yo female, C2E2c1e1, whose RBCs reacted 11 by ECHO and 31 by NEO with anti- D4, and'?' |
| cord-010119-t1x9gknd | Platelet Rich Plasma and Quality Control: Is There a Role for the Blood Bank? |
| cord-010119-t1x9gknd | Shortly after implementation, technologists reported increased time spent performing manual resolution of indeterminate( designated as"?") results. |
| cord-010119-t1x9gknd | Study Design/ Method: We analyzed allogeneic interview responses to the screening question,"In the past 12 months have you had a tattoo?" |
| cord-010119-t1x9gknd | Study Design/ Methods: With assistance from Ortho Diagnostics, analyzer archives were queried to identify the number of gel card columns used for screens, the number of columns with"?"results, and the gel card lot numbers used for testing from 1/29/2017 to 3/31/2017. |
| cord-010119-t1x9gknd | Testing Worth the Headache? |
| cord-010119-t1x9gknd | Texas Children's Hospital, 2 Baylor College of Medicine AP127 Vision Titers--Easier or Problematic? |
| cord-010119-t1x9gknd | The Future of Plasma Therapy? |
| cord-010119-t1x9gknd | The incidence of"?"and visually negative analyzer positive results is dependent on the specific lot of MTS- Gel TM cards used. |
| cord-010119-t1x9gknd | The objective of this study was to investigate the cause of"?"and apparent false positive results on VisionV R three- cell antibody screens. |
| cord-010119-t1x9gknd | Variations in Biochemical Markers of Bone Metabolism during Plateletpheresis: Impact of Socio- Demographic and Lifestyle Factors? |
| cord-010119-t1x9gknd | Were Patients Transfused after Testing? |
| cord-010119-t1x9gknd | What Is the Best Practice for Testing Residual White Blood Cells in Blood Components for Monthly Routine Quality Control? |
| cord-010119-t1x9gknd | Where We Go? |
| cord-340489-yo3cp5vs | Auf Befragen gibt er an Welche Frage ist zunächst zu stellen? |
| cord-340489-yo3cp5vs | Ist die Candidapneumonie eine häufige Erkrankung? |
| cord-340489-yo3cp5vs | Sie zunächst? |
| cord-340489-yo3cp5vs | Sprosspilzinfektionen endogen oder exogen erworben? |
| cord-340489-yo3cp5vs | Untersuchung veranlasst? |
| cord-340489-yo3cp5vs | Was empfehlen Sie dem Patienten? |
| cord-340489-yo3cp5vs | Welche sind die 3 wichtigsten Antimykotika- Substanzklassen? |
| cord-340489-yo3cp5vs | Welche therapeutischen Maßnahmen sind angezeigt? |
| cord-340489-yo3cp5vs | Werden Fadenpilzinfektionen endogen oder exogen erworben? |
| cord-340489-yo3cp5vs | Wie lautet Ihre Verdachtsdiagnose? |
| cord-340489-yo3cp5vs | Wie soll man HIV- infizierte Schwangere behandeln? |
| cord-340489-yo3cp5vs | Wie wird der Patient initial behandelt? |
| cord-340489-yo3cp5vs | Windpockenerkrankungen oder eine Gingivostomatitis herpetica behandelt werden? |
| cord-340489-yo3cp5vs | b. Welche Untersuchungen werden durchgeführt? |
| cord-340489-yo3cp5vs | c. Wie wird der Patient behandelt? |
| cord-340489-yo3cp5vs | d. Was wird dem Patienten gesagt? |
| cord-340489-yo3cp5vs | einer antiretroviralen Therapie bei HIV- Infektion? |
| cord-340489-yo3cp5vs | oder häufig gegen Fluconazol resistent? |
| cord-340489-yo3cp5vs | unteren Atemwege mit Candida species? |
| cord-340489-yo3cp5vs | unterschieden? |
| cord-340489-yo3cp5vs | werden? |
| cord-340489-yo3cp5vs | werden? |
| cord-264884-ydkigome | ,, 2005? |
| cord-264884-ydkigome | A subset of human immunodefi ciency virus type 1 long- term nonprogressors is characterized by the unique presence of ancestral sequences in the viral population Does common architecture reveal a viral lineage spanning all three domains of life? |
| cord-264884-ydkigome | Accordingly, when contemplating the amazing complexity of the P1 immunity and how it evolved, Yarmolinsky posed the question;"Could the byzantine complexity of the controls at ImmI be the outcome, not of successive host- parasite accommodations, but of competition among related phages?" |
| cord-264884-ydkigome | Also, how do we defi ne information content or integrity of a consortia? |
| cord-264884-ydkigome | Can cooperation( or consortia behavior) result from any of these models? |
| cord-264884-ydkigome | Can this be considered an example of symbiosis in the accepted sense? |
| cord-264884-ydkigome | Could the adaptation to a host- specifi c persistence- based basal life strategy provide some explanations for the evolution of the higher fi delity RNA replicase of these coronaviruses? |
| cord-264884-ydkigome | DNA Viral eukaryogenesis: was the ancestor of the nucleus a complex DNA virus? |
| cord-264884-ydkigome | Did the need and selection for a larger genome override the use of error to generate adaptability as seen in poliovirus and HIV-1? |
| cord-264884-ydkigome | Does such a distributed pattern of evolution and gene novelty also apply to the phycodnaviruses? |
| cord-264884-ydkigome | Here a virus, there a virus, everywhere the same virus? |
| cord-264884-ydkigome | How can genetic complexity be created in such a circumstance? |
| cord-264884-ydkigome | How do we defi ne such fi tness since the mixture clearly matters? |
| cord-264884-ydkigome | How does MHV attain such stable and prevalent persistence in natural population yet retain the ability to cause disease in naive populations? |
| cord-264884-ydkigome | How generally important is this poliovirus in vivo quasispecies result? |
| cord-264884-ydkigome | How important are viruses in general to evolutionary biology? |
| cord-264884-ydkigome | How is information stability and higher fi tness attained with such errors? |
| cord-264884-ydkigome | How might such selection operate in natural populations? |
| cord-264884-ydkigome | How might we explain the increased fi delity and genome size of the nidoviruses? |
| cord-264884-ydkigome | How then do we link poxvirus evolution to other more ancient DNA viruses, such as PBCV-1 which has the same DNA replication mechanism, but distinct replication proteins? |
| cord-264884-ydkigome | If so, what selective pressures might have changed this seemingly basic feature? |
| cord-264884-ydkigome | If so, why is it that in sheep a distinctly different lineage of retrovirus( enJSRV) was also selected to provide a related placental function to a another mammal with signifi cantly different placental reproductive biology? |
| cord-264884-ydkigome | If we can accept the above conclusion concerning the role for viruses in the evolution of prokaryotes, we must then ask why such a successful evolutionary strategy was not apparently maintained in eukaryotes? |
| cord-264884-ydkigome | Is there any evidence that this result with poliovirus indeed represents a general virus- host evolutionary relationship in natural settings? |
| cord-264884-ydkigome | Protein repertoire of double- stranded DNA bacteriophages Characterization of the primary immunity region of the Escherichia coli linear plasmid prophage N15 Parvovirus variation for disease: a difference with RNA viruses? |
| cord-264884-ydkigome | Was there some change in viral adaptation in which quasispecies and generation of mixtures was no longer as important for adaptation? |
| cord-264884-ydkigome | Was this ERVL colonization of relevance to the ancient co- speciation of simian foamy virus and their primate host( Switzer et al., 2005)? |
| cord-264884-ydkigome | What could be more fascinating than a green sea slug- an animal that can use light for photosynthesis? |
| cord-264884-ydkigome | What do we know about the natural biology of these viruses, which might provide some insight into this? |
| cord-264884-ydkigome | What does structure tell us about virus evolution? |
| cord-264884-ydkigome | What exactly was the relevance of HERV endogenization to human survival and adaptations? |
| cord-264884-ydkigome | What is the fi tness consequence to the colony harboring MHV relative to its uninfected neighbor? |
| cord-264884-ydkigome | What maintains the MHV fi tness of natural persistence? |
| cord-264884-ydkigome | What then is the evolutionary relationship that links all of these seemingly distinct viruses? |
| cord-264884-ydkigome | What then is the fi tness and evolutionary consequence to E. coli harboring P1? |
| cord-264884-ydkigome | What was the role for SIV in the evolution of primate MHC( Vogel et al., 1999)? |
| cord-264884-ydkigome | Why is this relationship stable? |
| cord-264884-ydkigome | Why should prokaryotes and eukaryotes differ is such a fundamental way? |
| cord-264884-ydkigome | Why? |
| cord-264884-ydkigome | Why? |
| cord-264884-ydkigome | human and chimpanzee MHC I( Watkins, 1995; Kulski et al., 1999)? |
| cord-264884-ydkigome | tailed DNA bacteriophages Do viruses form lineages across different domains of life? |